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ABSTRACT 
A cell-based biological machine is a set of sub-components consisting of living cells and cell-
instructive micro-environments that interact to perform a prescribed task. Cell types such as neurons, 
muscle cells, and endothelial cells can be programmed for sensing, information processing, actuation, 
protein expression, or transport. By combining clusters of these different cell types, complex biological 
machines can be created for specific applications in health, security, and the environment. The potential 
benefits and social implications of these systems are enormous. In health, biological machines can 
enhance tissues and organs by engineering a collection of cells to sense drug levels in the bloodstream, 
process it, and instruct secretory cells to counteract it. In security, ‘noses’ can be grown that are 
comparable or even more sensitive than that of dogs to identify explosives or toxic substances during 
airport screenings. In the environment, biological robots or organisms can be produced to swim toward an 
oil spill, degrade it into harmless byproducts, and replicate as needed. Although this may seem like the 
stuff of science fiction, many scientists and researchers believe that some or all of these ideas could 
become a reality in the near-future. 
The realization of biological machines and their sub-components will require the development of 
enabling technologies. These technologies will be critical in studying the building blocks of the biological 
machinery. An intelligent and instructive micro-environment is critical in our efforts to understand and 
design cellular systems. The cells have to thrive, communicate, and proliferate in such a micro-
environment while performing their designated functions. These ‘instructive’ and ‘designer’ 2D and 3D 
micro-environments should form the scaffolding of biological machines, and have spatially controlled 
mechanical and chemical properties to control their functionalities. Advancements in enabling 
technologies that can fabricate the desired intelligent scaffold will greatly expedite our progress in 
developing biological machines. Our central hypothesis is that by integrating 3D printing technology with 
appropriate biomaterials, we will have the capability to create spatially controlled 2D and 3D micro-
environments that have the desired permeability, mechanical stiffness, chemical properties, and number 
of cell adhesion sites. With this technology, we will be able to build simple biological machines with 
prescribed tasks. In particular, we propose building two simple biological machines with the following 
functionalities: (i) a microvascular stamp that can pattern new blood vessels, and (ii) a locomotive bio-
robot that can walk in fluid. These modules can potentially interact as sub-components for more complex 
biological machines. Please refer to the posters for detailed information and accomplishments of these 
two biological machines. 
The idea of building biological machines with living cells is an innovative approach that is being 
developed as a new scientific discipline by the NSF Science and Technology Center (STC) entitled 
Emerging Behaviors of Integrated Cellular Systems (EBICS). New technological platforms are essential 
iii 
 
to bridge molecular scale interactions with macroscale behavior of complex multi-cellular systems. Our 
work to introduce 3D printing technology as one of these platforms will not only advance our long-term 
goal of creating complex biological machines, but also significantly enhance our understanding of 
emergent biological behaviors under integrated biochemical and physical cues at the cellular, cell 
network, and cell population levels. 
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CHAPTER 1: INTRODUCTION 
1.1 MOTIVATION 
A cell-based biological machine, dubbed ‘cellular system’, is a set of sub-components 
consisting of living cells and cell-instructive micro-environments that interact to perform a 
prescribed task. Cell types such as neurons, muscle cells, and endothelial cells can be 
programmed for sensing, information processing, actuation, protein expression, or transport. By 
combining clusters of these different cell types, complex multi-cellular systems can be created 
for specific applications in health, security, and the environment. The central hypothesis in this 
dissertation is that 3D printing technology can be integrated with appropriate biomaterials to 
create spatially-controlled 2D and 3D micro-environments that have the desired permeability, 
mechanical stiffness, chemical properties, and number of cell adhesion sites. With this 
technology, we will be able to build cellular systems with prescribed tasks. In particular, we 
propose the development of miniaturized, walking bio-bots with biological actuators. 
1.2 OVERVIEW 
We summarized each chapter of the dissertation below with work achieved to date 
toward a locomotive bio-bot. Chapters 3, 4, 5, and 6 describe key developmental components in 
the creation of locomotive bio-bots, and Chapters 7 and 8 describe current work towards external 
control and scaling-up of these bio-bots. 
In Chapter 3 (“3D stereolithographic printing”), we developed a 3D printing technology, 
called stereolithography, for cell-based hydrogel applications. We examined the mechanical 
properties of the hydrogels that were fabricated, and evaluated the survival of encapsulated cells 
(fibroblasts) exposed during the fabrication process. Furthermore, we attempted to control both 
the spatial distribution of cells and bioactive molecules in distinct 3D layers by exploiting the 
capabilities of our modified ‘bottom-up’ approach in the printer. 
In Chapter 4 (“Biological actuators”), we utilized the 3D printer to fabricate ‘soft’ 
hydrogel cantilevers with tunable elastic properties. In particular, we cultured a cell sheet of 
cardiomyocytes on the backsides of the cantilevers to measure their contractile forces at varying 
stiffnesses. In addition, we evaluated how changes in cantilever stiffness affected the 
2 
 
contractility of the cardiomyocytes. The intent of these studies was to aid in the design of cell-
based biohybrid actuators for locomotion. 
In Chapter 5 (“Cell alignment on bioactuators”), we developed a simple method to align 
cells on the hydrogel cantilevers fabricated in the previous chapter. Cell organization and 
alignment has been demonstrated to increase the contractile force of cardiomyocytes. This was 
accomplished by stamping polydimethylsiloxane (PDMS) line patterns of acryl-fibronectin using 
micro-contact printing (µCP) and transferring the patterns to the surface of the hydrogels with 
the 3D printer. We evaluated pattern integrity and efficacy of fibronectin transfer from stamped 
glass to fabricated hydrogels. 
In Chapter 6 (“Locomotive bio-bots with 2D cell sheets”), we built on our earlier work of 
cell-based biohybrid actuators by incorporating it into the design of autonomous bio-bots for 
locomotion. We showed that the initial shape and degree of curvature of the bio-bot cantilever 
could be precisely defined by adjusting its thickness during fabrication. The tension generated by 
self-organizing cardiomyocytes into cell sheets on the cantilever resulted in the final curvature. 
By harnessing an asymmetric design and synchronous contraction of the cardiac cell sheet, we 
demonstrated a walking motion of the bio-bot. We then examined how altering the cantilever 
curvatures changed the surface area of contact, and hence, the friction between the bio-bot ‘legs’ 
to affect net forward movement. 
In Chapter 7 (“3D muscle strips for bio-bots”), we modified our locomotive bio-bots to 
incorporate clusters of light-activated skeletal muscle cells (C2C12-ChR2 myoblasts). To do this, 
we fabricated two-legged hydrogel constructs in a pillar/beam configuration with the 3D printer. 
The C2C12-ChR2 myoblasts were embedded in natural 3D scaffolding and cast around the 
pillars of the hydrogel constructs to form 3D muscle strips. The strips were optimized by 
evaluating a number of biological and mechanical parameters. We then assessed the 
differentiation and contractility of myotubes in these 3D muscle strips. 
In Chapter 8 (“Blood vessel patterning”), we focused on angiogenesis (new blood vessel 
formation) either for future therapeutic applications carried out by our bio-bots, or to support the 
scaling-up of 3D muscle strips, which are limited by oxygen and nutrient diffusion. We created a 
‘microvascular stamp’ with the 3D printer that released multiple angiogenic factors for new 
blood vessel growth and patterning. The stamp consisted of living cells that secreted angiogenic 
factors, an engineered hydrogel matrix that promoted cellular expression of angiogenic factors, 
3 
 
and a three-dimensional (3D) geometry that localized the angiogenic factors within the pattern. 
When the stamp was implanted on a target tissue, it created the desired pattern of new blood 
vessels based on the 3D geometry of the stamp.  
4 
 
CHAPTER 2: LITERATURE REVIEW ON BIOACTUATORS 
Nature, in order to carry out the marvelous operations in animals and plants, has 
been pleased to construct their organized bodies with a very large number of 
machines, which are of necessity made up of extremely minute parts so shaped 
and situated, such as to form a marvelous organ, the composition of which are 
usually invisible to the naked eye, without the aid of the microscope. 
-- Marcello Malpighi 
2.1 INTRODUCTION 
Nature has long been a source of wonderment and inspiration in producing complex yet 
elegant functional systems and life forms across a multitude of length scales.1 Marcello 
Malpighi, one of the greatest seventeenth-century life scientists, was one of the first to attribute 
body function to an organized series of minute ‘organic’, or biological, machines.2 The length 
scales of these biological machines span from the tiny machinery in cells that participate in 
replication (mitotic cell division) and locomotion (actin and myosin systems) to cell cluster 
interactions and formation of tissues having higher-order functionalities (or so-called ‘emergent 
properties’). In fact, the human body is a large and complex functional system – the ultimate 
biological machine.3 Traditionally, the study of these systems has been the domain of biology, 
while technological advances have been used by biologists as new tools to advance these studies. 
This has resulted in a one-way relationship between biology and engineering. However, recent 
advances in cellular and molecular biology, combined with new technologies to measure and 
manipulate cell behavior, have laid the foundation for the next frontier in biology, that of 
creating our own engineered biological machines.4 The potential benefits of a technology that 
can harness and control nature’s unique capabilities (e.g. self-organization, self-repair, and self-
replication) to either improve on it or utilize it for other purposes are enormous. 
Functional units of biological machines include sensing, information processing, 
actuation, protein expression, and transportation. These units can be combined into assemblages 
that work together seamlessly to significantly enhance or even transform our ability to 
accomplish certain tasks. Kamm et al. lists a few exemplary applications in the areas of health, 
security, and the environment that biological machines can have a significant impact.5 In health, 
cellular systems can enhance tissues and organs by engineering a collection of cells to sense drug 
levels in the bloodstream, process it, and instruct secretory cells to counteract it. In security, 
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‘noses’ can be grown that are comparable or even more sensitive than that of dogs to identify 
explosives or toxic substances during airport screenings. In the environment, biological robots or 
organisms can be produced to swim toward an oil spill, degrade it into harmless byproducts, and 
replicate as needed. Although this may seem like the stuff of science fiction, many scientists and 
researchers believe that some or all of these ideas could become a reality in the near future. 
Extensive research has been conducted in the past few years in an effort to exploit one of 
these functional units, the biological actuator (or ‘bioactuator’), at a multitude of length scales. 
While bioactuators do not surpass artificial actuators in any one aspect, there are a number of 
attractive design features that could be emulated to great advantage.6 In biomolecules, individual 
motor proteins can be combined to form multi-molecular assemblies that expand its utility to 
larger actuators compared to nanodevices. In cells and tissues, such as muscle, force can be 
graded by controlling the number of fibers that are activated in parallel, a process known as 
recruitment. This grading of force enables efficiency to be optimized over a wide range of loads 
and contraction velocities to control acceleration and force.7 A further advantage of muscle is its 
ability to convert chemical energy to mechanical work. The ‘combustion’ of sugars and fats 
using freely available oxygen provides a fuel energy density that is two orders of magnitude 
greater than that of batteries.8 Many of muscle’s advantages relative to artificial actuator 
technologies stem from nature’s ability to fabricate and control on length scales ranging from the 
molecular to the macroscopic. As fabrication technology improves and nature’s mechanisms are 
better understood, a number of muscle’s properties, including regeneration, nanostructuring, and 
direct chemical actuation, will likely become common in artificial actuators. 
This review summarizes the recent developments in the emerging field of bioactuators 
across a multitude of length scales. First, we discuss the use of biomolecules as nano-scale 
actuators, from their ex vivo assembly to their various functional uses, such as for cargo selection 
and transport. Second, we discuss the use of single and small clusters of cells to power micro-
scale devices. We will focus on both microorganisms, including bacteria, protozoa, and algae, 
and on mammalian cells, such as cardiomyocytes. Finally, we discuss the utilization of natural 
and synthetic 2D- and 3D-assembled tissues and other complex hierarchies. We are not aware of 
another review to date that catalogs the assembly, utilization, and external control of bioactuators 
across a multitude of length scales and in the context of driving new technologies. 
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2.2 BIOMOLECULAR ACTUATORS 
 Biomolecular motors are considered promising materials for constructing biological 
actuators.9 In general, biomolecular actuators are driven by the conversion of adenosine 
triphosphate (ATP) to drive their movement. These actuators can be used in nanoscale 
mechanical devices to pump fluids, open and close valves, and provide translational movement 
of cargo.10 The difficulty lies in how to integrate these sophisticated functions to do specific 
tasks. In the following section, we take a look at the current state of the field, from the ex vivo 
assembly of motor proteins, such as DNA, kinesin/microtubules, actin/myosin, and F1-ATPases, 
to the transport and external control of these nanoscale engineered systems for carrying out 
distinct functions. 
2.2.1 DNA AS A MOLECULAR MOTOR 
DNA is an attractive nanodevice because of its self-assembly properties. It has been 
shown previously that branched motifs of DNA can provide components for the assembly of 
nanoscale objects, links, and arrays.11,12 However, switchable biomolecular machines can also be 
assembled with DNA. The basic concept of DNA as a biomolecular actuator is based on the fact 
that DNA can switch between two stable conformational states. These states can be controlled 
based on the ionic composition of the medium or the presence of complementary single-stranded 
molecules. There have been several successful demonstrations that harness this ability for the 
construction of biomolecular actuators. Here, we describe several different types of motion with 
DNA machines: (1) rotation, (2) extension and folding, and (3) walking. 
To achieve a rotational motion, Seeman and colleagues assembled a switchable molecular 
machine from synthetic DNA molecules.13 The construct consisted of two rigid ‘arms’ of DNA 
that were rotated between fixed positions. The DNA arms consisted of ‘double-crossover’ (DX) 
molecules that linked to the long central DNA strand of 4.5 double-helical turns. The central 
strand had a base-paired sequence d(CG)10, called a ‘proto-Z’ sequence that switched between 
the right-handed helical B-conformation and the left-handed Z-state at high ionic strength. When 
this conformational change occurred, the two DX-stabilized strands rotated around their 
longitudinal axes and twisted about 200o relative to each other. This event was able to induce 
atomic displacements of 20-60 Å. 
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To achieve a ‘scissor-like’ extension and folding motion, Neumann and colleagues 
exploited the ability of DNA hybridization as an energy source to power a pair of ‘nano-
tweezers’ constructed from three DNA molecules.14 The DNA molecules were constructed with 
a rigid, double-stranded region and two flexible, single-stranded dangling ends. When single-
stranded DNA ‘fuel’ was added, they hybridized with the dangling ends to pull the tweezers 
closed. The mechanism of movement was a change in flexural persistence length upon 
hybridization, which altered the bending stiffness.15 Complementary strands that compete for 
hybridization of the DNA fuel were then added to allow the tweezers to open. In similar fashion, 
Yurke and colleagues constructed a ‘nano-actuator’ with two strands of DNA that hybridized 
together to form a loop-like structure.16 The structure had two rigid double-stranded arms held 
together by one short and one long single-stranded region. Upon hybridization, the DNA fuel 
pushed the arms apart into a straightened configuration. The nano-actuator was relaxed by 
adding complementary strands of the DNA fuel. 
To achieve a walking motion, Shin and Pierce developed a very simple DNA walker 
based on hybridization and branch migration.17 The walker consisted of a DNA duplex with two 
single-stranded feet. The track also consisted of a DNA duplex with branched single-stranded 
extensions as binding sites for the walker. The feet of the walker were attached to the track by 
linker molecules in the solution. One of the linker molecules was then removed by competitive 
binding to free the foot for the next binding site. This was repeated several times to move the 
walker to arbitrary locations on the track. The downsides to these DNA walkers were that they 
simply detached from the track and that their next binding sites were found diffusively. Other 
DNA walkers used gears18 or enzymes19 to facilitate unidirectional movement, but the overall 
mechanisms were similar. 
2.2.2 MICROTUBULE-DEPENDENT MOTOR PROTEINS 
Microtubules are intracellular filaments involved in many cell processes.20 They are 
involved in forming the mitotic spindle during cell division, maintaining cell structure, providing 
platforms for transport, and locomotion. The main building blocks of microtubules are - and -
tubulin, which spontaneously bind together to form heterodimers. These tubulin heterodimers 
assemble into linear protofilaments that make up the structure of microtubules. Microtubules are 
hollow tubes of 25 nm in diameter and consist of 13 protofilaments in vivo. They have polarity 
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with the plus-end at the side that the -tubulins point towards and the minus-end at the side that 
the -tubulins point towards. Microtubules provide linear substrates that motor proteins, such as 
kinesin, can move along. 
Kinesins are one class of motor proteins that use microtubules as a transport system for 
nanoscale cargo. Kinesins consist of two motor ‘head’ domains that are connected to an -helical 
neck by short, highly flexible neck linkers. The neck is connected to a linear stalk that has cargo 
binding sites at its ‘tail’. Each head has two separate binding sites: one for the microtubule and 
the other for ATP. Hydrolysis of ATP and subsequent ADP/Pi release changes the conformation 
of the microtubule-binding domain and the orientation of the neck linker that results in the 
walking motion of the kinesin. The walking motion proceeds in 8 nm steps using a ‘hand-over-
hand’ mechanism that puts one motor domain before the other. The short neck linker is important 
for guiding the direction of movement of cargo. The linear stalk is important not only for binding 
cargo, but also for regulating motor activity. Without cargo, kinesin is turned off by self-
inhibition. 
It is not a trivial task to engineer microtubule transport systems ex vivo, particularly in 
versatile geometries with intersections and complex shapes. Murphy and colleagues developed a 
microtubule motility assay by fixing microtubules onto glass substrates with glutaraldehyde, 
which also served to stabilize the polar arrangements of the microtubules.21 However, the 
movement of kinesin on the microtubules is only one dimensional, and the cargo drops off once 
the end of the filament is reached. Furthermore, kinesin only makes a few hundred steps before 
dissociating from the microtubule. Vale and colleagues demonstrated an inverted microtubule 
motility assay in vitro by immobilizing a bed of kinesin molecules on glass surfaces (Fig. 
2.1A).22 Microtubules were then perfused into the chamber and exhibited motility. Pivots around 
a single nodal point represented interaction of a microtubule with a single kinesin molecule. A 
number of track designs based on these inverted motility assays were fabricated to guide 
filaments efficiently. Tracks of kinesin were laid down on microscopic stripes of chemical 
adhesive surrounded by non-adhesive areas.23 Microtubules that crossed the chemical edge 
would ultimately fall off as they did not find kinesins on the non-adhesive areas. Microchannel 
walls were also constructed to keep microtubules on the desired path as they were forced to 
bend.24 Finally, the most efficient design that guided microtubules along a track was the 
construction of overhanging walls.25 Since microtubules can still travel in opposite directions, 
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unidirectional motion was achieved by sorting microtubules with asymmetric channel features, 
such as dead-ends26 or arrow-heads27. Microtubules that wandered into these channels were 
forced to turn around.  
For cargo selection, the molecular recognition sites of microtubules have been engineered 
to allow desired cargo to be bonded and transported. This is typically done by tagging the cargo 
with antibodies or biotinylating microtubules and coating cargo with avidin or streptavidin (Fig. 
2.1B). Polymeric and magnetic beads,28,29 gold nanoparticles,30,31 DNA,32,33 and viruses,34,35 have 
all been coupled to microtubules through these linkages. Furthermore, cargo loading zones have 
been built for large-scale transport applications.31 Passing microtubules collide with cargo, pick 
them up, and transport them into cargo-free areas (Fig. 2.1C). 
2.2.3 ACTIN-DEPENDENT MOTOR PROTEINS 
Actin is another type of cytoskeletal filament and is important in cell motility, 
cytokinesis, and cell attachment to substrates by focal adhesions.36 In many ways, they resemble 
microtubules. Actin filaments have polarity because their monomers orient with their cleft 
toward the same end of the filament (plus-to-minus). Their monomers also spiral around the axis 
of the filament with a structure similar to a double helix. They are highly dynamic and can 
polymerize and depolymerize rapidly. Like kinesin, myosin molecules are a class of motor 
proteins that bind to actin, hydrolyze ATP, and move along the filaments. They also tend to 
move toward the barbed end of actin. 
The technologically-motivated development of classical motility assays into devices for 
controlled microscale transport has not been as rapid in actomyosin systems as in the case of 
microtubule/kinesin. There are several reasons for this. The most widely available myosin is 
myosin II, which is not ‘processive’.37,38 This means that after one step (ATP hydrolysis that 
leads to a conformational change), the myosin detaches from the actin. This makes it almost 
impossible to transport cargo along actin filaments. However, there does exist variants of myosin 
that are processive (myosin V and VI),39,40 but there have not been many reports of its use as a 
biological machine. Furthermore, the stiffness of actin is much less than the stiffness of 
microtubules. As a result, the filaments are ‘floppy’ and can maneuver around microfabricated 
structures easily.41 Because of the helical structure of actin, myosin will follow a helical path 
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when actin is attached to the substrate, or actin filaments gliding along a bed of myosin will 
rotate and eventually the cargo will inhibit its movement. 
2.2.4 F1-ATPASE, A ROTARY MOTOR 
To date, F1-ATPase is probably the best understood biomolecular motor. Coupled with 
the membrane-embedded proton-conducting unit F0, it forms the H+-ATP synthase that 
reversibly couples transmembrane proton flow to ATP synthesis/hydrolysis in respiring and 
photosynthetic cells. F1-ATPase consists of a hexamer stator of alternating  and  subunits. In 
the central cavity of the hexamer is a stalk rotor made up of , , and  subunits. This -subunit 
rotates within the -subunit. 
Kinosita and colleagues first isolated and immobilized the F1 complex on a glass surface 
by linking its histidine tags with Ni2+-nitrilotriacetic acid (Ni-NTA).42 Fluorescently-labeled 
actin filaments were attached to the -subunits to visualize its rotation directly. In the presence 
of ATP, the filaments rotated for more than 100 revolutions in an anticlockwise direction, and 
the rotary torque produced more than 40 pN nm-1 under high load. Montemagno and colleagues 
combined inorganic and biological materials in a hybrid system by fabricating nickel 
nanopropellers (length 750 to 1400 nm, diameter 150 nm) that were attached to the -subunit 
of F1-ATPase through biotin-streptavidin linkages.43 The torque on the motors were 20 and 19 
pN nm-1 with a rotational velocity of 8.0 and 1.1 rps for the 750 and 1400 nm propeller, 
respectively. The F1-ATPase motors were mounted on nickel-capped SiO2 posts (height 200 nm) 
to prevent drag on the propellers due to proximity interactions with the substrate. 
A reversible on/off ‘switch’ was added to the F1-ATPase motor to control its function and 
the nanopropeller rotation. The same research group introduced a zinc-binding site to the -
subunit of the motor by site-directed mutagenesis. Rotation of the nanopropeller could then be 
inhibited in the presence of zinc because it interfered with the cyclic conformation changes that 
occurred during ATP hydrolysis. Removal of zinc by chelation restored both ATP hydrolysis and 
nanopropeller rotation.44 
2.3 BIOLOGICAL ACTUATORS WITH SINGLE CELLS OR CELL CLUSTERS 
 Unlike biomolecules, single cells and microorganisms can self-replicate and perform 
multiple functions at once, such as synthesizing organic and inorganic materials, sensing, 
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communicating, converting energy, and generating mechanical motion. They are also larger in 
size and can be used to power microdevices in ways that would exceed the limits of conventional 
microfabrication technologies. Here, we discuss a number of cell-based biological actuators, 
including bacteria, protozoa, algae, and cardiomyocytes, and describe current efforts to control 
their movements externally. 
2.3.1 BACTERIAL MICROORGANISMS 
Several research groups have exploited the motility of bacteria for bioactuation because 
of the unique advantages of flagellar motors.45 First, they offer a degree of miniaturization of a 
fully-powered actuator that has not been achieved to date. Second, the culture of bacteria is rapid 
and inexpensive. Third, bacteria draw chemical energy directly from the environment and are 
able to survive in a wide range of temperatures and pH. Finally, they are controllable en masse 
through different sensory mechanisms. 
The flagellar motors can potentially be used as pumps to control fluid flow. Berg and 
colleagues absorbed the cell bodies of Serratia marcescens swarmer cells onto flat 
polydimethylsiloxane (PDMS) surfaces to form bacterial “carpets” with freely rotating flagellar 
filaments.46 Tracer beads (1 µm diameter) near the surface of the carpet were displaced, 
revealing linear and rotational flow patterns. They also made simple “auto-mobile” chips and 
beads by similarly absorbing the swarmer cells to polystyrene beads (10 µm diameter) and 
various PDMS geometries to demonstrate translation and rotation. Breuer and colleagues used 
these bacterial carpets in microfluidic channels to pump and mix two fluid streams. Tung and 
Kim also demonstrated this with Escherichia coli.47 
In addition, bacteria can be used to translate or rotate a microdevice. Uyeda and 
colleagues fabricated silicon dioxide micro-rotors and coated them with streptavidin.48 The 
micro-rotors were released and attached to a silicon circular track functionalized with the sialic 
protein, fetuin. Biotinylated Mycoplasma mobile bacteria were introduced, binding to the micro-
rotor and gliding unidirectionally along the track. As a result, rotation of the micro-rotor was 
achieved at a rate of 2 rpm. Similarly, Aranson and colleagues harnessed the collective 
swimming of randomly moving Bacillus subtilis bacteria to directionally rotate asymmetric gears 
at 1-2 rpm.49 
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The transport of synthetic cargo can be achieved by selectively attaching the cell bodies 
of bacteria to it. Park and colleagues fabricated poly(ethylene glycol) (PEG) microbeads that 
were selectively-coated on one half of the microbeads with poly-L-lysine (PLL).50 This was 
meant to enhance the velocity and directionality of the microbeads as opposed to coating the 
entire PEG microbead. Salmonella typhimurium bacteria were mixed with the PEG microbeads 
and allowed to attach selectively to PLL-coated regions. The microbeads traveled at an average 
velocity of 0.37 µm s-1. 
Finally, bacteria can be controlled externally to enhance desired functionalities. Pappas 
and colleagues controlled a monolayer of Serratia marcescens swarmer cells with galvanotaxis 
using direct current (DC) electric fields.51 The swarmer cells were blotted on the surface of SU-8 
rectangular microstructures (100L x 50W x 5T) to form MicroBioRobots (MBRs). A star-shaped 
trajectory with 5 destination points was fed to a feedback control algorithm that used the real-
time location of the MBR and the position of the next destination to control the applied voltage 
at a frequency of 8 Hz. Kim and colleagues used phototaxis as a switch to control a 50 µm 
triangular microstructure blotted with the swarmer cells.52 After exposure of the cells with 
ultraviolet (UV) light, motility temporarily stopped until the light was removed. 
2.3.2 PROTOZOAN MICROORGANISMS 
In parallel to the bacteria work, some research groups are using complex eukaryotic 
microorganisms for bioactuation. Itoh controlled the motion of Paramecium caudatum, a 
unicellular microorganism, by changing the electrical potential gradient of the culture medium.53 
The paramedium exhibited negative galvanotaxis, and when a DC electric field was applied, the 
paramecium aligned to the electric field and started to swim toward the cathode at an applied 
electric potential grade of 0.3 V mm-1. Using an automatic motion control program, the 
paramecium was guided along a figure 8 and star-shaped course, and it was used to rotate a 1 
mm micro-impeller. 
Kim and colleagues used ‘artificial’ magnetotaxis to control the movement of 
Tetrahymena pyriformis, a ciliate protozoan, with ferromagnetic nanoparticles and an external 
time-varying magnetic field.54 Spherical iron oxide particles (50 nm diameter) were internalized 
by the protozoa and magnetized. When an electromagnet with magnetic field strength of 2 mT 
was applied, the protozoa aligned (or anti-aligned depending on the dipole) to the field. A 
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tracking algorithm was then used to guide a single protozoan through a sequence of five 
destination points. 
2.3.3 ALGAL MICROORGANISMS 
Whitesides and colleagues took it a step further by attaching cargo loads to biflagellated 
algae, Chlamydomonas reinhardtii, steering the swimming cells to a targeted location with 
phototaxis, and releasing those loads with photochemistry (Fig. 2.2).55 Specially-modified 
polystyrene beads (1 to 6 µm diameter) attached to the cells on contact. As long as the beads did 
not interfere with the flagella, the cells continued to travel at velocities between 100-200 µm s-1. 
The loaded cells were placed in a microfluidic channel with low intensity LEDs ( = 505 nm) 
embedded at both ends. Alternating LEDs were illuminated and the loaded cells swam back and 
forth with rapid phototactic responses (<1 sec). The cells could be unloaded by photochemical 
cleavage of the modified polystyrene beads. UV irradiation ( = 365 nm) of the cells released the 
loads within 18 seconds without damaging the cells. 
2.3.4 SINGLE AND CLUSTERED CARDIOMYOCYTES 
Cardiomyocytes are very promising as bioactuators because they are: (1) synchronous, 
(2) spontaneously contracting, and (3) powered by glucose as its only energy source without 
applied electrical power or stimulus.56 A single cardiomyocyte can generate at least 1 µN of 
force. The concept of bioactuators using cultured cardiomyocytes is to couple them to polymer-
based microstructures to convert chemical energy into mechanical energy to move the structures. 
Kitamori and colleagues fabricated arrays of PDMS micropillars using a replica molding 
process and coated them with fibronectin to promote cardiomyocyte attachment.57 Isolated from 
primary neonatal rat hearts, cardiomyocytes were cultured over the micropillars. About 80% of 
the pillars were coupled with cardiomyocytes that spontaneously beat at 1.4 Hz after the third 
day in culture. Contraction of the cardiomyocytes displaced the micropillars at a calculated force 
of 3.5 µN. 
Lee and colleagues fabricated arrays of PDMS microcantilevers using a sandwich 
molding process and coated them with a fibronectin/gelatin mixture.58 Cardiomyocytes were 
seeded on the microcantilevers and contractile forces caused them to deflect. Using analytical 
and numerical analysis, the contractile force of the cardiomyocytes on the microcantilevers was 
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2-5 nN µm-2. This was improved to 7-10 nN µm-2 by fabricating grooves on the microcantilevers. 
Hickman and colleagues also did this with silicon microcantilevers. 
Kim and colleagues developed a PDMS microgear using a sandwich molding process.59 
Poly(ethylene glycol) PEG microwells were patterned onto a glass substrate and the microwells 
were coated with collagen. The collagen selectively absorbed to the exposed glass. Small 
aggregates of cardiomyocytes were seeded on the microwells and had an estimated contractile 
force of 9.06 mN mm-2 (about 6 cells). The PDMS microgears were gently attached to these cell 
aggregates. However, the authors did not show directional movement of the gears by contraction 
of the cardiomyocyte aggregates. 
2.4 BIOLOGICAL ACTUATORS WITH NATURAL AND SYNTHETIC TISSUES 
 While biomolecules and unicellular microorganisms are being extensively studied as 
bioactuators, there is surprisingly little effort directed towards the creation of bioactuators with 
tissues and other complex hierarchies. Although single or small clusters of cells can drive micro-
scale structures, it is difficult to do this for higher-ordered structures. Nature provides an elegant 
solution by forming complex hierarchies of tissues using cells as building blocks. This hierarchy 
of increasing complexity is tied to an increase in functionalities. Based on active and passive 
self-organization principles, it has been demonstrated that more complex hierarchical structures 
can work as bioactuators for improved functional performance. In this last section, we focus on 
research related to mammalian-derived cardiac- and skeletal-based tissues and also the early 
development of insect-derived dorsal vessel-based tissue as bioactuators. 
2.4.1 CARDIAC MUSCLE-BASED TISSUES 
The assembly of cell sheets of cardiomyocytes can be harnessed to generate larger forces 
and be used to drive more complicated structures or fluids. One method that garnered a lot of 
attention was the use of temperature-responsive polymers functionalized with cell-adhesive 
ligands to culture cell sheets of cardiomyocytes. Okano and colleagues uniformly grafted 
poly(N-isopropylacrylamide) (PIPAAm) on polystyrene culture dishes by irradiation with an 
electron beam.60 PIPAAm is a thermo-responsive polymer that shows remarkable changes in 
swelling by changing its temperature. Above 32 oC, PIPAAm was compact and hydrophobic. 
Cells were able to adhere, grow, and form sheets on these surfaces. When the temperature was 
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lowered, PIPAAm became hydrophilic and swollen. As a result, the cell sheets detached from the 
surface of the polymer (Fig. 2.3A). The cell attachment and adherence were prevented by the 
difficulty of displacing adsorbed water molecules on highly hydrated hydrophilic surfaces. The 
advantage of this technique was that only the connection between cell adhesive proteins and the 
PIPAAm surface was broken, and the cells remain connected together as a cell sheet. Cell sheets 
of cardiomyocytes grown using this method kept their cell-cell junctions, remained synchronous, 
and could be overlaid for increased contractility.61 
While microdevices are usually powered by external energy sources, cell sheets of 
cardiomyocytes can be used to create self-actuated, wireless, and mechanochemical transducers 
that require no externally coupled energy source or stimuli. Kitamori and colleagues developed 
the first demonstration of a micropump powered by a cell sheet of cardiomyocytes.62 A square 
microchip (2 x 2 cm) consisted of four PDMS-based elements: a push-bar, a chamber layer, a 
diaphragm membrane, and a microchannel layer with two holes for fluid transfer. A cell sheet of 
cardiomyocytes was layered on top of the push-bar and diaphragm. Spherical polystyrene 
tracking particles (1 µm diameter) were dispersed in the medium, and spontaneous, oscillating 
fluid motion was observed by their movement with optical microscopy. The fluid oscillating 
frequency was 0.7 Hz with 150 µm maximum linear displacement of tracking particles. 
Directional fluid flow was demonstrated with check valves, but only flow rates of 2 nL min-1 
were achieved. The same group recently improved on their method by wrapping a sheet of 
functional primary cardiomyocytes around a hollow PDMS sphere with inlet and outlet capillary 
tubes to engineer a bio-artificial hybrid pump (Fig. 2.3B).63 The sphere is strained by the 
collective contractile motions of the attached cardiomyocyte sheet, and the fluid volume inside 
the hollow sphere chamber is reduced, producing flow into the capillary. The chamber diameter 
is millimeter-order (5 mm diameter); the capillaries are micrometer-order (200 µm inside 
diameter); the PDMS elastomer membrane is micrometer-order (250 µm thick). Oscillating fluid 
motion in the capillary was monitored by polystyrene tracking particles. The fluid oscillating 
frequency measured at 37 oC was 0.4 Hz and the maximum observed linear displacement of 
tracking particles was 70 µm. The expected flow rate was 47 nL min-1, which was an 
improvement to the previous design.  
Besides bioactuators that act like pumps to direct fluid flow, there has also been growing 
interest in creating structures that swim or walk with a sheet of cardiomyocytes. Montemagno 
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and colleagues developed a microdevice using a silicon backbone with self-assembled 
cardiomyocytes grown on a chromium/gold layer.64 They used photolithographic techniques to 
fabricate a micron-sized, self-assembled, and self-actuated walking bio-microactuator powered 
by cardiomyocyte muscular tissue. Cardiomyocytes were aligned on a patterned film of Cr/Au, 
which was attached to a thin Si beam. After the microdevice was released from the PIPAAm 
coating, muscle contractions caused the beam to break from the rest of the device. This allowed 
the structure to “walk” freely. The leg dimensions were 138 µm long, 40 µm wide, and 20 
nm/300 nm (Cr/Au) thick; the average step frequency was 1.8 Hz and its average maximum step 
size was 25 µm; the maximum speed was 38 µm/s. Park and colleagues established a swimming 
microrobot by micromolding PDMS.65 Using cardiomyocytes, cells were seeded on top of four 
conjoined cantilever beams that were grooved to influence the alignment and enhance their 
contractility relative to flat beams. An increase in force (88%) and bending (40%) was recorded, 
with an average swimming speed of 140 µm s−1.  
Parker and colleagues assembled cardiomyocytes on various PDMS thin films with 
proteins to create muscular thin films (MTFs).66 When released from thermoresponsive 
polymers, the thin films curled or twisted into 3D conformations that purportedly performed 
gripping, pumping, walking (133 µm s−1), and swimming functions (400 µm s−1). The MTFs 
generated specific forces as high as 4 mN mm-2. Recently, MTFs were used to reverse-engineer 
jellyfish-like constructs, dubbed “medusoids”, by studying the structural design, stroke 
kinematics, and fluid-solid interactions of the Aurelia aurita moon jellyfish (Fig. 2.3C).67 The 
artificial jellyfish, dubbed “medusoids”, were composed of a bilayer of living muscle tissue and 
synthetic elastomer arranged in freely moveable lobes around a central disc. Medusoid 
propulsion, like that of jellyfish, was externally-driven by electrically-paced power and recovery 
strokes that alternately contracted the body into a quasi-closed “bell” and then relaxed into the 
open lobed form. The muscle layer, comprised of anisotropic rat cardiac tissue that intrinsically 
enables spatiotemporally synchronous contraction, replicated the power stroke of the jellyfish. 
The recovery stroke, which is a consequence of elastic recoil in the jellyfish compliant matrix, 
was replicated by tuning the stiffness of the synthetic elastomer substrate. The geometry was 
further refined to allow the formation of overlapping boundary layers between lobes, thereby 
resisting flow across the lobe gaps. Qualitative and quantitative comparisons of jellyfish and 
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medusoid propulsion showed that the engineered system was able to replicate the momentum 
transport and body lengths traveled per swimming stroke of the natural system. 
2.4.2 SKELETAL MUSCLE-BASED TISSUES 
There is considerable interest in using skeletal muscle as a cell source for the bio-bots 
because of the favorable attributes not available in cardiac muscle.68 In the body, skeletal muscle 
facilitates movement by applying forces against bones and joints. The organization of the muscle 
is modular, having many longitudinally-aligned, multinucleated muscle fibers assembled 
together by connective tissue to form a densely-packed structure.69 Recruitment of these fibers 
can be finely controlled by the nervous system, which innervates individual muscle fibers at 
localized regions.7 By adjusting the number of contractile muscle fibers and the tension 
developed collectively, the nervous system can regulate graded muscle response for controlled 
movement.  
There are two current methods for engineering artificial skeletal muscle in 3D: (1) 2D-to-
3D, and (2) 3D-to-3D. The first method was developed by Dennis and Kosnik.70,71 It consisted of 
myotubes, fibroblasts, cell-secreted ECM, and synthetic tendons. The beauty of this approach 
was that it did not require a pre-existing scaffold. Briefly, PDMS was set in a culture dish, and 
absorbed with a thin layer of laminin. Synthetic tendons were fixed at opposite ends and at a 
desired distance apart. Cells of myoblasts and fibroblasts were seeded, and upon reaching 
confluence, the medium was switched from growth to differentiation. After 2-3 weeks, the 
monolayer of myotubes would detach and self-organize to form a 3D muscle strip, dubbed 
‘myooids’. Baar and colleagues later modified the method to improve the speed of myooid 
formation.72 Takayama and colleagues used wavy PDMS substrates to align the myotubes in the 
myooids.73 The second method was developed by Karlisch and colleagues,74 although many 
variations exist.75-77 It typically consisted of a pre-existing scaffold in 3D, either derived 
naturally (most common) or synthetically. Myoblasts with or without fibroblasts were embedded 
in the 3D scaffold and casted in molds. The molds were there for 3D scaffolds compacted by 
cells to retain certain shapes, such as strips and rings. 
Herr and Dennis demonstrated a swimming robot actuated by living skeletal muscle (Fig. 
2.4A).78 It was actuated by two explanted frog semitendinosus muscles and controlled by an 
embedded microcontroller with muscle stimulators. Using open loop stimulation protocols, the 
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robot performed basic swimming maneuvers such as starting, stopping, turning (400 mm radius), 
and straight-line swimming (>1/3 body lengths per second). The robot swam for a total of 4 hour 
over a 42 hour lifespan before its velocity degraded below 75% of its max. The length of the 
robot is nearly 80 cm long. 
Consequently, skeletal muscle can be used in bio-bot designs to switch locomotion on 
and off by neural signals, to regulate step stroke and pacing by altering the combined contractile 
force, and to generate a wide range of motion by localized innervation of muscle fibers. 
Recently, optical methods have been developed to depolarize or hyperpolarize neurons using 
specific wavelengths of light.79-81 This method, known as ‘optogenetics,’ combines the temporal 
and spatial precision of light pulses with cellular specificity of genetic targeting. The general 
strategy of optogenetics involves introducing a light-sensitive protein, such as channelrhodopsin-
2 (ChR2, discovered in green algae) to a specific cell type, illuminating the cells with defined 
spatiotemporal parameters, and obtaining reliable readout of the cellular behavior.82 This past 
year, the method was applied to cardiac83,84 and skeletal85,86 muscle cells to rhythmically control 
their contractions. It was also used to locally innervate specific regions of muscle tissue to 
generate movement in multiple degrees of freedom (multi-DOF). Overall, the advantage of 
optogenetics is its fast, precise, and local stimulation of cells and tissues, relative to electrical 
stimulation. Moreover, it does not require complex heterotypic cell-cell interactions that are need 
for neuromuscular (neuron-to-muscle) junctions.87,88 
2.4.3 INSECT DORSAL VESSEL-BASED TISSUES 
Research groups are also beginning to take advantage of the muscular power from the 
dorsal vessels of insects to power actuators because of their robustness between 5 and 40 oC. The 
dorsal vessel of insects is the major structural component of an insect’s circulatory system. It is a 
tube that runs longitudinally through the thorax and abdomen, along the inside of the dorsal body 
wall. In the abdomen, the dorsal vessel is called the heart, and it has valves and musculature that 
contract autonomously. Morishima and colleagues removed the dorsal vessel tissue (DVT) from 
the larvae of Lepidopteran inchworms (Ctenoplusia agnate) and fixed them between micropillars 
of a “polypod microrobot” (PMR) made out of micromolded PDMS (12.5L x 1.35W x 0.2T mm 
dimensions) (Fig. 2.4B).89 The PMR moved at 3.5 ± 0.7 µm s-1 with a contractile force of 20 µN. 
Electrical stimulation could be applied at 10 V with 20 ms durations and 50 ms delays to regulate 
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contractility and force output. In a separate study, dorsal vessel tissue of Drosophila 
melanogaster larvae were also excised and demonstrated to contract on their micropillars at 1.6 
Hz with a contractile force of 197 nN.90 
2.5 CONCLUSION 
This review highlights the recent advancements in the emerging field of bioactuators 
across a multitude of length scales, including biomolecules, cells and microorganisms, and 
tissues. Clearly, there is an emphasis on closing the feedback loop between the biological and 
engineering worlds, and to use biological systems to improve engineering ones. However, 
despite the significant progress in the last few years, there are still plenty of opportunities to 
explore and challenges to overcome. In addition, this review is limited to one functional element, 
that of actuation. There are a number of other elements to be developed, such as sensing, 
information processing, protein expression, and transport. It is the realization and utility of all of 
these functional elements, either alone or combined, that will have significant impact in health, 
security, and the environment. These bioactuators represent one key component in this grand 
vision, and future developments will depend on an integrated approach to combine them in an 
effort to perform prescribed tasks. 
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2.7 FIGURES AND CAPTIONS 
 
 
Fig. 2.1 | Molecular-level biological machines. (A) A bed of kinesin molecules coated on to 
glass substrates can be used to guide microtubules along patterned tracks or microchannels 
[Reprinted from (26)]. (B) Molecular recognition sites of microtubules have been engineered to 
allow desired cargo to be attached and transported. This is typically done by tagging the cargo 
with antibodies or biotinylating microtubules and coating cargo with avidin or streptavidin. (C) 
Cargo loading zones have been built for large-scale transport applications. Passing microtubules 
collide with cargo, pick them up, and transport them into cargo-free areas [Reprinted from (31)]. 
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Fig. 2.2 | Cellular-level biological machines. (A) Specially-modified polystyrene beads (1 to 6 
µm diameter) were attached to biflagellated algae on contact. The cells were able to transport the 
beads at velocities of 100-200 µm s-1 and could be controlled through phototactic responses 
using low intensity LEDs ( = 505 nm). (B) The cells could be unloaded by photochemical 
cleavage of the modified polystyrene beads. UV irradiation ( = 365 nm) of the cells released the 
loads within 18 seconds without damaging the cells [Reprinted from (55)]. 
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Fig. 2.3 | Tissue-level (synthetic) biological machines. (A) Cardiomyocytes can be grown on 
thermo-responsive polymers called poly(N-isopropylacrylamide) (PIPAAm) to form a 2D cell 
sheet. These sheets can be detached intact by lowering the temperature below 32 oC [Reprinted 
from (60)]. (B) The cell sheet of cardiomyocytes can be wrapped around a hollow PDMS sphere 
with inlet and outlet capillary tubes to engineer a bio-artificial hybrid pump. Oscillating fluid 
motion in the capillary was monitored by polystyrene tracking particles. The maximum observed 
linear displacement of tracking particles was 70 µm (1 to 2) [Reprinted from (63)]. (C) These 
cell sheets can also be grafted on PDMS thin films with carefully designed geometry and 
organized cardiomyocytes to mimic the swimming motion of jellyfish [Reprinted from (67)].  
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Fig. 2.4 | Tissue-level (natural) biological machines. (A) Two explanted frog semitendinosus 
muscles (M) were attached by sutures (s) to a swimming robot for actuation. The robot was 
controlled by an embedded microcontroller with muscle stimulators. Basic swimming maneuvers 
such as starting, stopping, turning (400 mm radius), and straight-line swimming (>1/3 body 
lengths per second) were demonstrated [Reprinted from (78)]. (B) The muscular power from 
dorsal vessel tissues (DVTs) of insects can also be used as actuators and are robust between 5 - 
40 oC. DVTs from the larvae of Lepidopteran inchworms (Ctenoplusia agnate) were fixed 
between micropillars of a “polypod microrobot” (PMR) made out of micromolded PDMS, which 
moved at 3.5 ± 0.7 µm s-1 with a contractile force of 20 µN. Electrical stimulation could be 
applied at 10 V with 20 ms durations and 50 ms delays to regulate contractility and force output 
[Reprinted from (90)]. 
   
29 
 
CHAPTER 3: 3D STEREOLITHOGRAPHIC PRINTING 
3.1 INTRODUCTION  
The need for in vitro 3D model systems that can substitute for specific tissues is 
becoming increasingly prevalent in applications ranging from fundamental scientific studies, 
cancer metastases, stem cell biology, drug discovery, and the replacement of organs.1 Native 
tissues are composed of heterogeneous mixtures of cell types and extracellular matrix (ECM) 
molecules that are arranged in complex 3D hierarchies and supported by an intricate network of 
blood vessels. Mimicking the spatial organization of these cells and ECM molecules is one of the 
major challenges toward developing tissue equivalents. 
Hydrogels have been of particular interest as biomaterial scaffolds in these systems 
because of their close resemblance to native tissues. They are crosslinked polymer networks that 
are highly hydrated and possess tissue-like elasticity.2,3 In particular, poly(ethylene glycol) 
(PEG) is a synthetic hydrogel that has been widely used because of its hydrophilicity, 
biocompatibility, and ability to be chemically tailored.4 Cell adhesion domains,5,6 growth 
factors,7 and hydrolytic8 and proteolytic9,10 sequences have also been incorporated into PEG 
hydrogels to guide cellular processes such as differentiation, proliferation, and migration. By 
modifying the ends with either acrylates or methacrylates, PEG hydrogels can be 
photocrosslinked in the presence of appropriate initiating agents.11,12 This type of curing offers 
spatial control over polymerization that, while increasingly popular,13–15 has not been fully 
exploited. 
Computer-aided design (CAD)-based rapid prototyping technologies have recently been 
applied as enabling tools that provide excellent spatial control over scaffold architecture.16,17 
Rapid prototyping is the process of creating complex 3D structures by repetitive deposition and 
processing of individual layers using computer-controlled devices. Usually, a blueprint is 
developed first and translated into a 3D design in a format that can be used by the rapid 
prototyping system. The design is sliced into a collection of 2D cross-sectional layers that is then 
processed into a real 3D structure using layer-by-layer deposition. By controlling the micro- and 
macro-architecture of these scaffolds, rapid prototyping technologies can potentially be used to 
create artificial vasculature to facilitate the flow of oxygen and nutrients into the construct, 
thereby increasing the potential size of the tissue.18,19 Additionally, angiogenic factors can be 
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added to the vasculature to induce the formation of new blood vessels.20 Because of their 
excellent spatial control, it is possible to create 3D structures with multi-cellular components that 
are required for complex tissue function.21–23 Furthermore, rapid prototyping technologies 
provide a means for large-scale production of reproducible tissue constructs that can be used in a 
variety of applications. 
A common issue in the vast majority of rapid prototyping technologies is the acellular 
environment in which the scaffolds are fabricated in. Because cells cannot survive these 
processing conditions, they are normally seeded on top of the scaffolds and induced to migrate 
and populate into the inner regions. In this approach, however, it is often difficult to obtain 
scaffolds that are evenly seeded with cells.24 An approach where it might be possible to entrap 
cells in the scaffolds during the fabrication process would be very advantageous because of their 
homogeneous distribution. One of the technologies that may be mild enough to encapsulate 
living cells during the fabrication process is stereolithography. 
The conventional stereolithography apparatus (SLA) uses ultraviolet (UV) light to 
selectively solidify photosensitive polymers. There are two main approaches in the SLA: (1) 
masked-based writing and (2) direct or laser writing. Photopolymerizable PEG diacrylate 
(PEGDA) hydrogels have been used to encapsulate hepatocytes for up to 7 days in masked-based 
writing methods, which employ a flood lamp to shine UV light through the openings of a mask.15 
This method requires lots of masks to create a complex structure, and it is difficult to control the 
amount of energy that the cells are being exposed to in each layer. Direct-writing approaches, 
which employ a UV laser to selectively cure the liquid polymer in a predetermined manner, have 
also been explored with hydrogels recently.25–28 However, long-term viability of cells 
encapsulated within these hydrogels has not yet been demonstrated. 
In this study, a commercially available SLA was modified to accommodate for two 
fabrication methods: (1) the ‘top-down’ approach, which employs a process similar to the 
conventional SLA, and (2) the ‘bottom-up’ approach, which allows for multiple cell types and 
material compositions to be arranged in their own layers within a structure. Laser polymerization 
characteristics of PEGDA hydrogels were examined and optimized for their utilization in the 
SLA. The swelling and mechanical properties of these hydrogels were measured as a function of 
Mw. Long-term viability, proliferation, and spreading of encapsulated NIH/3T3 cells over 14 
days were evaluated in single-layer and multi-layer 3D structures prepared from PEGDA 
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hydrogels with a range of Mw and RGDS peptide sequences. Furthermore, controlled spatial 
distribution of cells and bioactive molecules in distinct layers was achieved by exploiting the 
capabilities of the ‘bottom-up’ SLA approach. 
3.2 MATERIALS AND METHODS 
3.2.1 APPARATUS 
A stereolithography apparatus (SLA, Model 250/50, 3D Systems, Rock Hill, SC, USA) 
was used for all experiments. Modifications were made to accommodate for two types of 
fabrication processes as shown in Fig. 3.1. In the ‘top-down’ approach, the standard vat and 
platform were removed to allow for low volume materials, including those containing living 
cells. A smaller custom-made mini-platform was fabricated and screwed into an aluminum shaft 
that was clamped to the elevator of the SLA. In the ‘bottom-up’ approach, the vat was removed 
and replaced with a 35 mm diameter culture dish. The dish was placed at the center of the 
platform with an 18 mm2 cover glass bonded to the bottom to allow the cured hydrogel to 
temporarily attach to it during processing. This method was used for layering multiple cell types 
and material compositions in distinct regions of the structure. 
3.2.2 CELL CULTURE 
NIH/3T3 cells (ATCC, Manassas, VA, USA) were cultured in Dulbecco's modified 
Eagle's medium (DMEM, Sigma Aldrich, St Louis, MO, USA) containing 4.5 g L−1 glucose and 
supplemented with 10% fetal bovine serum (FBS, Sigma Aldrich, St Louis, MO, USA), 100 U 
mL−1 penicillin, and 100 µg mL−1 streptomycin (Gibco, Carlsbad, CA, USA). Cells were 
incubated in 175 cm2 flasks (Fisher Scientific, Springfield, NJ, USA) at 37 °C and 5% CO2. 
Cells grown to pre-confluency were passaged no more than 10 times using 0.25% trypsin and 
0.04% EDTA in HBSS (Gibco, Carlsbad, CA, USA). Prior to encapsulation in hydrogels, cells 
were added to the pre-polymer solution and mixed gently. For multi-cell type layering, cells were 
split into two separate suspensions and labeled with either CellTracker® CMFDA or CMTMR 
fluorescent dyes (Molecular Probes, Eugene, OR, USA). 
3.2.3 PRE-POLYMER PREPARATION 
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Poly(ethylene glycol) diacrylates (PEGDAs) of Mw 700 (Sigma Aldrich, St Louis, MO, 
USA), 3,400, 5,000, and 10,000 Da (Laysan Bio, Arab, AL, USA) were dissolved in DMEM 
without phenol red (Gibco, Carlsbad, CA, USA) to form a 40% (w/v), or 2X, pre-polymer 
solution. The photoinitiator, 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-
one (Irgacure 2959, Ciba, Tarrytown, NY, USA), was dissolved in dimethyl sulfoxide (DMSO, 
Fisher Scientific, Springfield, NJ, USA) at 50% (w/v) stock solution and added to the 2X pre-
polymer solution to form 1.0% (w/v) of photoinitiator. Medium with or without cells and 20% 
fetal bovine serum (FBS, Sigma Aldrich, St Louis, MO, USA) were added to the pre-polymer 
solution in a 1:1 volumetric ratio prior to each SLA run. The final pre-polymer solution consisted 
of 20% (w/v) PEGDA, 0.5% (w/v) photoinitiator, and 10% FBS in DMEM without phenol red. 
For studies with bioactive groups, RGDS peptide sequences (Arg-Gly-Asp-Ser, Sigma Aldrich, 
St Louis, MO, USA) were conjugated to acrylate-PEG-NHS (Mw 3500, JenKem Technology, 
Allen, TX, USA).15 Acryloyl-PEG-RGDS was added to the pre-polymer solution to make a final 
concentration of 5 mM RGDS. 
3.2.4 ENERGY DOSE CHARACTERIZATION 
0.1% (w/v) fluorescent Nile Red microparticles (0.7‐0.9 μm, Spherotech, Lake Forest, IL, 
USA) were incorporated into the pre‐polymer solution at a 1:1000 dilution. The solution was 
then pipetted into a custom‐made container with a thin cover glass on top, in contact with the 
solution. Samples were cured in the SLA by writing a cross‐hatched pattern using a range of 
laser energy doses (Eavg). The energy doses were controlled by varying the laser beam writing 
speed in the SLA software. After polymerization, the cover glass was lifted off with the 
polymerized gel layer attached. The thickness of the cured gel (Cd) was then measured using an 
inverted fluorescent microscope (IX81, Olympus, Center Valley, PA, USA) and IPLab software 
(BD Biosciences, Rockville, MD, USA). The measured thicknesses were plotted on a 
semilogarithmic graph as a function of energy dose. Using the working curve equation,  
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 (3.1) 
where Dp is the penetration depth and Ec is the critical exposure energy, Dp and Ec were 
calculated with linear regression analysis software (OriginPro 8.1, OriginLab, Northampton, 
MA, USA). 
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3.2.5 SEQUENTIAL LAYER-BY-LAYER HYDROGEL PHOTOPATTERNING 
CAD models were generated using AutoCAD 2009 (Autodesk, San Rafael, CA, USA) 
and exported to stereolithography (STL) format. The SLA software, 3D Lightyear v1.4 (3D 
Systems, Rock Hill, SC, USA), was used to slice the 3D models into a series of 2D layers from a 
user-specified thickness. The penetration depth (Dp) and critical exposure energy (Ec) 
parameters, which are constants specific to a desired pre-polymer solution, were acquired from 
energy dose characterizations and entered into the SLA software. For the ‘top-down’ fabrication 
process, the platform was immersed just below the surface of the pre-polymer solution with or 
without cells. For the ‘bottom-up’ fabrication process, the pre-polymer solution with or without 
cells was pipetted into the culture dish at the correctly characterized volume. The laser was used 
to selectively crosslink the pre-polymer solution at a precisely calculated energy dose. The 
elevator controlled by the SLA was lowered by a specified distance, and the part was recoated. 
The process was repeated until completion of the complex 3D structure. The structure was rinsed 
several times in the appropriate medium to remove uncrosslinked polymer. 
3.2.6 HYDROGEL CHARACTERIZATION 
Gel disks fabricated in the SLA were subjected to compression using a mechanical 
testing system (Insight, MTS Systems, Eden Prairie, MN, USA). The elastic modulus (E) of the 
gel was measured by compressing at a constant deformation rate of 1.0 mm s−1 at 25 °C. From 
the strain limit to the first 10%, the elastic modulus was calculated using the slope of the stress 
(σ) vs. strain (λ) curve. Assuming that the gels follow an affined network model, the shear 
modulus (S) was calculated from the slope of the σvs. −(λ − λ − 2) curve, where λ is the ratio of 
the deformed length to the undeformed length of the hydrogel.10,29 
The swelling ratios of the gels at equilibrium were determined by measuring the weight 
of the swollen gels after 24 hours in pH 7.4 buffer solutions at 37 °C and the weight of the dried 
gels. The degree of swelling (Q), defined as the reciprocal of the volume fraction of a polymer in 
a hydrogel (ν2), was calculated from the following equation, 
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 (3.2) 
where ρS was the density of water, ρP was the density of polymer , and Qm was the swelling ratio, 
the mass ratio of swelled gel to dried gel. 
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The average pore size (ξ) was calculated from the polymer volume fraction (ν2,s) and the 
unperturbed mean-square end-to-end distance of the monomer unit (ro−2) using Equations (3.3) 
and (3.4): 
   1/21/3 22,s ov r    (3.3) 
    1/2 1/22 1/2 1/22 2co
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 (3.4) 
where l is the average value of the bond length between C–C and C–O bonds in the repeatable 
unit of PEG [–O–CH2–CH2–], which is taken as 1.46 Å; Mc is the average molecular mass 
between crosslinks in the network; Mr is the molecular mass of the PEG repeating unit (44 g 
mol−1); C is the characteristic ratio for PEG, which is taken here as 4. 
3.2.7 CELL VIABILITY 
Cell viability was quantitatively measured using MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, Promega, Madison, WI, USA), a 
tetrazolium compound which, in the presence of phenazine methosulfate (PMS, Sigma Aldrich, 
St Louis, MO, USA), is reduced by living cells to yield a water-soluble formazan product. MTS 
(333 µg mL−1) and PMS (25 µM) were added to the cell-laden hydrogels in DMEM without 
phenol red in an incubator at 37 °C and 5% CO2. After incubating for 4 hours, 20% SDS (Fisher 
Scientific, Springfield, NJ, USA) in sterilized H2Odd was added to stop the reaction. The 
hydrogels were incubated at 37 °C for 15 hours to allow diffusion of formazan into the medium. 
The absorbance was measured at 490 nm using a Synergy HT microplate reader (BioTek, 
Winooski, VT, USA). Viability was qualitatively evaluated in stereomicroscopy using an MTT 
assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma Aldrich, St Louis, 
MO, USA) by incubating the cell-laden hydrogels in a 10% solution of DMEM without phenol 
red at 37 °C and 5% CO2 for 4 hours. Fluorescence microscopy using calcein AM and ethidium 
homodimer stains was also used for qualitative evaluation (Molecular Probes, Eugene, OR, 
USA). 
3.2.8 CELL SPREADING 
In order to visualize spreading, cell -laden hydrogels were examined every day by bright-
field microscopy. After 14 days, cells were fixed using 4% formaldehyde solution (Fisher 
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Scientific, Springfield, NJ, USA) overnight at room temperature. After washing several times in 
PBS, the gels were incubated in Triton X-100 (Sigma Aldrich, St Louis, MO, USA) for 20 min 
and stained with rhodamine phalloidin (Molecular Probes, Eugene, OR, USA) and 4′,6-
diamindino-2-phenylindole (DAPI, Sigma Aldrich, St Louis, MO, USA) for 30 minutes at 37 °C. 
The cells were imaged using an inverted fluorescent microscope (IX81, Olympus, Center Valley, 
PA, USA). 
3.2.9 STATISTICAL ANALYSIS 
Error bars represent standard deviation, with n=3 for all experiments. Statistical 
significance was determined using one-way ANOVA followed by Tukey's Multiple Comparison 
Test (P < 0.05). 
3.3 RESULTS 
3.3.1 CHARACTERIZATION OF HYDROGELS FOR STEREOLITHOGRAPHY 
In order to build complex 3D hydrogels in the SLA with the highest levels of accuracy, 
two constants, Dp and Ec, need to be precisely determined. The SLA software utilizes these 
constants in Equation 3.1 to calculate the energy dose (Eavg) required to cure a layer of desired 
thickness (Cd) of that material. If the layer is not cured deeply enough, it will not attach to the 
layer below it, resulting in delamination. If the layer is cured too greatly, it will distort and 
reduce part accuracy.30 In this experiment, the energy dose of the laser was varied to obtain a 
series of gels with different thicknesses. The thickness of each gel was measured by taking 
advantage of the transparent property of hydrogels and embedding fluorescent microbeads within 
each sample. These thicknesses were plotted as a function of energy dose on a semilogarithmic 
graph to obtain a linear working curve. By rearranging Equation 3.1 in linear form, it becomes 
apparent that Dp and Ec can be found by taking the slope and y‐intercept of that curve, 
respectively. 
The working curves for 20% (w/v) PEGDA with Mw 700, 3,400, and 5,000 Da are 
shown in Fig. 3.2(a). The R2 values, 0.973 for MW 700 Da, 0.999 for Mw 3,400 Da, and 0.999 
for MW 5,000 Da, indicate that the measurements fit the linear regression model extremely well. 
The average standard deviation of all the layer thickness measurements was ± 11.9 μm. The Dp 
values, 0.346, 0.258, and 0.231 mm, and Ec values, 40.89, 11.10, 7.17 mJ cm-2, for Mw 700, 
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3,400, and 5,000 Da, respectively, indicate a decreasing Dp and Ec trend with increasing Mw. To 
test whether these values were accurate, they were inputted into the SLA software, along with 
user‐specified Cd, to make a new series of gels. As an example, the measured thicknesses for 
MW 700 Da were comparable to their specified thicknesses (Fig. 3.2(b)), showing very little 
deviation. As shown in Fig. 3.2(c) and 3.2(d), complex 3D structures prepared from these 
PEGDA hydrogels were successfully fabricated following the characterization process. For the 
bottom‐up approach, a second characterization step was performed to determine the amount of 
volume required to cure a layer of specific thickness. This process is described in Fig. 3.3. 
3.3.2 SWELLING AND MECHANICAL PROPERTIES OF HYDROGELS 
The degree of swelling and the mechanical properties of laser-polymerized PEGDA 
hydrogels were investigated as a function of Mw. At the time of the study, the laser power of the 
SLA was about 15 mW and the average energy dose used to photopolymerize the gel disks was 
1600 mJ cm−2. The swelling ratios (Q) and elastic moduli (E) for 20% (w/v) PEGDA hydrogels 
with Mw 700, 3,400, 5,000, and 10,000 Da were measured and calculated from these gel disks 
(Fig. 3.4). As expected, the Q increased and the E decreased with increasing PEG Mw. The 
swelling ratios were also used to calculate the average pore size of the gel disks as a function of 
Mw (Table 3.1). The elastic moduli obtained ranged from 4.73 ± 0.46 kPa for Mw 10,000 Da to 
503 ± 57 kPa for Mw 700 Da, which covers quite an array of native tissues having similar 
moduli.31 Stereomicroscopic images of PEG hydrogels after 24 hour incubation in cell culture 
medium showed an increase in swelling capacity with increasing Mw (Fig. 3.5).  
3.3.3 CELL ENCAPSULATION 
Cell encapsulation was initially accomplished by using the ‘top-down’ fabrication 
process, which held all the pre-polymer solution in a stationary container. A 2 mm thick complex 
3D structure, which was composed of 20 layers (100 µm per layer), was fabricated using this 
approach (Fig. 3.6(a)). The distribution of cells embedded within these structures was examined 
using MTT stain and stereomicroscopy (Fig. 3.6(b)). The purple formazan crystals produced by 
the viable cells appeared to have an inhomogeneous distribution with more cells being embedded 
at the bottom of the structure than at the top of it. This was caused by cells that settled toward the 
bottom of the container due to gravity. To prevent this, the ‘top-down’ approach was altered, and 
the same complex 3D structure was fabricated using the ‘bottom-up’ fabrication process. In this 
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approach, the pre-polymer solution containing cells was pipetted into the container one layer at a 
time. The cells did not have time to settle to the bottom before the layer was cured. As a result, a 
uniform distribution of cells was achieved throughout the hydrogel, which was evident by the 
homogeneous distribution of purple formazan crystals (Fig. 3.6(c)). To quantitatively evaluate 
this, an intensity profile at different regions of the hydrogel was examined and confirmed to be 
uniform (Fig. 3.6(d)). 
3.3.4 CELL VIABILITY 
Two methods were used to evaluate long-term cell viability in the SLA: (1) encapsulation 
in single-layer 3D hydrogels (1 total layer, 1 mm thick per layer), and (2) encapsulation in multi-
layer 3D hydrogels (10 total layers, 100 µm thick per layer). 
In the first study, NIH/3T3 cells at a density of 2.0 × 106 cells mL−1 were encapsulated in 
20% PEGDA hydrogels patterned in single-layer disks with dimensions of 1 mm thickness and 5 
mm diameter. These disks were cultured over a period of 14 days. To achieve 1 mm thickness, 
the average energy dose of the laser during polymerization was 1,000 mJ cm−2. Cell viability was 
quantitatively evaluated using MTS assays. The optical density (OD) measurements obtained 
from these assays on 1, 4, 7, and 14 days were converted to relative cell viability (%) by 
normalizing to 0 day (Fig. 3.7). 
Cells encapsulated in PEGDA hydrogels with Mw 700 Da survived the initial processing 
conditions of the SLA , but died within 24 hours of culturing. This was seen with and without 5 
mM RGDS functionalization. By increasing the Mw to 3,400 Da, cells survived both the 
processing and culturing conditions. Viability remained statistically constant through 4 days. 
Subsequently, there was a decrease in viability to 65.10 ± 9.81% after 7 days and to 47.46 ± 
15.39% after 14 days. Adhesive RGDS peptide sequences at 5 mM concentration were 
chemically linked to PEGDA hydrogels with Mw 3,400 Da to test for any improvement in cell 
viability and proliferation. This resulted in a 1.6-fold increase in cell numbers after 24 hours, 
which was maintained over 7 days. The effect of an even greater Mw on cell viability was also 
evaluated. Cells encapsulated in PEGDA hydrogels with Mw 5,000 Da followed the same trend 
as that of Mw 3400 Da. Except for an unsustained rise in metabolic activity after 24 hours, the 
cell viability was relatively steady through 7 days, followed by a decrease in viability to 60.00 ± 
0.2% viability after 14 days. This was an improvement over the 14 day viability of PEGDA 
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hydrogels with Mw 3,400 Da (47.46 ± 15.39%). When 5 mM RGDS was chemically linked to 
PEGDA hydrogels with Mw 5,000 Da, there was a 1.4-fold increase in cell numbers after 24 
hours, which was maintained over 7 days. A significant increase in viability was seen after 14 
days for Mw 3,400 and 5,000 Da with RGDS peptide sequences due to high cell spreading, 
proliferation, and network formation on the exterior of the gels. Cell viability was also related to 
average pore size in Fig. 3.8. The relative cell viability and proliferation generally increased with 
increasing average pore size. 
Since cell viability in single-layer disks may not be truly representative of viability in 
complex 3D structures, the second study evaluated cells encapsulated in multi-layer 3D 
hydrogels over 14 days. RGDS peptide sequences at 5 mM concentration were chemically linked 
to PEGDA with Mw 5,000 Da for this study. According to Fig. 3.9(a), the cell numbers were 
increased 1.7-fold after 24 hours, which was maintained through 7 days. By the end of 14 days, 
46.44 ± 19.56% of the cells were viable. Distribution of cells in single-layer and multi-layer 
PEGDA Mw 5,000 Da hydrogels can be seen from stereomicroscopic images of hydrogels 
subjected to MTT staining (Fig. 3.9(b) and (c)). Although there was a decrease in cell numbers 
after 14 days compared to 7 days, the distribution of the cells was homogeneous at both time 
points. 
Qualitative LIVE/DEAD cell viability stain was performed during the same time points 
as the MTS assays. Representative images (Fig. 3.10) showed an increase in the dead cells over 
later time points, which supported the results of the more quantitative MTS assays. Nevertheless, 
in all cases except PEGDA Mw 700 Da, the number of live cells was much more abundant than 
the number of dead ones. 
3.3.5 CELL SPREADING 
NIH/3T3 cells encapsulated within multi-layer PEGDA hydrogels with Mw 5,000 Da 
were examined for cell spreading and attachment. Spreading, which involves the active processes 
of actin polymerization and myosin contraction,32 is a sign of cell viability and function. Viable 
cells did not spread in hydrogels without adhesive RGDS peptide sequences. Cells in multi-layer 
PEGDA hydrogels with RGDS-linked groups (5 mM) were examined in bright-field microscopy 
and fluorescence microscopy after rhodamine phalloidin (cytoskeleton) and DAPI (nuclei) 
staining (Fig. 3.11). Cell spreading was clearly seen within hours of incubation and continued 
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through 14 days. Some of these cells formed 3D connections with other cells in different layers, 
suggesting network formation. 
3.3.6 MULTI-CELL TYPE LAYERING 
The concept of incorporating multiple cell types within hydrogels in a spatially 
predetermined manner was demonstrated by using NIH/3T3 cells. These cells were separated 
into two suspensions: one labeled with CellTracker® CMFDA (green) fluorescent dye, and the 
other labeled with CellTracker® CMTMR (red) fluorescent dye. Fig. 3.12 illustrates top- and 
side-view fluorescent images of a complex 3D structure with overhangs containing two 
differently labeled cell suspensions. The thickness of each set of layers was uniform and showed 
minimal mixing. Quantitative results confirmed the distribution of these cells in uniformly 
distinct layers.  
3.4 DISCUSSION 
Functional 3D tissues that are designed for individual patients using multi-cellular and 
multi-material compositions in an automated, high-throughput device will soon be the next 
generation in tissue engineering. The combination of process-optimized rapid prototyping 
technologies, such as stereolithography, with novel biomaterials may be one possible path 
toward this goal. 
Cooke et al.25 reported the use of stereolithography for tissue engineering applications by 
designing biodegradable scaffolds prepared from poly(propylene fumarate) (PPF) and diethyl 
fumarate (DEF). While this study demonstrated the capability of using photopolymerizable 
biomaterials in the SLA, cells were not seeded in or on any of these fabricated PPF/DEF 
structures. Subsequently, Dhariwala et al.26 encapsulated Chinese hamster ovary (CHO) cells in 
poly(ethylene oxide) (PEO) and poly(ethylene glycol) dimethacrylate (PEGDM) hydrogels. A 
fluorescence-based LIVE/DEAD assay was used to evaluate cells immediately after 
polymerization in the SLA, but the results lacked any substantive evidence supporting sustained 
viability or proliferation. Moreover, the cells were only encapsulated within single layer 
structures. This study also reported hydrogel samples with an average elastic modulus of 1.116 ± 
0.21 kPa, which limits its applications to very soft tissue types.31 In contrast, our own studies 
using 20% PEGDA hydrogels with Mw from 700 to 10,000 Da had elastic moduli that varied 
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from 4.73 ± 0.46 kPa to 503 ± 57 kPa. These values are more suitable for a wider range of 
tissues.31 Recently, Arcaute et al.27 demonstrated complex 3D hydrogels in the SLA using low-
swelling PEGDM hydrogels with Mw 1,000 Da. Their viability studies were performed with 
human dermal fibroblasts (HDFs) encapsulated in gel disks for up to 24 hours. Similar to the 
previous study, these results were short-term and made with single-layers. 
In this study, we demonstrated that NIH/3T3 cells encapsulated in both single-layer and 
multi-layer 3D hydrogels retained long-term viability, proliferation, and spreading over 14 days 
using the SLA. This is a significant step toward the development of rapid prototyping 
technologies for cell encapsulation applications. The SLA is advantageous because it allows for 
precise internal pore structures and defined macroscopic shapes, as well as the potential to 
control the spatial organization of multi-cellular and material compositions within the complex 
3D structure. Studies in literature have investigated the behavior of various multi-cellular 
cultures within hydrogels. Although the cultures were shown to enhance desired cellular 
functions and behaviors, there was no real control over the spatial distribution of these cells.33,34 
Other studies have shown more controlled distribution, but with micropatterned 2D surfaces.35,36 
Since native tissues are composed of more than one cell type, the ‘bottom-up’ SLA fabrication 
process described in our study can be used to study these multi-cellular cultures in defined 3D 
patterns. 
The ‘bottom-up’ approach in the SLA also allowed us to use a variety of material 
compositions within the same structure for engineering the physical properties of the 3D matrix. 
It is now well-established that intrinsic mechanical properties of substrates have significant 
influences on the behavior of both somatic and stem cells in terms of development, 
differentiation, disease, and regeneration.31,37 The promising results from these 2D experiments 
have given rise to new studies attempting to spatially control the physical properties in 3D. In a 
recent study, this was accomplished by sequential cross-linking of hyaluronic acid (HA) 
hydrogels using addition reactions and mask-based photoinitiated crosslinking. The result was a 
difference in mechanical properties stemming from variations in the crosslinking densities.38 
When a similar setup was used for stem cell encapsulation, cells with different morphologies on 
different regions of the hydrogel were obtained.39 The fabrication process in our study may offer 
such control not only by varying the crosslinking density in different regions of the same 
material, but also by enabling the use of various types and concentrations of materials. 
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All PEGDA hydrogels tested in this study, except for Mw 700 Da, showed long-term 
viability for cells encapsulated over 14 days. The reason for poor viability in PEGDA with Mw 
700 Da was most likely due to low degrees of swelling caused by small pore sizes. This 
restricted the diffusion of oxygen and nutrients into the inner core of the hydrogels. When 
PEGDA was functionalized with 5 mM RGDS at higher Mw, cells were not only viable, but they 
also spread and proliferated. Proliferation was observed through 7 days, followed by a decrease 
in the cell numbers after 14 days. A similar result was obtained when smooth muscle cells were 
encapsulated in RGDS-functionalized PEGDA hydrogels with Mw 3400 Da using bulk UV 
exposure.40 Although there was a severe decrease in the initial cell viability after 24 hours, the 
same increasing trend in cell numbers were observed after 7 days. The initial decrease in their 
viability could have been due to cell damage caused by bulk polymerization conditions, such as 
the photoinitiator concentration, UV exposure time, and presence of organic solvents. The elastic 
modulus of the hydrogels produced from 20% PEGDA with Mw 3400 Da in the study by Peyton 
et al.40 was approximately 400 kPa, while the modulus in our study was approximately 17 kPa. 
This discrepancy could be due to variations in the polymerization process or even the method of 
measurement. The advantage of the SLA process is its precise control over the average energy 
dose, which can limit the adverse effects to cells. 
In general, PEG hydrogels have many attractive properties, including excellent 
biocompatibility and hydrophilicity. Even though PEG is an inert molecule, cell -surface 
recognition sites can be chemically tailored to it in a controllable manner.40 During SLA 
fabrication of multi-layer 3D hydrogels, the first and last layers of the 10-layer structure were 
made without RGDS, while the middle layers were made with RGDS. While this was done to 
prevent cell growth at the exterior of the hydrogels, it also demonstrates the ability to spatially 
organize bioactive molecules in multi-layer 3D structures. The addition of these adhesive 
molecules or other types of molecules regulating cell function into distinct layers can easily be 
achieved by using the ‘bottom-up’ fabrication method in the SLA. 
It should be noted that the PEG hydrogels used in this study were not biodegradable, 
which could have prevented further cell proliferation and extensive network formation. This may 
have been the reason for the decrease in cell viability after 14 days. Future studies can 
incorporate biodegradable matrix molecules or sequences within the hydrogels during the SLA 
process. Another reason for the decrease in cell viability after 14 days may have been the 
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constraints caused by low nutrient and waste transport in the hydrogels. Although PEG hydrogels 
used in our studies had high enough porosity for the diffusion of small molecules up to 22 kDa,11 
including oxygen and glucose, MTT staining after 14 days suggested problems caused by 
diffusion because there were more cells located at the periphery than at the middle of the 
hydrogels. This effect was only seen in long-term cultures. A possible explanation may be the 
diffusion restrictions caused by larger molecules like ECM components secreted by the cells 
building up around the cells that were secreting them, thereby causing a decrease in the diffusion 
of smaller Mw compounds. These issues can be overcome by providing degradable units in the 
PEG hydrogels. There are different methods reported in literature to render PEG degradable by 
including short peptides in its backbone for enzymatic cleavage by the encapsulated cells41 or by 
making a copolymer with a hydrolytically degradable polymer like PLA8. A recent study 
supported this discussion by showing that SMCs and mesenchymal stem cells encapsulated in 
enzymatically degradable PEG possessed high cell spreading, network formation, and expression 
of matrix metalloproteinases for up to 21 days in culture.41 Therefore, providing degradability in 
the hydrogels and combining that with our current technology could be the next step forward. 
3.5 CONCLUSION 
A custom-modified SLA was used to fabricate complex 3D structures from 
photopolymerizable PEG hydrogels to accommodate for two fabrication methods: (1) the ‘top-
down’ approach, which employs a process similar to the conventional SLA, and (2) the ‘bottom-
up’ approach, which allows for multiple types of cells and polymers to be arranged in their own 
layers within a structure. NIH/3T3 cells were successfully encapsulated within these structures, 
and by increasing the Mw of PEG and covalent linkage of bioactive RGDS groups, the cell 
viability, proliferation, and spreading were greatly improved over 14 days. The variation in PEG 
Mw also established the ability to tune the elasticity of the hydrogel to specific tissue types 
without sacrificing viability. The SLA is an enabling tool with excellent spatial control that can 
potentially be used to recapitulate the complex 3D hierarchy of the tissue microenvironment. 
This may have significant impact on driving the development of in vitro 3D models toward 
broader applications, including those in tissue engineering, cell mechanics, and bio-hybrid 
artificial devices and machines. 
3.6 ACKNOWLEDGMENTS 
43 
 
This project was made possible by a cooperative agreement that was awarded and 
administered by the US Army Medical Research & Materiel Command (USAMRMC) and the 
Telemedicine & Advanced Technology Research Center (TATRC), under Contract #: 
W81XWH0810701. 
3.7 REFERENCES 
1. E. J. Suuronen, H. Sheardown, K. D. Newman, C. R. McLaughlin and M. Griffith, Building 
in vitro models of organs, Int. Rev. Cytol., 2005, 244, 137–173.  
2. J. L. Drury and D. J. Mooney, Hydrogels for tissue engineering: scaffold design variables 
and applications, Biomaterials, 2003, 24(24), 4337–4351.  
3. B. V. Slaughter, S. S. Khurshid, O. Z. Fisher, A. Khademhosseini and N. A. Peppas, 
Hydrogels in regenerative medicine, Adv. Mater., 2009, 21, 3307–3329.  
4. C. C. Lin and K. S. Anseth, PEG hydrogels for the controlled release of biomolecules in 
regenerative medicine, Pharm. Res., 2009, 26(3), 631–643.  
5. D. L. Hern and J. A. Hubbell, Incorporation of adhesion peptides into nonadhesive hydrogels 
useful for tissue resurfacing, J. Biomed. Mater. Res., 1998, 39, 266–276.  
6. B. K. Mann, A. S. Gobin, A. T. Tsai, R. H. Schmedlen and J. L. West, Smooth muscle cell 
growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable 
domains: synthetic ECM analogs for tissue engineering, Biomaterials, 2001, 22, 3045–3051.  
7. E. A. Phelps, N. Landázur, P. M. Thule, R. Taylor and A. J. García, Bioartificial matrices for 
therapeutic vascularization, Proc. Natl. Acad. Sci. U. S. A., 2010, 107(8), 3323–3328. 
8. T. Metters, K. S. Anseth and C. N. Bowman, Fundamental studies of a novel, biodegradable 
PEG-b-PLA hydrogel, Polymer, 2000, 41, 3993–4004.  
9. J. L. West and J. A. Hubbell, Polymeric biomaterials with degradation sites for proteases 
involved in cell migration, Macromolecules, 1999, 32, 241–244.  
10. G. P. Raeber, M. P. Lutolf and J. A. Hubbell, Molecularly engineered PEG hydrogels: a 
novel model system for proteolytically mediated cell migration, Biophys. J., 2005, 89, 1374–
1388.  
11. G. M. Cruise, D. S. Scharp and J. A. Hubbell, Characterization of permeability and network 
structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels, 
Biomaterials, 1998, 19(14), 1287–1294.  
12. J. L. Ifkovits and J. A. Burdick, Review: photopolymerizable and degradable biomaterials for 
tissue engineering applications, Tissue Eng., 2007, 13(10), 2369–2385.  
44 
 
13. Y. Du, E. Lo, S. Ali and A. Khademhosseini, Directed assembly of cell-laden microgels for 
fabrication of 3D tissue constructs, Proc. Natl. Acad. Sci. U. S. A., 2008, 105(28), 9522–
9527.  
14. M. S. Hahn, J. S. Miller and J. L. West, Three-dimensional biochemical and biomechanical 
patterning of hydrogels for guiding cell behavior, Adv. Mater., 2006, 18, 2679–2684.  
15. V. L. Tsang, A. A. Chen, L. M. Cho, K. D. Jadin, R. L. Sah and S. DeLong, et al., 
Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels, FASEB 
J., 2007, 21(3), 790–801.  
16. V. L. Tsang and S. N. Bhatia, Fabrication of three-dimensional tissues, Adv. Biochem. 
Eng./Biotechnol., 2006, 103, 189–205.  
17. S. M. Peltola, F. P. Melchels, D. W. Grijpma and M. Kellomäki, A review of rapid 
prototyping techniques for tissue engineering purposes, Ann. Med., 2008, 40(4), 268–280.  
18. J. J. Pancrazio, F. Wang and C. A. Kelley, Enabling tools for tissue engineering, Biosens. 
Bioelectron., 2007, 22(12), 2803–2811.  
19. M. Rücker, M. W. Laschke, D. Junker, C. Carvalho, F. Tavassol and R. Mülhaupt, et al., 
Vascularization and biocompatibility of scaffolds consisting of different calcium phosphate 
compounds, J. Biomed. Mater. Res., Part A, 2008, 86a(4), 1002–1011.  
20. R. Yao, R. J. Zhang, Y. N. Yan and X. H. Wang, In vitro angiogenesis of 3D tissue 
engineered adipose tissue, J. Bioact. Compat. Polym., 2009, 24(1), 5–24.  
21. P. Yang, C. Wang, Z. Shi, X. Huang, X. Dang and S. Xu, et al., Prefabrication of 
vascularized porous three-dimensional scaffold induced from rhVEGF(165): a preliminary 
study in rats, Cells Tissues Organs, 2009, 189(5), 327–337.  
22. E. A. Silva and D. J. Mooney, Effects of VEGF temporal and spatial presentation on 
angiogenesis, Biomaterials, 2010, 31(6), 1235–1241.  
23. K. Kyriakidou, G. Lucarini, A. Zizzi, E. Salvolini, M. M. Belmonte and F. Mollica, et al., 
Dynamic co-seeding of osteoblast and endothelial cells on 3D polycaprolactone scaffolds for 
enhanced bone tissue engineering, J. Bioact. Compat. Polym., 2008, 23(3), 227–243.  
24. K. F. Leong, C. K. Chua, N. Sudarmadji and W. Y. Yeong, Engineering functionally graded 
tissue engineering scaffolds, J. Mech. Behav. Biomed. Mater., 2008, 1(2), 140–152.  
25. M. N. Cooke, J. P. Fisher, D. Dean, C. Rimnac and A. G. Mikos, Use of stereolithography to 
manufacture critical-sized 3D biodegradable scaffolds for bone ingrowth, J. Biomed. Mater. 
Res., 2003, 64b(2), 65–69.  
26. B. Dhariwala, E. Hunt and T. Boland, Rapid prototyping of tissue-engineering constructs, 
using photopolymerizable hydrogels and stereolithography, Tissue Eng., 2004, 10(9/10), 
1316–1322.  
45 
 
27. K. Arcaute, B. K. Mann and R. B. Wicker, Stereolithography of three-dimensional bioactive 
poly(ethylene glycol) constructs with encapsulated cells, Ann. Biomed. Eng., 2006, 34(9), 
1429–1441.  
28. G. Mapili, Y. Lu, S. Chen and K. Roy, Laser-layered microfabrication of spatially patterned 
functionalized tissue-engineering scaffolds, J. Biomed. Mater. Res., Part B, 2005, 75(2), 
414–424.  
29. C. Chu, B. W. Schaefer, R. J. DeVolder and H. J. Kong, Quantitative analysis of the cross-
linked structure of microgels using fluorescent probes, Polymer, 2009, 50, 5288–5292.  
30. D. E. Discher, P. Janmey and Y. L. Wang, Tissue cells feel and respond to the stiffness of 
their substrate, Science, 2005, 310(5751), 1139–1143.  
31. H. Nguyen, J. Richter, P. F. Jacobs, On Windowpanes and Christmas Trees: Diagnostic 
Techniques for Improved Part Accuracy, in Proc. 1st Eur. Conf. Rapid Prototyping, ed. P. M. 
Dickens, University of Nottingham, Nottingham, 1992, pp. 133–161. 
32. J. McGrath, Cell spreading: the power to simplify, Curr. Biol., 2007, 17(10), R357–R358.  
33. H. N. Yang, J. S. Park, K. Na, D. G. Woo, Y. D. Kwon and K. H. Park, The use of green 
fluorescence gene (GFP)-modified rabbit mesenchymal stem cells (rMSCs) co-cultured with 
chondrocytes in hydrogel constructs to reveal the chondrogenesis of MSCs, Biomaterials, 
2009, 30(31), 6374–6385.  
34. X. T. Mo, S. C. Guo, H. Q. Xie, L. Deng, W. Zhi and Z. Xiang, et al., Variations in the ratios 
of co-cultured mesenchymal stem cells and chondrocytes regulate the expression of 
cartilaginous and osseous phenotype in alginate constructs, Bone, 2009, 45(1), 42–51.  
35. S. A. Lee, S. E. Chung, W. Park, S. H. Lee and S. Kwon, Three-dimensional fabrication of 
heterogeneous microstructures using soft membrane deformation and optofluidic maskless 
lithography, Lab Chip, 2009, 9(12), 1670–1675.  
36. J. Fukuda, A. Khademhosseini, Y. Yeo, X. Yang, J. Yeh and G. Eng, et al., Micromolding of 
photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures, Biomaterials, 
2006, 27(30), 5259–5267. 
37. A. J. Engler, S. Sen, H. L. Sweeney and D. E. Discher, Matrix elasticity directs stem cell 
lineage specification, Cell, 2006, 126(4), 677–689.  
38. S. Khetan, J. S. Katz and J. A. Burdick, Sequential crosslinking to control cellular spreading 
in 3-dimensional hydrogels, Soft Matter, 2009, 5, 1601–1606.  
39. R. A. Marklein and J. A. Burdick, Spatially controlled hydrogel mechanics to modulate stem 
cell interactions, Soft Matter, 2010, 6, 136–143.  
40. S. R. Peyton, C. B. Raub, V. P. Keschrumrus and A. J. Putnam, The use of poly(ethylene 
glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth 
muscle cells, Biomaterials, 2006, 27(28), 4881–4893.  
46 
 
41. C. Adelöw, T. Segura, J. A. Hubbell and P. Frey, The effect of enzymatically degradable 
poly(ethylene glycol) hydrogels on smooth muscle cell phenotype, Biomaterials, 2008, 29(3), 
314–326. 
  
47 
 
3.8 FIGURES AND CAPTIONS 
 
 
Fig. 3.1 | A schematic representation of the SLA modifications. (a) In the top-down approach, 
the layout consists of a platform immersed just below the surface of a large tank of pre-polymer 
solution. After the layer is photopolymerized, the platform is lowered a specified distance to 
recoat the part with a new layer. (b) In the bottoms-up approach, the pre-polymer solution is 
pipetted into the container one layer at a time from the bottom to the top. This setup was 
modified especially for cell encapsulation applications, which required: (1) reduction in total 
volume of photopolymer in use, and (2) removal of photopolymer from static conditions that 
cause cells to settle. 
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Fig. 3.2 | Fabrication of complex 3D hydrogels in the SLA. (a) Characterization of the laser 
energy dose required to cure 20% PEGDA hydrogels with MW 700, 3,400, and 5,000 Da. (b) 
Example test of Dp and Ec parameters found in (a) for MW 700 Da. (c and d) CAD drawings and 
actual images of complex 3D hydrogels prepared from MW 700 Da and fabricated in the 
bottoms-up SLA modification. All experiments used 0.5% photoinitiator concentration. Scale 
bars are 1 mm. 
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Fig. 3.3 | Volume deposition characterization. For all multi-layer experiments utilizing the 
bottoms-up approach, the thickness of each layer was, on average, 100 μm. In order to do this, 
the volume had to be calibrated precisely for each layer due to surface tension between the walls 
of the container and the pre-polymer solution. 1 X 2 mm blocks were built in the SLA with 
embedded fluorescent microbeads. Each block had up to 20 layers. The thickness of each layer 
was measured by tipping the block on its side and visualizing in fluorescence microscopy. 
ImageJ analysis software was used to determine the thickness. The volume was then adjusted 
until the average of all layers reached 100 μm. All values are mean ± standard deviation of n = 
10. 
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Fig. 3.4 | Mechanical properties and swelling of hydrogels. The elastic moduli (E, left axis) 
and swelling ratios (Q, right axis) were measured and calculated for 20% PEGDA hydrogels as a 
function of MW (700, 3,400, 5,000, and 10,000 Da). All experiments used 0.5% photoinitiator 
concentration. 
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Fig. 3.5 | Swelling of hydrogels as a function of Mw. 20% PEGDA hydrogels with MW (a) 
700, (b) 3,400, (c) 5,000, and (d) 10,000 Da were used to make disks with a diameter of 5 mm in 
the SLA. The gel disks were incubated in culture medium for 24 hours at 37oC before imaging in 
the stereomicroscope. The diameter of the gel disks increased as a function of increasing MW. 
Scale bars are 1 mm. 
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Fig. 3.6 | Encapsulation of NIH/3T3 cells in hydrogels. (a) Fabrication of a 2 mm thick 
complex 3D structure composed of 20 layers (with CAD images). Two approaches were used to 
encapsulate 10 x 106 cells/mL: (b) top-down and (c) bottoms-up SLA modifications. Cells were 
immediately stained with MTT (over 4 hours) for visualization. In the top-down approach, cells 
settled to the bottom of the container and did not encapsulate well. In the bottoms-up approach, 
cells and pre-polymer were added before polymerization of each layer, which led to 
homogeneous and high cell densities. (d) Intensity measurements of an MTT stain quantitatively 
showed homogeneity throughout the structure immediately after encapsulation. Scale bars are 1 
mm. 
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Fig. 3.7 | NIH/3T3 cell viability over 14 days in single-layer approach. The Mw of PEGDA 
hydrogels were varied using 700, 3,400, and 5,000 ± RGDS groups. OD (490 nm) values 
quantified by MTS assays were normalized to 0 day. All values are mean ± standard deviation of 
n = 3. (*) denotes statistical difference compared to 0 day of same MW. 
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Fig. 3.8 | Effect of average pore size on cell viability. The relative cell viability and 
proliferation generally increased with increasing average pore size. It is well-known that larger 
pore sizes increase the diffusion of oxygen, nutrients, and waste into and out of the cell-
embedded gels. Larger pore sizes also remove the photoinitiator compounds and its free radical 
by-products out of the gel quicker, thereby increasing initial cell viability. Additionally, cell 
spreading and protein synthesis/secretion is improved in higher chain length gels, even in the 
absence of adhesion peptides. 
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Fig. 3.9 | NIH/3T3 cell viability over 14 days in multi-layer approach. The Mw of PEGDA 
hydrogels were varied using Mw 5,000. (a) OD (490 nm) values quantified with MTS assay 
were normalized to Day 0. All values are mean ± standard deviation of n = 3. (*) denotes 
statistical difference compared to 0 day of same approach. (^) denotes statistical difference 
compared to different approach of same day. (b) MTT staining that shows living cells in a 
patterned multi-layer PEGDA hydrogel with MW 5,000 Da after 14 days. (c) MTT staining that 
shows living cells in single-layer PEGDA hydrogel disks with MW 5,000 Da after 0, 4, 7, and 14 
days. There is a noticeable difference in intensity after 14 days. Scale bars are 1 mm. 
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Fig. 3.10 | Qualitative LIVE/DEAD staining of PEGDA hydrogels. NIH/3T3 cells were 
encapsulated in laser-polymerized 20% PEGDA hydrogels at a density of 1 X 106 cells/mL and 
cultured over 14 days. Viability was evaluated at 0, 4, 7, and 14 days using calcein AM and 
ethidium homodimer in fluorescence microscopy. Green indicates live cells and red indicates 
dead cells. Scale bars are 200 μm. 
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Fig. 3.11 | NIH/3T3 cells spreading in hydrogels containing bioactive RGDS groups. Single 
and clustered cells were clearly seen spreading in patterned multi-layer PEGDA hydrogels with 
MW 5,000 Da. These hydrogels were tailored with bioactive RGDS groups at a concentration of 
5 mM. (a) and (b) Bright-field and (c) and (d) fluorescence microscopy images of the cells were 
taken after 14 days. For fluorescence microscopy, cells were fixed and stained with rhodamine 
phalloidin (cytoskeleton) and DAPI (nuclei). Scale bars are 20 μm. 
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Fig. 3.12 | Spatial 3D layer-by-layer cell patterning of viable cells at distinct layers. (a) CAD 
rendering of cross-hatch pattern used for layer-by-layer spatial patterning. Each layer set was 1 
mm thick (10 total layers, 100 μm each). (b) Fluorescence image of NIH/3T3 cells encapsulated 
on different layer sets stained with either CellTracker(R) CMFDA (green) dye or CMTMR 
(orange) dye. (c) Cross-sectional view of a block pattern consisting of alternating layer sets (5 
total layers, 100 μm each). (d) Quantitative analysis of (c) showing layer sets comparable to the 
desired 500 μm thickness. All values are mean ± standard deviation of n = 4. Scale bars are 1 
mm. 
  
59 
 
 
 
Table 3.1 | Calculated average pore size of PEGDA hydrogels as a function of Mw. The 
average pore size of 20% PEGDA hydrogels with MW 700, 3,400, 5,000, and 10,000 Da were 
calculated from values obtained by measuring the swelling ratios of gel disks with a diameter of 
5 mm. The pore size increased as a function of increasing MW. 
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CHAPTER 4: BIOLOGICAL ACTUATORS 
4.1 INTRODUCTION 
Cell-based biohybrid actuators are integrated systems that employ elements of biology to 
power synthetic structures. The biological and synthetic components have a dependent 
relationship, which pass information in one or both directions; this direct interaction forms a 
‘biohybrid’ system. For example, cells are able to sense the mechanical properties of the 
substrate they are grown on and respond through biological functions such as migration, 
differentiation, or proliferation.1 Driven by cells, biohybrid actuators can be autonomous, or 
controlled chemically or electrically. Using glucose as a chemical energy source, cells can 
generate power by converting it to mechanical energy. These systems could be used to promote 
the design of more effective and intelligent bio-machines (i.e. bio-bots2–4 and power generators5), 
help us understand the emergent behavior of cellular systems, and have applications in drug 
discovery. 
Significant progress in developing cell-based biohybrid actuators has recently been 
reported. Contractile stresses and forces of single cells and cell sheets of cardiomyocytes and 
skeletal myotubes cultured on silicon6 and PDMS7 micro-cantilevers have been measured. Xi et 
al.2 developed a microdevice using a silicon backbone with self-assembled cardiomyocytes 
grown on a chromium/gold layer. The collective and cooperative contraction of the cells caused 
the backbone to bend and stretch in a walking motion, which traveled at a maximum speed of 38 
μm s−1. Kim et al.3 established a swimming microrobot by micromolding PDMS. Using 
cardiomyocytes, cells were seeded on top of four conjoined cantilever beams that were grooved 
to influence the alignment and enhance their contractility relative to flat beams. An increase in 
force (88%) and bending (40%) was recorded, with an average swimming speed of 140 μm s−1. 
Feinberg et al.4 assembled cardiomyocytes on various PDMS thin films with proteins to create 
muscular thin films. When released, these thin films curled or twisted into 3D conformations that 
purportedly performed gripping, pumping, walking (133 μm s−1), and swimming functions (400 
μm s−1). 
However, progress in developing cell-based biohybrid actuators has been limited to rigid 
materials, ranging in elastic moduli on the order of mega (106) to giga (109) Pascals. Recent 
reports in the literature have established a correlation between substrate rigidity and its influence 
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on the contractile behavior of cardiomyocytes.8-11 These studies show that cardiomyocytes 
cultured on hard substrates overstrain themselves, lack striated myofibrils, and stop beating. 
Conversely, substrates showing a close correspondence to tissue elasticity (10 kPa) are optimal 
for transmitting contractile work to the substrate and for longer periods of time.8 Therefore, it is 
worthwhile to explore and evaluate more compliant cantilevers with tissue-like elasticity on the 
order of kilo (103) Pascals, and subsequently measure the contractile stresses and forces of 
cardiomyocytes on these devices. 
While its mechanical properties can easily be altered in the kilo (103) Pascal range12–14 by 
changing the monomer-to-curing agent mixing ratio, functionalization of PDMS-based substrates 
for cell adhesion is challenging.15 This can be attributed to its chemical inertness, 
hydrophobicity, and high chain mobility. In particular, chain mobility is probably the key 
limiting factor in modifying PDMS; surface treatments lead to unstable and short-lived oxidized 
layers.16 Thus, physical adsorption is relatively inefficient and transient on PDMS. Furthermore, 
PDMS-based microfabrication requires master molds patterned by photolithography with SU-8 
photoresist and silicon. This conventional photolithography process requires clean room facilities 
and costly equipment, which limits the complexity of multi-layer constructs and the ability to 
make changes quickly and cheaply. 
In contrast, poly(ethylene glycol) (PEG) is a synthetic polymer that has tissue-like 
elasticity, which can be fine-tuned by changing its molecular weight or percent composition.17 
PEG-based hydrogels are hydrophilic and can be functionalized by activating with Sulfo-
SANPAH and conjugating with full-length ECM molecules.18 Cell adhesion domains,19,20 growth 
factors,21 and hydrolytic22 and proteolytic sequences23,24 can also be incorporated directly into 
the PEG backbone. Additionally, PEG is highly permeable to oxygen, nutrients, and other water-
soluble metabolites. This is especially advantageous for cell-encapsulated, three-dimensional 
(3D) model systems. PEG-based hydrogels can be photopolymerized with a UV laser or lamp 
based on 3D CAD images; thus, complex 3D geometries can be formed through direct exposure. 
This study uses a 3D stereolithographic printer to rapidly fabricate multi-material 
hydrogel cantilevers with varying stiffness. A stereolithography apparatus (SLA) is a rapid 
prototyping tool25,26 used to produce three-dimensional (3D) models, prototypes, and patterns by 
repetitive deposition and processing of individual layers.27,28 It uses a UV laser (325 nm) to 
directly write on and polymerize photosensitive liquid materials based on a CAD-designed 
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digital blueprint, sliced into a collection of two-dimensional (2D) cross-sectional layers, and 
processed into a real 3D part using layer-by-layer deposition. The automated, high-throughput 
process is particularly useful for biohybrid systems due to its multi-material capability, which 
can be used to change the synthetic material composition or insert cells or proteins at precise 
locations on the structure.29 It has recently been adapted for use with photopolymerizable 
hydrogels,30,31 which are highly hydrated and crosslinked polymer networks. The SLA is 
particularly useful for testing biohybrid actuator designs because of the ease in changing the 
dimension and shapes quickly and producing new ones to seed cardiomyocytes on. The aim of 
this paper is to incorporate acrylic-PEG-collagen into photopolymerizable PEGDA hydrogels 
(PEGDA-PC) to create cantilevers in the SLA that can be used to measure contractile forces at 
different stiffnesses and to see how those stiffnesses affect the contractility of cardiomyocytes 
for the design of cell -based biohybrid actuators. 
4.2 MATERIALS AND METHODS 
4.2.1 APPARATUS AND PREPARATION OF PRE-POLYMER SOLUTION 
A commercial stereolithography apparatus (SLA, Model 250/50, 3D Systems, Rock Hill, 
SC, USA) was modified for the fabrication of biohybrid cantilevers. The modification employed 
an additive “bottom-up” method as previously described.31 The laser wavelength was in the UV-
A region (325 nm) with a 250 μm beam diameter at the set focal plane. The platform had a 
minimum Z-step of 50 μm. Acrylic-PEG-collagen was prepared by mixing a working solution of 
acrylic-PEG-NHS (50 mg mL−1 in ice cold HBSS ) with collagen I (3.68 mg mL−1, rat tail; BD 
Biosciences) at a 1:1 acryl-to-lysine molar ratio for 30 minutes at 4 °C. A 50% (v/v) acrylic-
PEG-collagen solution was mixed with 20% poly(ethylene glycol) diacrylate (PEGDA) and 
0.5% Irgacure 2959 photoinitiator in ice cold HBSS to form the pre-polymer solution. The 
PEGDA molecular weight (Mw) was varied to fabricate the base (Mw 700 Daltons) and beam 
(either Mw 700 or Mw 3,400 Daltons) of the cantilevers. PEGDA was purchased from Sigma-
Aldrich (Mw 700 Daltons) and Laysan Bio (Mw 3,400 Daltons). A working solution of Irgacure 
2959 photoinitiator (Ciba, Basel, Switzerland), which is only partially water-soluble, was 
prepared at 50% (w/v) by dissolution in DMSO. 
4.2.2 FABRICATION OF MULTI-MATERIAL BIOPOLYMER CANTILEVERS 
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To prepare for use in the SLA, energy dose characterizations of the pre-polymer solutions 
were performed using a method described previously.31 Briefly, the pre-polymer solutions were 
pipetted into small containers capped on top by thin cover glasses. The SLA laser was used to 
draw circles that were 1 cm in diameter through the cover glass. The energy dose was varied by 
changing the scan speeds of the laser, which produced cylindrical gels of different thicknesses 
attached to the cover glasses. The thicknesses of these gels were measured and a working curve 
was plotted to determine the penetration depth (Dp) and critical exposure energy (Ec) of the pre-
polymer solution necessary to produce cantilever beams with precise thicknesses. It was also 
observed that a change in the energy dose affected the elastic modulus of the gels. As a result, a 
constant energy dose (150 mJ cm−2) was used to polymerize both the PEGDA-PC 700 and 3400 
cantilever beams so that only the Mw of the hydrogels would affect the elastic modulus. 
The fabrication setup consisted of a 35 mm diameter Petri dish and an 18 × 18 mm cover 
glass that was bonded to the dish with double-sided tape. The dish was positioned at the center of 
the SLA platform, and a carefully characterized volume of pre-polymer solution was added into 
it. The beam of the cantilever was fabricated first, by selective laser crosslinking of the 
prepolymer solution, to ensure the precise thickness was not affected by the energy dose. The 
unpolymerized solution was then evacuated using a pipette and an equal volume of the pre-
polymer solution for the cantilever base was added. The SLA then polymerized the first layer of 
the base (300 μm thick) according to the characterized energy dose for PEGDA-PC 700. The 
pre-polymer solution was added, and the elevator controlled by the SLA was lowered to a 
specified distance. After photopolymerization, the part was recoated, and the process was 
repeated until completion. In all, the fabrication of the cantilevers took not more than 15 minutes, 
although the processing time can be accelerated. The cantilevers were then transferred to a 0.02 
N acetic acid solution to be washed. This step prevented the high collagen concentration in the 
unpolymerized pre-polymer solution from gelling around the cantilever; however, this step 
should only be done for less than a minute as acetic acid affects cardiomyocyte adhesion on the 
polymerized collagen from the cantilever beams. After washing out the pre-polymer solution, the 
cantilevers were moved to a physiological pH buffer solution to swell overnight. A total of 4 
cantilevers were fabricated in one run, but the SLA process can easily be scaled up to 
accommodate many more. 
4.2.3 CARDIOMYOCYTE ISOLATION AND CULTURE 
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The warm growth medium consisting of Dulbecco's modified Eagle's medium (DMEM) 
and 10% fetal bovine serum (FBS) was prepared for cell culture. Cardiomyocytes were obtained 
from 2 day old neonatal Sprague-Dawley rats (Harlan Laboratories) using an approved protocol 
by the Institutional Animal Care and Use Committee (IACUC; Protocol #08190). Briefly, whole 
hearts were excised from the rats as described by Maass and Buvoli,32 and placed in an ice-cold 
HBSS buffer. Using small scissors, the left and right atria were removed and the remaining 
ventricles were minced into 1 mm3 pieces. The minced ventricles were digested in 0.1% (w/v) 
purified trypsin (Worthington Biochemicals), while gently rocking at 4 °C overnight. After 18 
hours, warm growth medium was added for 5 minutes at 37 °C to inhibit trypsin digestion. The 
supernatant was discarded, and 0.1% (w/v) purified type II collagenase (Worthington 
Biochemicals) was added for 45 minutes while gently rocking at 37 °C. The digested tissue was 
triturated to mechanically loosen the cells, and the suspension was filtered through a 75 μm cell 
strainer to remove undigested connective tissue. The suspension was removed after 
centrifugation at 150 × g for 5 minutes. The remaining cell pellet was re-suspended in warm 
growth medium and pre-plated for 1 hour to enrich the suspension for cardiomyocytes. The 
cardiomyocytes were then counted and seeded on the backside of the cantilevers. To do this, 
individual cantilevers were placed in a 24-well plate, turned upside down, and evacuated of all 
liquid. They were allowed to dry for 10 min so that the cantilevers would temporarily attach to 
the bottom of the dish. The cantilevers were then seeded at 2 million cells per well (1 × 106 cells 
cm−2) and incubated for 12 hours. After cell attachment, the cantilevers were transferred to a new 
dish with fresh medium and cultured overnight. 
4.2.4 HYDROGEL CHARACTERIZATION 
The stiffness of a gel disk fabricated in the SLA was evaluated by measuring the elastic 
modulus (E) using a mechanical testing system (Insight, MTS Systems, Eden Prairie, MN, USA). 
The gel disk with a diameter of 5 mm was compressed at a constant deformation rate of 1.0 mm 
s−1 at 25 °C, and the resulting stress was recorded by MTS software (Testworks 4). From the 
strain limit to the first 10%, the elastic modulus was calculated using the slope of the stress (σ) 
vs. strain (λ) curve. 
The swelling ratios of the gels at equilibrium were determined by measuring the weight 
of the swollen gels after 24 hours in pH 7.4 buffer solutions at 37 °C and the weight of the dried 
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gels. The degree of swelling (Q), defined as the reciprocal of the volume fraction of a polymer in 
a gel (v2), was calculated from the following equation: 
 
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where ρS was the density of water, ρP was the density of polymer, and Qm was the swelling ratio, 
the mass ratio of the swelled gel to the dried gel. 
4.2.5 EXPERIMENTAL SETUP FOR MEASURING CANTILEVER BENDING ANGLES 
Vertical motion and bending angles of the cantilevers due to cardiomyocyte cell sheet 
contraction were captured using a camcorder (HandyCam, Sony USA, New York, NY USA) 
with an advanced HAD CCD imager at 720 × 480 pixel video capture resolution. The camcorder 
recorded at 60 fps with a 60× optical zoom. It was fixed on a multi-axis stage (Thorlabs) and 
placed in a temperature- and CO2-controlled culture chamber due to cardiomyocyte sensitivity to 
changes in the outside environment. The temperature and CO2 were set to 37 °C and 5%, 
respectively. The bending angles, θ, and deflection values, δ, were measured using the Measure 
Tool in Adobe Photoshop software (Fig. 4.1). Still images were taken by the camcorder, and a 
line was fitted along the slope of the free end of the deformed cantilever. A second line was 
drawn along the horizontal axis of the undeformed cantilever, which created a protractor for 
measuring the angle. The vertical distance of the cantilever from the undeformed base to its 
deformed base was also measured to determine the deflection value. The smallest resolution that 
could be measured with this software platform was 0.1°. 
4.2.6 MODELING AND ANALYSIS METHODS 
Modeling and analysis of the cell -based biohybrid cantilevers were carried out using an 
analytical solution based on finite element modeling (FEM) analysis and validated by classical 
beam equations. FEM is a powerful technique when used to find numerical solutions to problems 
with irregular geometries or nonlinear material behavior. This is especially the case for 
cantilevers in which the beam width cannot be ignored. The intrinsic stress calculations were 
validated using the following equation:33 
 2
2
L
tE bb
beam
   (4.2) 
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where σbeam is the intrinsic stress (Pa), Eb is the elastic modulus of the beam, δ is the deflection of 
the beam (m), tb is the thickness of the beam (m), and L is the length of the beam (m). 
Cells seeded on the cantilevers formed sheets that were considered thin films, and the 
cantilevers were modeled as composite, two-component systems. The model was validated by 
simulating cantilevers with beam dimensions and comparing the stress calculations to Atkinson's 
approximation, a variant of Stoney's equation:8 
   Lttt tE bfbf bbfilm  

14
3
 (4.3) 
where σfilm is the cell sheet stress (Pa), tf is the thickness of the cell sheet (m), and νb is Poisson's 
ratio of the beam. 
The simulations were performed with measured elastic moduli of 503 kPa for PEGDA-
PC 700 and 17.82 kPa for PEGDA-PC 3400. Poisson's ratio of PEGDA-PC was assumed to be 
0.499. Based on the literature, the elastic modulus of a sheet of cardiomyocytes was assumed to 
be 10 kPa with a thickness of 10 μm.34,35 The density of cardiomyocytes and the PEGDA-PC 
material was assumed to be 1.06 kg m−3 and 1.12 kg m−3, respectively. 
4.2.7 IMMUNOSTAINING 
Cells seeded on cantilevers after 3 days were washed twice with HBSS and fixed in 4% 
(v/v) formaldehyde solution for 10 minutes at room temperature. The cantilever beams were 
physically detached from their bases with a sharp razor. The beams were permeabilized in 0.2%    
(v/v) Triton-X 100 in HBSS for 10 minutes at room temperature. The samples were washed 
twice with HBSS before a blocking agent, Signal FX (Invitrogen), was added for 30 minutes. 
After another wash step, the samples were incubated overnight at 4 °C with primary antibodies , 
mouse anti-α-actinin (sarcomeric) and rabbit anti-connexin-43. The tissues were washed twice 
before being incubated with Alexa Fluor 488 goat anti-mouse and Alexa Fluor 594 goat anti-
rabbit secondary antibodies for 2 hours at 37 °C. The stained samples were washed with HBSS 
and subsequently stained with an antibody for DNA, 4′,6-diamindino-2-phenylindole (DAPI, 
Sigma Aldrich, St Louis, MO, USA) for 5 minutes. After a final wash step, the cells on the 
cantilevers were imaged using an inverted fluorescent microscope (IX81, Olympus, Center 
Valley, PA, USA). 
4.3 RESULTS AND DISCUSSION 
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4.3.1 CANTILEVER FABRICATION 
The cantilevers were fabricated using a PEGDA backbone that was chemically linked 
with acrylic-PEG-collagen (Fig. 4.2A). PEGDA is a tissue-like, synthetic hydrogel that can be 
crosslinked in the presence of a photoinitiator.36,37 It is mechanically stable, and its properties can 
be tuned by varying the polymer molecular weight, percent composition, or laser energy dose. It 
was previously established that changing the molecular weight of 20% PEGDA from 700 to 
10,000 Daltons and photopolymerizing it in the SLA could be used to modulate the elasticity 
from 503 ± 57 kPa to 4.73 ± 0.46 kPa, respectively.31 Collagen was chemically linked to the 
PEGDA backbone by acrylating its lysines, making them photocrosslinkable. Because PEGDA 
is normally inert, the collagen served to promote cell adhesion to the cantilever beams. The 
addition of collagen to the PEGDA backbone did not noticeably affect the mechanical properties 
of the hydrogel. Both the elastic modulus (Fig. 4.2B) and swelling ratio (Fig. 4.2C) were 
conserved for PEGDA-PC 700 and 3,400. For 20% PEGDA-PC 700, the elastic modulus was 
507 ± 110 kPa, and the swelling ratio was 6.25 ± 0.06. For 20% PEGDA-PC 3,400, the elastic 
modulus was 29.8 ± 17 kPa, and the swelling ratio was 13.6 ± 0.95. From a biological 
perspective, mechanical properties of these hydrogels are closer to the in vivo environment of 
cells than either silicon or PDMS. They are also optically transparent, and therefore force 
measurements and immunofluorescence imaging of specific biological markers can be made 
simultaneously under light microscopes.38,39 
Eight cantilevers were built for every fabrication run, with two sharing a common base. 
The SLA setup (Fig. 4.3A) can be easily modified with a larger-sized container to scale up the 
number of cantilevers in each run. The original dimensions (length × width × thickness) for the 
cantilevers were specified in CAD-based software, with the bases being 2 × 2 × 4 mm and the 
cantilever beams being 2 × 4 × 0.45 mm (Fig. 4.3B). An inherent characteristic of PEGDA 
hydrogels, however, is its tendency to imbibe water and swell many times beyond its intended 
dimensions. The cantilever thickness had to be adjusted to account for this swelling. The actual 
dimensions of PEGDA-PC 700 and 3,400 cantilevers after 24 hours of equilibrium swelling were 
4.1 × 2.1 × 0.45 mm and 4.3 × 2.3 × 0.45 mm, respectively. One major benefit of the SLA 
approach is that more than one biomaterial, growth factor, or cell type can be introduced and 
spatially defined in the same 3D construct.40 This is especially useful for creating gradients of 
varying mechanical or bioactive properties. In particular, cantilevers were fabricated on a base 
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consisting of PEGDA 700. The beams themselves were exchanged for either PEGDA-PC 700 or 
3,400, depending on the desired elasticity. As shown in the simplified process flow (Fig. 4.3C), 
the cantilever beams were fabricated first in the SLA to ensure the correct thickness, while 
maintaining the laser energy dose (150 mJ cm−2) between PEGDA-PC 700 and 3,400 materials 
to preserve the same trend in elasticity. The resulting PEGDA-PC 700 (Fig. 4.4A) and PEGDA-
PC 3,400 (Fig. 4.4B) cantilevers are shown with comparable dimensions after equilibrium 
swelling in HBSS. 
4.3.2 CANTILEVER BEAM INTRINSIC STRESS 
Following the fabrication phase, cantilevers were rinsed in 0.02 N acetic acid to remove 
unpolymerized material before soaking overnight in HBSS. The cantilever beams would initially 
bend downward due to the weight of the unpolymerized pre-polymer solution and begin to swell 
as water diffused into them. Over time, the cantilevers would reach an equilibrium swelling state 
and bending would resolve to a final angle. These angles were measured using ImageJ analysis 
software and converted to displacement values. It was found that as the average molecular 
weight of the PEG-based cantilevers increased, the bending angle would increase upward in the 
clockwise direction. Similarly, the bending angle of the cantilevers would increase as the 
thickness of the cantilever decreased (Fig. 4.5). PEGDA-PC 3,400 had a bending angle of 67.1 ± 
7.9° (3,420 ± 560 μm deflection), whereas PEGDA-PC 700 did not bend (0° angle and 0 μm 
deflection). 
Finite element analysis (COMSOL simulations) was used with the displacement values to 
calculate the intrinsic stress of the cantilever beams (Fig. 4.4C). The insets in Fig. 4.4C show the 
simulated displacement values, which were used to calculate the intrinsic stress for PEGDA-PC 
700 and 3,400. The intrinsic stresses obtained were 0 ± 0 Pa and 4160 ± 910 Pa, respectively. 
One hypothesis for the cantilever bending due to non-uniform residual stress is that during the 
UV laser polymerization in the SLA, the highest concentration of energy is focused at the surface 
of the pre-polymer solution. As the laser penetrates into the solution, it is absorbed by the 
photoinitiator and monomers. By the time it reaches a penetration depth of 450 μm at the other 
end of the beam, the energy is decreased, which reduces the overall crosslinking density. A 
simple calculation using the Beer–Lambert law reveals a 79.1% decrease in light transmittance 
(λ = 325 nm) through the pre-polymer solution at a depth of 450 μm. This leads to a gradient in 
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microstructure of the polymerized gel across the thickness. Consequently, the properties of the 
gel, such as swelling due to water absorption and stiffness, also have a gradient. This gradient in 
swelling across the thickness causes bending of the cantilever. 
4.3.3 CANTILEVER BENDING DUE TO NON-UNIFORM STRESS GRADIENT 
The Beer-Lambert law was used to calculate the absorbance of the SLA laser (λ = 325 
nm) through the pre-polymer solution: 
 ܣ = ߝ݈ܿ (4.4) 
where A is the absorbance, ε is the molar extinction coefficient (L mol-1 cm-1), l is the pathlength 
(cm), and c is the concentration of the solution (mol L-1). The molar extinction coefficient, ε, at 
the laser wavelength of 325 nm was obtained experimentally for the photoinitiator, Irgacure 
2959: 676.7 L mol-1 cm-1, which was similar to results extrapolated from Fairbanks et al.41 
Next, the absorbance was calculated through the pre-polymer solution using ε = 676.7 L 
mol-1 cm-1, l = 450 μm (cantilever thickness), and c = 0.0223 mol L-1 (Irgacure 2959 
concentration). The resulting absorbance, A, was 0.679. To be clear, this is the absorbance of the 
SLA laser at the bottom of the pre-polymer solution, or the back face of the cantilever hydrogel. 
The absorbance was converted to percent transmittance, %T, to better understand the 
significance of this value: 
 ܣ = 2 − log10 %ܶ (4.5) 
The resulting percent transmittance, T, was 20.9%. That means at the surface of the pre-
polymer solution, or the incident face of the cantilever hydrogel, there was 100% transmittance. 
At the bottom or back face, the transmittance decreased to 20.9%, which was a difference of 
79.1%, due to the absorbance of the laser by the photoinitiator. Therefore, there was a significant 
difference in the UV exposure dose at the incident face and back face of the cantilever hydrogel, 
which supports the hypothesis that a gradient in the swelling due to water absorption and 
stiffness caused the cantilever to bend due to non-uniform residual stress. Finally, there may be 
other factors that affect the stress gradient. For example, total energy dose may play a critical 
role during the photopolymerization process. As the crosslinking density reaches a maximum at 
the incident face, overexposure can continue to crosslink the back face of the cantilever and 
minimize or even eliminate the stress gradient.  
4.3.4 CARDIOMYOCYTE ADHESION AND SPREADING 
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PEGDA hydrogels are hydrophilic and well-known to resist cell adhesion. Many groups 
have chemically modified them with proteins and peptide sequences to make them more 
amenable to cell attachment.19 One of the most frequently used sequences with PEGDA is RGD 
(arginine-glycine-aspartic acid), which is found in numerous extracellular matrix proteins. 
However, several reports have suggested that while RGD peptides promote cardiomyocyte 
adhesion, they are unable to promote the signaling required for normal FAK expression and 
complete sarcomere formation in cardiomyocytes.42 Sarin et al.43 went further to demonstrate 
that RGD depressed the rate of contractile force by altering the myofilament activation process. 
Based on these findings, we sought to improve cardiomyocyte function by chemically attaching 
collagen molecules to PEGDA hydrogels. This chemistry was performed by the reaction of 
lysine amines on collagen to acrylate-PEG-NHS, which is an N-hydroxysuccinimidyl ester 
reactive to amines. The acrylate-PEG-collagen was then combined in solution with PEGDA to 
form a PEG-based hydrogel linked with bioactive collagen for cell adhesion. 
Cardiomyocytes extracted from neonatal rat ventricular myocytes were seeded on 
PEGDA, PEGDA-RGD, and PEGDA-collagen (PEGDA-PC) hydrogels. After 2 days, cells were 
qualitatively evaluated for cell adhesion and spreading. It was clear that cardiomyocytes spread 
much better on PEGDA-PC hydrogels than PEGDA and PEGDA-RGD (Fig. 4.6). The cells on 
PEGDA and PEGDA-RGD appeared to remain balled up in spheres and preferentially attached 
to each other rather than on the substrate. Many of the cells had washed off after a change of 
media indicating poor cell attachment. On the other hand, cardiomyocytes on PEGDA-PC spread 
greatly, formed gap junctions, and began to contract in synchrony. Because of that, we used 
PEGDA-PC hydrogels as our material choice for cantilever fabrication, which has the bioactivity 
for cell attachment and function, and ability to change its mechanical stiffness through its 
molecular weight. 
4.3.5 CANTILEVER BENDING DUE TO CELL TRACTION FORCES 
As a result of the intrinsic stress, the curvature of the PEGDA-PC 3,400 cantilevers made 
it difficult to seed cells uniformly and at high densities on the beams. One solution was to turn 
the cantilevers on their back sides and evacuate the liquid they were immersed in. This created a 
surface tension that mechanically flattened the curved cantilever beams onto the bottom of the 
plate. Neonatal rat ventricular myocytes were then extracted and seeded on the flattened 
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cantilever beams at 1 million cells cm−2. This backside seeding also prevented the cell sheets on 
the two cantilevers from linking together, so that they could be examined as two independent 
measurements. The cantilevers with seeded cells were centrifuged to distribute cells evenly on 
the cantilevers. 
After seeding, cardiomyocytes were allowed to adhere for 24 hours. By then, the 
cantilevers had already started to bend downward due to cell traction forces as the 
cardiomyocytes began to spread and reorganize themselves. Cell traction forces are generated by 
actomyosin interactions and actin polymerization, and regulated by intracellular proteins such as 
α-smooth muscle actin and soluble factors such as TGF-β. Once transmitted to the extracellular 
matrix through stress fibers via focal adhesions, which are assemblies of ECM proteins, 
transmembrane receptors, and cytoplasmic structural and signaling proteins , cell traction forces 
direct many cellular functions, including cell migration, ECM organization, and mechanical 
signal generation. The stress induced by the cell sheet is clearly seen by the change in 
displacement over time on the cantilever beams (Fig. 4.7A). The cell sheet continued to apply 
traction forces on the cantilevers over 72 hours before it stabilized. The bending angle of the 
curved beams was measured and recorded every day for 4 days (Fig. 4.7B). Because of the cell 
traction forces, the bending angle for PEGDA-PC 3,400 cantilevers was decreased from its 
intrinsic value of 67.1 ± 7.9° to 44.2 ± 6.0° by the third day of culture. PEGDA-PC 700 
cantilevers, having a high elastic modulus, did not bend at all during culture. The displacement 
values were also measured and used in FEM simulations to calculate the stress on the cantilever 
beams by the cell sheet. The simulated displacements and stresses for PEGDA-PC 700 and 3,400 
are shown in Fig. 4.7C. For PEGDA-PC 3,400, the highest level of stress was seen at the fixed 
end of the beam. The maximum stress values were calculated every day (Fig. 4.7D), and the 
change in stress was plotted every 24 hours. The cell sheet reached a maximum stress of 2,040 
Pa before it leveled off. The change in stress was highest after the first day and continually 
decreased before there was virtually no change between 72 and 96 hours. 
4.3.6 CANTILEVER ACTUATION AND FORCE 
Although cardiomyocytes began to contract individually as early as 24 hours after 
seeding, the cells did not beat synchronously as a whole sheet until at least 48 hours. During this 
period, cardiomyocytes formed electrical connections between each other through gap junctions. 
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Membrane proteins known as connexins formed six-membered rings called connexons on the 
sarcolemma of cardiomyocytes. When gap junctions are open, they provide direct 
communication between the sarcoplasmic spaces of adjoining cells, creating a functional 
synctium or network of synchronized cells.44,45 After 76 hours, when the majority of these 
connections were formed, cells were stained for sarcomeric α-actinin to qualitatively elucidate 
the morphology of cardiomyocytes on PEGDA-PC 700 and 3,400 cantilevers (Fig. 4.8A). In 
both cases, cardiomyocytes exhibited the expression of sarcomeric α-actinin, an actin-binding 
protein that plays a key role in the formation and maintenance of Z-lines, throughout the 
cytoskeleton . The localization of sarcomeric α-actinin in both PEGDA-PC 700 and 3,400 
demonstrated a typical periodicity in the Z-lines of cardiomyocytes. 
Actuation of the cantilevers is a consequence of the contraction and relaxation of the 
cardiomyocyte cell sheet through the sliding filament mechanism.46 During contraction, 
cardiomyocyte filaments shorten by the sliding of actin and myosin filaments in sarcomeres, as 
triggered by action potentials and intracellular calcium signals.47 Calcium is the critical part of 
the medium that allows the actin, myosin, and ATP to interact, causing crossbridge formation 
and muscle contraction. This process continues as long as calcium is available to the actin and 
myosin. During relaxation, cardiomyocyte filaments return to their original position as calcium is 
pumped back into the sarcoplasmic reticulum, preventing interaction of the actin and myosin. 
Cardiomyocyte cell sheets on PEGDA-PC 3,400 cantilevers had all started to actuate after 48 
hours (100%), whereas only a quarter of the cardiomyocyte cell sheets on PEGDA-PC 700 
cantilevers followed suit (25%) during the same time period (Fig. 4.8B). This percentage 
increased after 72 hours (83%), but the development of functional synctium was clearly slower. 
Furthermore, the beating frequency of the cardiomyocyte cell sheet was greater for PEGDA-PC 
3,400 than 700. After 48 hours, cardiomyocytes on cantilever plates with Mw 3,400 reached a 
beating frequency of 1.12 ± 0.14 Hz, while those for Mw 700 reached 0.39 ± 0.05 Hz, 
respectively (Fig. 4.8C). The frequency increased slightly for both after 72 hours to 1.40 ± 0.16 
Hz and 0.44 ± 0.06 Hz, respectively. These results seem to be in agreement with previous reports 
that claim that the substrate elasticity of the developing myocardial microenvironment are 
optimal for transmitting contractile work to the matrix and for promoting actomyosin striations.1 
In addition to the substrate elasticity, it is possible the hydrogels with higher molecular weight 
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have more cell adhesive sites exposed on the surface of the cantilever than hydrogels with lower 
molecular weight. 
Finally, we measured the actuation amplitudes of the cantilevers over 96 hours (Fig. 
4.9A). Similar to the beating frequency, the amplitudes reached a maximum on the third day 
post-seeding with values of 2 ± 8 μm and 390 ± 40 μm for PEGDA-PC 700 and 3400, 
respectively. The actuation amplitudes did not reach a maximum suddenly; rather, they increased 
linearly over time as more cardiomyocytes joined the synctium of cells. Using these amplitudes, 
we calculated the contractile forces of cardiomyocyte cell sheets on PEGDA-PC 700 and 3400 
cantilevers by using the following equations (Fig. 4.9B): 
 ckF   (3.6) 
    ffbbffbbffbbbbffbbffc tEtEtEtEtEtEtEtELtEtE
wk 322342423 4644
  (3.7) 
where F is the contractile force, kc is the stiffness of the cantilever, w is the width of the beam, 
and Ef is the elastic modulus of the film. Stiffness, kc, was derived for a composite, two-
component system.48 The stiffness values for PEGDA-PC 700 and 3,400 were calculated to be 
0.36 N m−1 and 0.013 N m−1, respectively. Using these values, and the peak deflection of 
actuated cantilevers (from its relaxation state to its contraction state), the total calculated forces 
were 0.89 ± 2.89 μN for PEGDA-PC 700 and 5.09 ± 0.48 μN for PEGDA-PC 3,400. 
The mechanical forces generated with cardiomyocyte cell sheets on elastic substrates 
near that of the native myocardium can be used to model and design self-propelled bio-bots. 
There are several ways to improve the current output of force, such as aligning the 
cardiomyocytes by patterning proteins or grooves into the substrate.49 The stiffness of the beam 
can be decreased by reducing the beam thickness or expanding its length. The density of cells 
can be increased by encapsulating them in 3D. Varying rigid (PEGDA-PC 700) and soft 
(PEGDA-PC 3,400) materials throughout the bio-bot design can also be beneficial for 
maximizing deflection in one direction and minimizing it in another. These designs can be used 
to form the basis of more complex cell systems. For example, cardiomyocytes can later be 
replaced with skeletal myoblasts and co-cultured with neurons to form neuromuscular junctions. 
The genetic machinery of the neurons can be reprogrammed to form simple functions of 
switching on and off chemical secretions, which in turn can be used to stimulate muscle cells to 
propel the bio-bot. The advantage of using this hydrogel system over silicon and PDMS is that 
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when we switch over to other cell types, which are sensitive to their environment, we can tune 
the elasticity of the substrate in accordance to them. As the stiffness is modulated for these 
specific cell types (i.e., neurons and skeletal muscle cells), this may affect the curvature of the 
material due to cell traction forces, in which case more rigid materials can be used to maintain 
the structural integrity of the bio-bot. Thus, a true living, multi-cellular machine could be created 
using the capabilities of the SLA, which can perform multiple functions such as sensing, moving, 
and effecting.50 
4.3.7 EFFECT OF FIBROBLASTS ON CARDIOMYOCYTE CULTURE 
Cells isolated from neonatal rat hearts consist predominantly of matrix-depositing 
fibroblasts by number and striated cardiomyocytes by volume. It has been argued that a 
minimum number of fibroblasts (10-20%) are necessary to maintain a proper functioning 
cardiomyocyte culture.51 There are at least three essential functions that fibroblasts play in the 
heart: (1) synthesis and deposition of ECM components, (2) synthesis and release of enzymes 
responsible for the degradation and turnover of the ECM, and (3) generation of mechanical 
tension on the epimysial collagen network.52 The third point would imply that fibroblasts also 
contribute to the initial static bending of the cantilevers. Like cardiomyocytes, active tension in 
fibroblasts is developed through microtubules and actomyosin-based forces, though the structure, 
assembly, composition, and contractile profile of these differ. In culture, however, fibroblasts 
divide more rapidly than cardiomyocytes and pervade the entire free substrate surface. An 
overgrowth of fibroblasts can cause diminished contractile capacity and phenotype plasticity. As 
such, it is important to keep the number of fibroblasts to a minimum. The majority of non-muscle 
cells, including the fibroblasts, were eliminated using a simple method developed by Blondel et 
al.53 that enriched for cardiomyocytes, purportedly as high as 97-99%. Therefore, the effect of 
fibroblasts on our cantilevers was minimized. 
4.3.8 CONTROL AND LONGEVITY OF CANTILEVERS AND ACTUATORS 
The influence of various drug treatments has been evaluated on the contractile activity of 
cardiomyocytes.54 For example, the addition of isoproterenol to the medium can cause an 
increase in the contraction frequency, whereas the addition of carbamylcholine chloride to the 
medium can cause a decrease in the contraction frequency. Gap junction blockers, such as 
heptanol, can completely stop synchronous contractility. These effects are reversible; after 10 
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min in the drug-free culture medium, the synchronous beating of the cardiomyocytes was 
restored to its original amplitude and frequency. Pulsatile electrical stimulation can also be used 
to pace the contractions of cardiomyocytes.55 Recently, light-induced stimulation of genetically 
engineered cardiomyocytes that express the light-activated cation channels, halorhodopsin or 
channelrhodopsin, was demonstrated.56,57 
Experimentally, these cantilevers have been verified to function optimally for at least 5 
days post-seeding. After this period, the frequency and amplitude of the actuating cantilevers 
decrease significantly. The lifetime of these cantilevers can be extended by reducing the 
overgrowth of fibroblasts in low serum medium.58 Other groups have demonstrated up to 16 days 
of functional components with cardiomyocytes.6 Furthermore, previous reported results on 
cardioids show that periods up to 60 days are readily attainable in culture.59 Lifetimes beyond 
this would require new technologies to support long-term survival in vitro. 
4.4 CONCLUSION 
Multi-material cantilevers were fabricated using a 3D stereolithographic printer with a 
PEGDA backbone that was incorporated with acrylic-PEG-collagen. The SLA allows us to 
quickly and easily change the material and its properties in the same 3D construct, which we 
show here with PEGDA-PC 700 and 3,400 cantilevers. Cardiomyocytes were extracted and 
seeded on the backside of the cantilevers and cultured to form cell sheets. Through its traction 
forces, the cardiomyocytes created a stress on the cantilever, causing it to bend. These stresses 
were modeled using finite element analysis by mimicking the displacement of the cantilevers. 
For PEGDA-PC 3,400, the maximum stress was 2040 Pa, while there was no stress on PEGDA-
PC 700 because of its high stiffness. The cardiomyocytes then began to beat in synchrony after 
two days in culture, and the contractile forces were calculated. The peak contractile forces were 
0.89 ± 2.89 μN for PEGDA-PC 700 and 5.09 ± 0.48 μN for PEGDA-PC 3,400. The stresses and 
forces calculated here can be used to design and optimize a cell -based biohybrid actuator that 
can generate net motion. The cantilevers can be used as an early prototype for the design and 
optimization of cell-based biohybrid actuators. 
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4.7 FIGURES AND CAPTIONS 
 
 
Fig. 4.1 | Schematic for measuring bending angles and deflection values. For bending angles, 
θ, a line was fitted along the slope of the free end of the deformed cantilever. A second line was 
drawn along the horizontal axis of the undeformed cantilever, which created a protractor for 
measuring the angle. For deflection values, δ, the vertical distance of the cantilever from the 
undeformed base to its deformed base was also measured to determine the deflection value. 
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Fig. 4.2 | Biohybrid material. (A) A mixture consisting of poly(ethylene glycol) diacrylate 
(PEGDA) and acrylic-PEG-collagen (PC) was formulated as photopolymerizable material for 
fabricating cantilever beams. Collagen I, extracted from rat tail, was modified on their lysine 
groups with acrylic groups to UV cross-link to the PEG backbone in the presence of a 
photoinitiator. (B and C) The mechanical properties of PEGDA-PC hydrogels were measured 
using a compression test at increasing molecular weight, demonstrating that the cantilever beams 
can be tuned to a wide range of elastic moduli and swelling ratios. These values did not change 
from that of PEGDA-only hydrogels, which suggests that the incorporation of acrylic collagen 
did not affect bulk mechanical properties. For n = 3 and SD. 
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Fig. 4.3 | Multi-material cantilever fabrication. (A) The cantilevers were fabricated with a 3D 
stereolithographic printer, which uses a UV laser to construct layer-by-layer patterns. (B) Two 
separate cantilevers (2 mm wide X 4 mm long X 0.45 mm thick) were built on opposite ends of 
one base (2 mm wide X 2 mm long X 4 mm thick). The molecular weight of the PEGDA-PC 
cantilever beam was varied using either PEGDA-PC 700 or 3400, while the base was kept 
constant using PEGDA-PC 700. (C) A simplified fabrication process flow is shown, which 
begins with the formation of the cantilever beam before the base. 
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Fig. 4.4 | Intrinsic stress calculations. After the fabrication process, (A) PEGDA-PC 700 and 
(B) PEGDA-PC 3400 cantilevers were washed in HBSS to remove uncrosslinked pre-polymer 
solution. Due to an intrinsic stress, PEGDA-PC 3400 cantilevers would bend upward to relieve 
stress in the beams. (C) The peak stress was calculated by using finite element analysis to 
simulate the deflection of the cantilever beam (Inset). Scale bars are 1 mm. Statistics by one-way 
ANOVA, Tukey’s test, *p < 0.05 for n = 8 and SD. 
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Fig. 4.5 | Intrinsic stress changes as the cantilever thickness varies. The thickness for 
PEGDA-PC 3400 cantilevers was decreased from (A) 450 µm to (B) 300 µm. Consequently, the 
beam curved upward sharply, decreasing its radius of curvature and increasing its intrinsic stress. 
This implied that stiffness has a role in determining the intrinsic stress of the beam. The 
PEGDA-PC 700 cantilever (450 µm) did not bend supported this line of reasoning. 
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Fig. 4.6 | Cardiomyocytes on PEGDA-based substrates. Cardiomyocytes were seeded and 
cultured on (A) PEGDA, (B) PEGDA-RGD (20 mM), and (C) PEGDA-PC (1.84 mg/mL) for 72 
hours before imaging. Compared to PEGDA and PEGDA-RGD, PEGDA-PC was a better 
substrate for cardiomyocyte attachment and spreading. (D) The cells on PEGDA-PC substrates 
were fixed and stained for α-actinin, connexin-43, and nuclei. Arrows indicate high density areas 
of connexin-43. 
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Fig. 4.7 | Cell sheet stress calculations. Cells from the ventricles of neonatal rat hearts were 
seeded on the backside of the cantilever beams. (A) The traction forces of these cells, which are 
responsible for migration, proliferation, and differentiation, caused the PEGDA-PC 3400 
cantilever beams to deflect downward in the Z-direction over time. (B) The average bending 
angles of the cantilevers were measured over a 96 hour period, which was used to calculate the 
deflection at the tip of the beams. (C) These deflections were simulated using finite element 
analysis to calculate the stresses exerted by the cell sheets due to traction forces. (D) These 
stresses exerted by the cell sheet and modeled as a thin film were plotted over time. The change 
in stress over 24 hour time points decreased and reached 0 by 96 hours. Scale bars are 1 mm. 
Statistics by one-way ANOVA, Tukey’s test, *p < 0.05 for n = 8 and SD. 
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Fig. 4.8 | Cardiomyocytes on PEGDA-PC substrates. (A) Cells on the cantilevers were 
fluorescently-labeled with anti-sarcomeric α-actinin and anti-DNA. Qualitatively, 
cardiomyocytes on PEGDA-PC 3400 and PEGDA-PC 700 both expressed actomyosin 
complexes (striations), but those on PEGDA-PC 3400 appeared to be more elongated and 
spindle-shaped. (B) None of the PEGDA-PC cantilevers actuated until at least the second day in 
culture, but the number of actuating cantilevers on this day was much greater for PEGDA-PC 
3400 than PEGDA-PC 700. (C) The beating frequency of the cardiomyocytes was also much 
greater for PEGDA-PC 3400 than PEGDA-PC 700, indicating a preference for the softer 
material. Statistics by one-way ANOVA, Tukey’s test, *p < 0.05 for n = 8 and SD. 
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Fig. 4.9 | Force of contraction. Using an equation for cantilever beam stiffness, the force of 
contraction was calculated by multiplying the stiffness by the deflection of the cantilever after 
contraction. Statistics by one-way ANOVA, Tukey’s test, *p < 0.05 for n = 8 and SD. 
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CHAPTER 5: CELL ALIGNMENT ON BIOACTUATORS 
5.1 INTRODUCTION 
The stereolithography apparatus (SLA) is a computer-assisted, three-dimensional (3D) 
printing system used for creating complex structures from photopolymerizable resins.1 
Traditionally, it is a manufacturing technique intended to produce 3D models and prototypes, but 
practitioners in the medical field have embraced it as a way to develop custom end-use parts and 
preoperative surgical plan.2,3 The SLA and other 3D printing platforms have greatly improved 
the performance and fit of prosthetics and implants in combination with computed tomography 
(CT) or magnetic resonance imaging (MRI) technologies.4 Fabricated parts from the SLA have 
been implanted as scaffolding for bone ingrowth,5,6 molds for breast reconstruction,7 replicas for 
aortic heart valves,8 and shells for ‘in-the-ear’ hearing aids. 
In the past few years, photopolymerizable hydrogels have been explored in the SLA as a 
potential class of implantable, soft materials.9 Hydrogels, which are networks of cross-linked 
polymers that imbibe large amounts of water, can be used directly with living cells as a synthetic 
extracellular matrix (ECM) analog for providing a variety of physical, chemical, and biological 
cues.10-13 In contrast to stiff 2D substrates made of polystyrene and glass, hydrogels possess 3D 
architecture and have tunable elasticity similar to tissues and organs. Cell attachment,12,14,15 
spreading,16-18 communication,19-21 and differentiation of stem cells16,22,23 are a few of the 
physical effects of matrix elasticity. 
Poly(ethylene glycol) diacrylate (PEGDA) is the most commonly used 
photopolymerizable hydrogel in the SLA. Using the working curve equation,1 PEGDA with 
varying molecular weights was characterized for building complex 3D structures.24 Living cells 
encapsulated in PEGDA (≥ MW 1,000) survived the stereolithographic process and remained 
viable within the hydrogel for up to two weeks.25 Integrating living cells with PEGDA hydrogels 
patterned in the SLA offers exciting new possibilities for tissue engineering and the development 
of cellular systems. For example, the SLA was used to examine cell interactions of co-cultures, 
such as neurons and muscle cells, encapsulated in discrete spatial locales in the same 3D 
construct.26 In another example, geometric patterns of hydrogels defined in the SLA were used to 
localize gradients of angiogenic growth factors secreted by encapsulated fibroblasts. When 
implanted in vivo on a vascular membrane, new blood vessels sprouted on the membrane in the 
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same pattern as the hydrogel.27 Furthermore, the SLA was modified for applications using 
multiple materials, such as hydrogel cantilevers and actuators that mimic the elasticity of the 
native myocardium for contractile muscle cells.28 
Despite recent progress, the SLA is limited to minimum feature sizes that are dependent 
on the diameter of the laser beam. Commercial SLA systems utilize gas or solid-state lasers that 
have a spot size between 75 and 250 µm. This limits the ability of researchers interested in 
creating patterns that control cell growth and alignment to imitate the in vivo tissue architecture. 
Distinct patterns are seen throughout the body, such as complex neural networks in the brain and 
linear arrangement of muscle cells around the myocardium.29 Protein immobilization for 
patterning has been shown on and in hydrogels30 using thiol chemistry and two-photon 
irradiation,31,32 and photolithography. Additionally, cell patterning has been shown mechanically 
by creating grooves,33-36 microchannels,37 and geometric restrictions;33,38 however, these methods 
can alter material properties and mechanics which are important to maintain for specific 
applications. 
In this current study, we exploited the cells’ dependence on ECM molecules to control 
their growth, organization, and distribution. Specifically, we have developed a simple method to 
align cells on structures fabricated using the SLA by first stamping polydimethylsiloxane 
(PDMS) patterns of acryl-fibronectin with micro-contact printing (µCP) and transferring the 
patterns to hydrogels fabricated in the SLA. This technique can then be used to align living cells 
on 3D hydrogel geometries, including neurons, muscle cells, and endothelial cells. From a 
biological perspective, the elastic properties of hydrogels combined with the ability to align cells 
allows for realistic in vitro models for understanding the biology of cell development, 
organization, and disease. From an engineering perspective, using the SLA to create 
geometrically-defined, biohybrid constructs generates exemplary new applications in tissue 
engineering, regenerative medicine, synthetic biology, and cellular machines. 
5.2 MATERIALS AND METHODS 
5.2.1 PREPARATION OF PDMS STAMP 
Master molds for the PDMS stamps were fabricated on a silicon wafer with SU-8 
negative photoresist following a standard procedure.39,40 The master molds contained patterns of 
10, 50, and 100 µm wide lines with equal spacing. The height of each pattern was 5 um. The 
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patterned master molds were silanized with (tridecafluoro-1,1,2,2-tetrahydrooctyl)-1-
trichlorosilane in vacuum for 1 hour. PDMS (Dow Corning Sylgard 184 Silicone Elastomer Kit) 
was weighed out at a 10:1 ratio of polymer-to-curing agent (heat activated). The materials were 
thoroughly mixed for 3 minutes to ensure even distribution of the curing agent and poured onto 
the patterned master molds. Samples were placed in a desiccator, pulled under vacuum, and 
baked at 80 oC overnight. 
5.2.2 PREPARATION OF FIBRONECTIN AND ACRYL-FIBRONECTIN INK 
Fibronectin from bovine plasma solution (Sigma Aldrich, St. Louis, MO, USA) was 
diluted in PBS to a concentration of 50 µg mL-1. For acryl-fibronectin ink, monoacrylated 
poly(ethylene glycol)-N-hydroxysuccinimide (acryl-PEG-NHS, MW 3500, JenKem Technology, 
Allen, TX, USA) was dissolved in PBS at a concentration of 30 mg mL-1. A working solution of 
acryl-fibronectin ink was prepared by mixing acryl-PEG-NHS with fibronectin at a 2:1 molar 
ratio of acrylate-to-lysine. The reaction was allowed to proceed for 30 minutes at 4 oC.   
5.2.3 MICRO-CONTACT PRINTING INK ON GLASS COVERSLIPS 
Glass coverslips were patterned by µCP39,40 using clean PDMS stamps. Fibronectin and 
acryl-fibronectin ink (50 µg mL-1) were coated onto PDMS stamps for one hour at 37 oC. After 
incubation, excess ink was aspirated and dried under a stream of N2. Stamps were placed pattern-
side down onto 18 mm2 glass coverslips. Pressure was applied for 30 s to allow adsorption of ink 
to the glass, and the coverslips were incubated for 45 minutes. Stamps were removed, and the 
coverslips were used within one hour. 
5.2.4 PREPARATION OF HYDROGEL PRE-POLYMER SOLUTION 
Hydrogel pre-polymer solutions were prepared by dissolving 20% poly(ethylene glycol) 
diacrylate (PEGDA, MW 3400, Laysan Bio, Arab, AL USA) in PBS. The photoinitiator, 1-[4-(2-
hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one (Irgacure 2959, Ciba, Basel, 
Switzerland), was diluted to a 50% (w/v) stock solution in dimethyl sulfoxide (DMSO, Fisher 
Scientific). A final concentration of 0.5% (w/v) was added to the pre-polymer solution. All 
materials were prepared immediately before photopolymerization in the SLA. 
5.2.5 FABRICATION OF PHOTOPOLYMERIZABLE HYDROGELS 
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Hydrogel constructs were fabricated with a modified stereolithography apparatus (SLA 
250/50, 3D Systems, Rock Hill, SC).25 Cylindrical disks (5 mm radius) were designed in 
AutoCAD 2012 (Autodesk, San Rafael, CA USA) and prepared in 3D Lightyear v1.4 software 
(3D Systems, Rock Hill, SC) for cross-sectional slicing into 2D layers. Parameters were 
specified based on desired layer thickness. An 18 mm2 glass coverslip with unpatterned and 
patterned lines of fibronectin or acryl-fibronectin ink 10, 50, or 100 µm wide was fixed to a 35 
mm polystyrene dish with double-sided tape. Surfaces with no patterns were always used as 
controls. The dish was coated with hydrogel pre-polymer solution at a characterized volume 
determined by desired layer thickness. It was positioned at the center of the SLA platform and 
photopolymerized with a characterized energy dose of 150 mJ cm-2. After photopolymerization, 
disks were rinsed in PBS and allowed to swell overnight before cell seeding. 
5.2.6 CELL CULTURE 
NIH/3T3 mouse embryonic fibroblasts (ATCC, Manassas, VA USA) were cultured at 37 
oC and 5% CO2 in Dulbecco’s modified Eagle medium (DMEM, Cellgro, Manassas, VA USA) 
supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich, St. Louis, MO USA), 100 U 
ml-1 penicillin, and 100 µg ml-1 streptomycin (Gibco, Carlsbad, CA USA). Cells were passaged 
no more than 10 times using 0.25% trypsin and 0.04% EDTA in HBSS (Gibco, Carlsbad, CA 
USA). Prior to cell seeding, hydrogel constructs were positioned in 12-well plates with 
fibronectin and acryl-fibronectin patterns facing up. Cells were then seeded at a density of 
90,000 cells cm-2 over the hydrogels. 
5.2.7 FLUORESCENCE IMMUNOSTAINING 
To verify fibronectin transfer from patterned glass slides to hydrogels, monoclonal anti-
fibronectin produced in mouse (Sigma-Aldrich, St. Louis, MO USA) was diluted at 1:300 in PBS 
and added to the samples overnight at 4 oC. The solution was then aspirated and rinsed there 
times with PBS. Alexa Fluor 488 goat anti-mouse IgG (Life Technologies, Grand Island, NY 
USA) was diluted at 1:1000 in PBS and added for 2 hours at 37 oC. After rinsing three times with 
PBS, the samples were imaged with an inverted fluorescence microscope (IX81, Olympus, 
Center Valley, PA USA). 
To visualize the morphology of fibroblasts on hydrogel constructs, the cells were fixed 
and labeled at different time points. For fixation, samples were rinsed with PBS and incubated in 
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4% paraformaldehyde (PFA, Sigma-Aldrich, St. Louis, MO USA) for 30 minutes. After rinsing 
three times with PBS, a solution of 3,3′-dihexyloxacarbocyanine iodide (DiOC6, Life 
Technologies) was added at 1:1000 dilution in PBS to stain for a cell’s endoplasmic reticulum, 
vesicle membranes, and mitochondria. Samples were then permeabilized with 0.1% Triton X-
100 (Sigma Aldrich) for 10 minutes and blocked with 2.5% bovine serum albumin (BSA) in PBS 
to prevent non-specific binding. Cell nuclei were stained with a 1:1,000 dilution of 2-(4-
amidinophenyl)-1H-indole-6-carboxamidine (DAPI, Life Technologies), and actin was stained 
with a 1:1,000 dilution of rhodamine phalloidin (BD Biosciences). Fluorescent images were 
taken with the inverted fluorescence microscope. 
5.2.8 FIBRONECTIN AND ACRYL-FIBRONECTIN TRANSFER TO HYDROGELS 
ImageJ software41 was used for analysis of fibronectin, acryl-fibronectin, and cell 
alignment patterns. Transfer of fibronectin and acryl-fibronectin from glass coverslips to 
hydrogels were confirmed quantitatively by measuring the pixel intensity of fluorescent images. 
To calculate pixel intensity values, a line profile was drawn across the image and grey values 
were extracted at each point on the line. To determine the integrity and resolution of patterns, 
line width measurements of µCP glass coverslips and patterned hydrogels were taken. The line 
profile tool was used to draw horizontal lines perpendicular to patterned lines on 40x images, and 
the measured line widths were recorded. 
5.2.9 FAST FOURIER TRANSFORM ANALYSIS 
Fast Fourier transform (FFT) image processing analysis was previously demonstrated for 
cell patterning on hydrogels.42 Briefly, ImageJ software was used to enhance image contrast, 
subtract the background, and filter noise from the image. Images were converted to the frequency 
domain by FFT transformation and rotated 90o to account for the inherent rotation that occurs 
during transformation. A circle was drawn over the FFT image, and the oval profile plugin was 
used to radially sum pixel intensities around the circle. A power spectrum was generated based 
on radially summated values, with 0o correlating to frequencies at 3 o’clock, 90o at 12 o’clock, 
180o at 9 o’clock, and 270o at 6 o’clock.  
5.2.10 CELL MORPHOMETRICS ANALYSIS 
The effect of patterning at the cellular level was analyzed by observing changes in cell 
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shape, direction of cell elongation, and orientation of nuclei. Post-image processing, a threshold 
was applied to make a binary image and individual cells were identified. Image J software object 
tools were used to measure and compare the cell circularity and nuclear orientation. Ten 
circularity bins of 0.1 intervals were set up, and circularity values between 0 and 1 were placed 
in each bin (0 being a line and 1 being a circle). Significance was verified with a Student’s t-test 
statistical analysis. Nuclear orientation was measured by using the ‘analyze particles’ tool to fit 
an ellipse to threshold images of DAPI-stained nuclei and measuring the angle of the ellipse. 
Direction and length of cell elongation was determined by measuring the angle and distance from 
the nucleus to the furthest edge of the actin stained cell.   
5.3 RESULTS 
5.3.1 FIBRONECTIN TRANSFER AND PATTERN RETENTION 
To create patterns of proteins on 3D hydrogel constructs, we modified fibronectin 
molecules with chemically linkable acrylate groups for crosslinking to the backbone of PEGDA 
hydrogels during photo-polymerization. This simple concept allowed us to utilize the µCP 
technique to pattern acryl-fibronectin onto hydrogels prepared with the SLA (Fig. 5.1). We 
confirmed the transfer of acryl-fibronectin from glass coverslips to hydrogels by quantitative 
analysis of immunofluorescence imaging. Comparison of hydrogels built on glass coverslips 
with fibronectin (Fig. 5.2A) and acryl-fibronectin (Fig. 5.2B) showed that acryl-fibronectin 
successfully transferred from the glass coverslip to PEGDA (MW 3,400) hydrogels. The average 
pixel intensity of acryl-fibronectin on hydrogels was measured at 129 ± 10.9, while fibronectin 
on hydrogels had an average pixel intensity of 2.6 ± 0.5 (Fig. 5.2C). 
Patterned line widths of 10, 50, and 100 µm on glass coverslips and hydrogels were 
measured to verify pattern integrity after acryl-fibronectin transfer. Fig. 5.3 shows fluorescent 
images of patterned lines on glass coverslips and hydrogels. The actual line widths were 11.5 ± 
0.4 µm, 49.1 ± 1.8 µm, and 98.7 ± 0.60 µm, respectively, after PDMS stamping on glass 
coverslips (Fig. 5.3A), and 13.4 ± 0.5 µm, 57.3 ± 0.6 µm, 110.5 ± 5.8 µm, respectively, after 
acryl-fibronectin transfer to the 3D hydrogel constructs (Fig. 5.3B). Fibronectin transfer did not 
occur without acrylate groups (Fig. 5.3C). It is well-known that PEGDA (MW 3,400) swells after 
photopolymerization and subsequent washing in PBS. This phenomenon caused the measured 
line widths on the hydrogels to be greater than those on the glass coverslip (Fig. 5.3D). However, 
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the average pixel intensity of fluorescently-labeled acryl-fibronectin patterns on hydrogels did 
not appear to decrease significantly to the extent that it would affect cell alignment. 
5.3.2 CELL GROWTH AND ALIGNMENT ON HYDROGELS 
NIH/3T3 mouse embryonic fibroblasts were cultured on 3D hydrogel constructs with 
acryl-fibronectin patterns of unpatterned, 10, 50, and 100 µm wide lines to demonstrate 
feasibility of cell alignment. The cells rapidly adhered to and began to spread on the line patterns 
after one hour in culture. Within 24 hours, the cells were activated to proliferate along the line 
patterns. Fig. 5.4A shows that the cells recognized the acryl-fibronectin patterns and aligned 
parallel to the lines. As the line spacing decreased from 100 to 10 µm, number of cells that 
bridged patterned lines increased. Regardless of cell bridging, the cells continued to align 
parallel to the lines. 
It was evident from the fluorescent images that as the line patterns decreased from 100 to 
10 µm, alignment of individual cells increased. At 100 µm line patterns, the cells were generally 
not spatially-confined, and they could spread in any direction that was not restricted by a 
neighboring cell. This was confirmed quantitatively with fast Fourier transform analysis (Fig. 
5.4B). Conversion of images to the frequency domain revealed directed fibroblast growth and 
linear pattern formation. Distinct peaks were seen in the power spectrum of fibroblasts grown on 
patterned lines of all widths at 0o and 180o. Fibroblasts grown on unpatterned hydrogels lacked 
these peaks and had more uniformly-scattered spectrums. Furthermore, as the line widths 
increased, the peaks also decreased, and the spectrums were more scattered. 
Cell morphometrics were used to examine the individual shape of cells on patterned and 
unpatterned 3D hydrogel constructs. Growth of cells along the patterned lines altered their shape, 
making them more linear. Fig. 5.4C shows the decreasing shift of cell circularity measurements 
between patterned and unpatterned cells. Average circularity was significantly different 
(Student’s t-test, p-values = 1.97E-25 and 4.83E-25 for 10 and 50 µm lines, respectively) between 
unpatterned fibroblasts (0.41 ± 0.22) and fibroblasts restricted to growth on 10 µm (0.15 ± 0.10) 
and 50 µm (0.15 ± 0.11) lines. Cell shape was altered on 100 µm lines but was not statistically 
significant. 
Fig. 5.5 shows further analysis of the effect of acryl-fibronectin patterns on cell shape and 
growth. Fibroblast elongation, which was measured from the furthest edge of stained actin on 
97 
 
each side of the cell to the nucleus, was parallel to line direction. Average angles were 90.86, 
88.85, and 89.92o for 10, 50, and 100 µm lines respectively. Unpatterned fibroblasts had an 
average angle of 95.35o which was significantly different than patterned fibroblasts (Student’s t-
test, p-values = 4.6E-2, 4.9E-3, and 8.6E-4, respectively). Length of elongation caused by 
patterning showed a significantly greater difference. The average length of extended actin in the 
cell was 44.33 µm for unpatterned fibroblasts. Patterned cells had average lengths of 78.8, 54.9, 
and 40.6 µm for 10, 50, and 100 µm lines, respectively (Student’s t-test, p-values = 9.16E-18, 
6.78E-08, and 2.05E-4). Nuclear alignment proved to be insignificant (Student’s t-test, p = 0.42, 
0.90, 0.52 for 10, 50, and 100 µm) on patterned and unpatterned lines, although there was a trend 
seen that nuclei aligned parallel to patterns (average orientation = 79.97, 89.98, 93.43, and 93.13o 
for unpatterned, 10, 50, and 100 µm). The scatter plots in Fig. 5.5A and B show the clustering of 
cell elongation around 90o for cells grown on patterns and the distribution of nuclear alignment, 
respectively. 
5.4 DISCUSSION 
Applications for the SLA and other 3D printing platforms using living cells and cell-
instructive 3D microenvironments are expanding rapidly. However, none of these enabling 
technologies are without their drawbacks, and continual development is needed to accommodate 
for the growing number of applications. One of the current limitations of commercial laser-based 
stereolithographic systems is the minimum feature size required to imitate cell growth and 
alignment patterns in complex tissue architecture. While photopolymerizable hydrogels can be 
functionalized with proteins and peptides to enhance cell attachment, it is difficult to pattern 
them with the SLA at length scales comparable to the cell size. Grooves, microchannels, and 
other geometrically-restrictive techniques that affect the topology of the hydrogels can alter 
mechanical properties, which are important in many of these applications. 
Micro-contact printing (µCP) is a well-established technique that does not affect the 
mechanical properties of hydrogels. It was chosen to pattern acryl-fibronectin in combination 
with the SLA based on its ease of use, compatible setup, and unrestricted variation in shapes and 
sizes. Modification of fibronectin with acrylate groups (acryl-fibronectin) was the key 
component to this method. Without tethered ECM proteins or peptides, PEGDA hydrogels are 
intrinsically resistant to protein adsorption and cell adhesion. Based on low measured fluorescent 
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intensity, unmodified fibronectin did not transfer to the PEGDA hydrogels (Fig. 5.2A). In 
contrast, acryl-fibronectin had uniform and high fluorescent intensity throughout the surface of 
the hydrogels (Fig. 5.2B). This method is not restricted to fibronectin; other proteins or peptides 
with free lysine (-NH3) groups, such as laminin, collagen, and gelatin, can also be modified with 
acrylate groups using the same method described. The amino acid sequence for fibronectin was 
collected from a protein database (NCBI) to calculate the number of free lysine groups. 
PEGDA was chosen as the hydrogel material based on its tunable swelling ratio, elastic 
modulus, and pore size. It can also be modified for cell-specific adhesion, enzyme-sensitive or 
hydrolytic degradation, and growth factor-binding signals.43 The swelling ratio and pore size 
should be large enough to allow for an adequate supply of oxygen and nutrients, while the elastic 
modulus and patterning resolution should be high enough for the specific application. Fig. 5.3, 
which compared the measured line widths on glass coverslips and hydrogels, shows a decrease in 
the patterning resolution on the PEGDA (MW 3,400) hydrogels. By decreasing the MW of 
PEGDA, the patterning resolution can be improved because of the reduced swelling, but this can 
also affect the organization and function of cells on the hydrogels.  
Although a variety of other configurations are possible, we used line patterns to 
demonstrate directed cell growth and alignment on the hydrogels. The widths of those line 
patterns were varied to determine the length scale at which cells would align on the hydrogels. If 
widths are too thin, cell bodies may be larger than the lines, preventing appropriate cell 
attachment; if widths are too wide, cells may not recognize the patterns and align to them.44 
Previous findings show that individual cells can recognize lines measuring 5-100 µm wide.45 
Trends in our data support these findings, with single cells patterning to 10-50 µm wide lines and 
multiple cells patterning to 100 µm wide lines. In addition, a reduction in circularity can be seen, 
length of cell elongation, and angle of cell elongation differs between cells grown on patterned 
lines opposed to unpatterned cells. 
Line spacing was also varied to determine length scales at which ‘bridging’ of cells 
between patterns occurred. This could prove useful for applications that require cell-cell 
connections between patterns or formation of cell sheets, without disturbing their alignment. For 
example, it is known that the complex organization of cardiac muscle cells and fibroblasts is 
critical to electrical and mechanical properties in the heart. Because of this, biological cantilevers 
and actuators cultured with aligned sheets of contractile muscle cells could generate more force 
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than unaligned sheets. Cell bridging would synchronize contraction of the aligned muscle cells 
and increase density of cells on the devices. However, an optimum line width and spacing would 
need to be characterized to maximize the performance of the muscle cell sheet. If line spacing 
was too small, cells may not be restricted to the acryl-fibronectin patterns and align properly on 
the hydrogels. 
Other biological applications that study co-cultures and emerging behaviors of cells can 
benefit from this method. Motor neurons can be directed to align and interact with contractile 
muscle cells to form functional neuromuscular junctions (NMJ).46 These motor neuron and 
muscle co-cultures can be used as in vitro models to understand NMJ-related pathogenesis, drug 
discovery, and even creation of cellular machines that utilize the sensing and actuation 
capabilities of the two cell types. This method can also be directly employed to study stem cell 
niches based on various physical properties, such as cellular organization and matrix elasticity.47 
Organized cell alignment is critical to controlling tissue architecture and biological function. 
Overall, there are numerous future experiments and applications that can be explored with the 
ability to design 3D hydrogel substrates that can support, pattern, and harness the outputs of 
multiple cell types. 
5.5 CONCLUSION 
We have demonstrated a simple method for patterning and aligning living cells on 
hydrogel substrates by combining the micro-contact printing (µCP) technique with the 
stereolithographic process. The key component of this method was acryl-fibronectin, which 
could be patterned onto glass surfaces and transferred to photopolymerizable PEGDA hydrogels. 
NIH/3T3 mouse embryonic fibroblasts were cultured on hydrogels patterned with acryl-
fibronectin of various line widths. While resolution of the line widths depended on swelling 
ratios of the hydrogels, it did not visibly affect cell attachment or alignment on the patterns. 
Analysis of cells cultured on the hydrogels showed cells spreading and growing parallel to the 
direction of the lines. Cell ‘bridging’ occurred between patterns and increased as line spacing 
decreased. Overall, µCP can be used to enhance cell-based applications with the SLA by 
patterning proteins of various shapes and size on photopolymerizable hydrogels for directed cell 
growth and alignment. It can be used to increase hierarchical organization of cells in engineered 
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biohybrid systems, or to expand our understanding of developmental biology and mechanism of 
diseases. 
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5.8 FIGURES AND CAPTIONS 
 
 
Fig. 5.1 | Patterning acryl-fibronectin hydrogels. (1) Silicon wafers were coated with 5 µm of 
SU-8 photoresist. (2) Line patterns were formed after exposure of photoresist and silicon with 
UV light through a chrome mask. (3) PDMS was poured over the silicon master and polymerized 
by baking. A negative of the pattern from the silicon master was imprinted on the surface of the 
PDMS making a stamp. (4) An ink solution containing acryl-fibronectin was pipetted onto the 
PDMS stamp. Acrylic fibronectin was made by mixing acryl-PEG-NHS and fibronectin in PBS 
and allowing the PEGDA cross-linker to attach to free lysine groups in fibronectin. (5) After 
stamps were incubated with ink, line patterns were transferred to glass slides by stamping. (6) 
Pre-polymer solution of PEGDA (MW 3,400) and a photoactivator is poured into a dish over 
patterned glass slides. (7) The dish containing pre-polymer and patterned glass is put into the 
stereolithography apparatus (SLA) and polymerized to form a hydrogel. (8) 3D structures were 
built layer-by-layer adding additional pre-polymer before crosslinking. (9) Hydrogels were 
inverted and seeded with cells. During building of the first layer, acryl-fibronectin was 
transferred to the surface of the hydrogel allowing for cell attachment. 
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Fig. 5.2 | Measuring the transfer of fibronectin and acryl-fibronectin on hydrogels. 
Hydrogels were fabricated on glass slides with fluorescently-labeled fibronectin and acryl-
fibronectin. (A) Fluorescent image of a hydrogel fabricated on a glass slide with fibronectin. (B) 
Fluorescent image of a hydrogel built on a slide with acryl-fibronectin. (C) Using Image J 
software, fluorescent intensity of fibronectin and acryl-fibronectin images were extracted and 
compared. Hydrogels with fibronectin had an average intensity of 2.6, while those with acryl-
fibronectin had an average intensity of 129.9. This confirmed that acryl-fibronectin chemically 
cross-linked fibronectin to the hydrogels. 
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Fig. 5.3 | Transferring fibronectin patterns from glass coverslips to hydrogels. (A) Glass 
coverslips with fluorescently-labeled acryl-fibronectin lines 10, 50, and 100 µm wide. (B) 
Hydrogels with fluorescently-labeled acryl-fibronectin lines 10, 50, and 100 µm wide transferred 
from glass coverslips. (C) Hydrogels with fluorescently-labeled fibronectin lines 10, 50, and 100 
µm wide (control). (D) Comparison of measured line widths on glass coverslips and hydrogels.  
Scale bars represent 50 µm wide. 
  
107 
 
 
 
Fig. 5.4 | Aligning fibroblasts on unpatterned and patterned hydrogels. (A) Fibroblasts with 
fluorescent nuclear (DAPI) and actin (rhodamine-phalloidin) stains were cultured on hydrogels 
with unpatterned and patterned acryl-fibronectin with lines 10, 50, and 100 µm wide. (B) Power 
spectrum generated by radially summating frequencies from fast Fourier (FFT) converted 
images. Peaks at 90o and 180o correspond to vertical alignment in images and can be seen for 
fibroblasts patterned on lines. (C) Analysis of fibroblasts at the cellular level shows a significant 
decrease in circularity for cells grown on 10 and 50 µm lines. A small but insignificant shift can 
be seen on 100 µm lines. A decrease in circularity can be attributed to a constriction of cellular 
growth area. Scale bars represent 50 µm wide. 
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Fig. 5.5 | Measuring direction of cell elongation and nuclear alignment of fibroblasts. (A) 
Cell elongation and direction was measured by drawing a line from the nucleus to the furthest 
extended edge of the cell. Scatter distribution shows clustering of cell elongation near 90o for 
fibroblasts grown on 10 and 50 µm lines. Unpatterned cells were significantly different in both 
elongation and uniform distribution of edge direction. (B) Nuclear alignment was measure by 
fitting an ellipse to images of cell nuclei labeled with DAPI. There was no significant difference 
in the elongation or alignment of cell nuclei, but a trend in clustering near 90o for patterned cells 
was seen. 
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CHAPTER 6: LOCOMOTIVE BIO-BOTS WITH 2D CELL SHEETS 
6.1 INTRODUCTION 
A ‘biological machine’ or cellular system can be defined as a set of sub-components 
consisting of living cells and cell-instructive micro-environments that interact to perform a range 
of prescribed tasks.1 Examples of prescribed tasks include sensing, information processing, 
transport, protein expression, and actuation. By combining clusters of different cell types, such 
as neurons, muscle cells, and endothelial cells, complex biological machines can possibly be 
created for specific applications in health, security, and the environment. Exemplary biological 
machines include organ mimics for drug testing, biological robots for replication and repair, and 
implantable systems for drug sensing, synthesis, and release.2 An intelligent and instructive 
micro-environment is critical in these efforts to understand and design biological machines. The 
cells have to thrive, communicate, and proliferate in such a micro-environment while performing 
their designated functions. These engineered 2D and 3D micro-environments should form the 
scaffolding of biological machines, and should have spatially controlled mechanical and 
chemical properties to control their functionalities.3 The development of enabling technologies 
that can fabricate the desired intelligent scaffold will greatly expedite the development of 
biological machines.4-8 
Progress in developing biological actuators powered by mammalian cells has been 
limited to just a few reports. Carlo Montemagno and colleagues9 cultured cardiomyocytes on a 
patterned film of chromium and gold attached to a thin silicon beam. After releasing the 
microdevice, muscle contractions caused the beam to break from the rest of the structure and 
bend/stretch in a walking motion, traveling at a maximum speed of 38 µm·s-1. Sukho Park and 
colleagues10 created a microrobot with grooved cantilever beams by micromolding PDMS and 
aligning primary cardiac cells on the grooves to enhance their contractility. Relative to flat 
beams, an increase in force (88%) and bending (40%) was recorded, with an average walking 
speed of 140 µm·s-1. Finally, Kevin Kit Parker and colleagues11 seeded cardiomyocytes on 2D 
thin films of PDMS, which were cut into various shapes. When released, the thin films curled or 
twisted into 3D conformations that performed customized functionalities of gripping, pumping, 
walking (133 µm·s-1), and swimming functions (400 µm·s-1). Recently, these thin film devices 
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were used to reverse engineer jellyfish-like constructs with comparable functional 
performance.12 
In this study, we built a biological machine with an actuation module for locomotion, 
which we refer to as an autonomous “bio-bot”. Actuation produced by a cluster of muscle cells 
when appropriately designed can be used to power the bio-bot. Our central hypothesis is that by 
integrating 3D lithographic technology with appropriate biomaterials, we can ‘forward-engineer’ 
spatially organize contractile cardiac cells on a bio-bot with desired geometry, mechanics, and 
cell adhesion molecules for optimal and robust locomotion. A stereo-lithographic apparatus 
(SLA) is a rapid prototyping tool13,14 used to produce 3D models, prototypes, and patterns by 
repetitive deposition and processing of individual layers.15,16 It uses an ultraviolet laser (325 nm) 
to directly write on and polymerize photosensitive liquid materials based on a computer-aided 
design (CAD)-based digital blueprint, sliced into a collection of 2D cross-sectional layers, and 
processed into a real 3D part using layer-by-layer polymerization. The automated, high-
throughput process can be particularly useful for the development of cellular systems due to its 
multi-material capability,17-19 which has been used with photopolymerizable hydrogels20,21 to 
pattern cells or proteins at precise locations on the structure.22,23 Cell adhesion domains, growth 
factors, and hydrolytic and proteolytic sequences can be incorporated into the backbone. With 
this technology, we expect to build biological machines with a number of prescribed tasks. 
Here, we build on our earlier work of developing cell-based biohybrid actuators19 by 
incorporating it into the design of our autonomous bio-bots for locomotion. We show that the 
initial shape and degree of curvature of the bio-bot cantilever can be precisely defined by 
adjusting its thickness during fabrication. The tension generated by self-organizing 
cardiomyocytes into cell sheets on the cantilever results in the final curvature. Based on its radii 
of curvature, the residual stress and cell-induced surface stresses on the cantilevers can be 
simulated and used in future designs. By harnessing an asymmetric design and the synchronous 
contraction of the cardiac cell sheet, we demonstrated a walking motion of the bio-bot. 
Locomotion was predicated on varying friction between the bio-bot legs and the substrate during 
the course of contraction. We examined how altering the cantilever curvatures can change the 
surface area of contact, and hence, the friction, and its effect on net forward movement of the 
bio-bot. Together, these studies demonstrate a unique approach to the design and fabrication of a 
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walking, autonomous bio-bot with hydrogels and cardiomyocytes, and explain the mechanisms 
underlying the directional actuation. 
6.2 MATERIALS AND METHODS 
6.2.1 PREPARATION OF 3D PRINTER AND PRE-POLYMER SOLUTION 
The 3D printer, SLA 250/50 (3D Systems), was modified as described previously.23 
Briefly, an 18 x 18mm square No. 1 cover glass (0.13-0.17 mm thick, Corning) was attached to 
the center of a 35 mm culture dish (Corning) using two 1 x 1mm squares of double-sided tape. 
The dish was positioned at the center of the printing platform. Poly(ethylene glycol) diacrylate 
(PEGDA) of Mw 700 (Sigma-Aldrich) or 3400 (Laysan Bio) was dissolved in sterilized distilled 
water (dH2O) to form a 20% (w/v) pre-polymer solution. The photoinitiator, 1-[4-(2-
hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one (Irgacure 2959, Ciba), was 
dissolved in dimethyl sulfoxide (DMSO, Fisher Scientific) at 50% (w/v) stock solution and 
added to the pre-polymer solution to form 0.5% (w/v) of photoinitiator. 
6.2.2 BIO-BOT FABRICATION 
CAD models of bio-bot arrays were generated using AutoCAD 2012 (Autodesk) and 
exported to 3D Lightyear v1.4 (3D Systems) in .stl format. The models were sliced into thin 2D 
cross-sectional layers. PEGDA MW 3400 pre-polymer solution was pipetted into the culture dish 
at carefully characterized volumes. An ultraviolet laser beam was used to selectively crosslink 
the bio-bot cantilever structures at 150 mJ/cm2. The elevator controlled by the SLA 250/50 was 
lowered by a distance equal to the thickness of the layer. Uncrosslinked PEGDA MW 3400 was 
removed, and replaced with PEGDA MW 700 to begin building the bio-bot bases. PEGDA MW 
700 was pipetted into the culture dish at the same volume that PEGDA MW 3,400 was removed. 
The laser was used to selectively crosslink the bio-bot base. The part was recoated with 250 µL 
of PEGDA MW 700, and the process was repeated until completion of the bio-bot base structures. 
The bio-bot arrays were rinsed with dH2O in a shaker to remove uncrosslinked pre-polymer 
solution. 
6.2.3 SURFACE FUNCTIONALIZATION WITH COLLAGEN 
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The bio-bot constructs invariably swelled and lifted-off the glass coverslips because of 
their hydrogel material. Each construct was transferred using a small spatula onto individual 12 
mm circular glass coverslips (Fisher Scientific) with cantilevers down (as fabricated). 
Sufosuccinimidyl-6-(4’-azido-2’-nitrophenylamino)-hexanoate (Sulfo-SANPAH; Pierce 
Biotechnology) was prepared at 0.5 mg/mL in sterilized 50 mM HEPES, pH 8.5 immediately 
before use. Approximately 100 µL volume of Sulfo-SANPAH solution was added to cover the 
bio-bot cantilever structures. The solution was exposed to a 302 nm ultraviolet lamp (UVP Blak-
Ray) at a distance of 3 inches for 5 min. The solution was aspirated out and the bio-bots were 
rinsed with HEPES solution to eliminate excess solution. Collagen was prepared at a 
concentration of 0.10 mg/mL in 0.1 N acetic acid. It was added to cover the bio-bot cantilever 
structures and incubated overnight at 37 oC. The solution was then aspirated and rinsed with 
sterilized water and PBS, pH 7.4. 
6.2.4 RAT HEART DISSECTION AND CELL SHEET FORMATION 
Complete growth medium consisted of Dulbecco’s modified Eagle’s medium (DMEM, 
Corning cellgro), 10% horse serum (HS, Lonza), 2.5% fetal bovine serum (FBS, Atlanta 
Biologicals), 100 U mL-1 penicillin, and 100 µg mL-1 streptomycin (Gibco). Neonatal hearts 
obtained from 0-5 day old Sprague-Dawley rats were dissected according to the Institutional 
Animal Care and Use Committee (IACUC) at the University of Illinois, Urbana-Champaign, 
under an approved protocol #11160. Briefly, whole hearts were excised from the rats and 
immediately placed in ice-cold HBSS buffer. Ventricles were separated from the hearts and 
minced into 1 mm3 pieces with small scissors in ice-cold HBSS. The minced ventricles were 
gently rocked in sterilized 0.1% (w/v) purified trypsin (Worthington Biochemical) in ice-cold 
HBSS for 18 hours at 4 oC. Complete growth medium was added to inhibit trypsin digestion and 
warmed in the water bath at 37 oC for 5 min. The tissue was then digested in warm 0.1% (w/v) 
purified type II collagenase (Worthington Biochemical) in HBSS on a rocker for 45 min at 37 
oC. The tissue was gently triturated to mechanical loosen cells and passed through a 75 µm cell 
strainer to filter undigested connective tissue. Cells were pelleted by centrifugation at 150 x g for 
5 minutes to remove the supernatant with trypsin and type II collagenase. After re-suspension in 
warm complete growth medium, the cells were pre-plated twice for 30 minutes each to enrich for 
cardiac myocytes. The cells were counted and seeded on the bio-bot cantilever structures at 
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1,800 cells mm-2. The cell-laden bio-bots were incubated overnight at 37 oC and 5% CO2 before 
changing the medium. 
6.2.5 EXPERIMENTAL SETUP AND ANALYSIS 
Side-view images and movies of the bio-bots were taken with a Sony Handycam DCR-
SR68 camcorder at 30 frames per second (fps). The camcorder was fixed on a custom-made 
multi-axis stage (Thorlabs). Top-view images and movies of the bio-bots were taken with digital 
microscope cameras (Flex and RT3, SPOT) and software on either an inverted microscope 
(IX81, Olympus) or stereomicroscope (MZ FL III, Leica). Movies were recorded at 
approximately 11 fps. Net displacement of bio-bot forward motion was measured using the 
Measure Tool in Photoshop software (CS5.1, Adobe) by superimposing consecutive frames. 
Frames (3 ms) were extracted in Movie Maker (Windows) software. Contact area of the bio-bot 
legs to the substrate was also measured with side-view movies in Movie Maker and Photoshop, 
with the assumption that the contact was uniform into the frame.  
6.2.6 CHARACTERIZATION OF CANTILEVER THICKNESS 
Thicknesses were characterized by embedding 0.1% (w/v) fluorescent polystyrene beads 
(500 nm, Spherotech) at 1:500 dilution in the cantilevers during photopolymerization. To change 
the cantilever thickness, the volume of the pre-polymer solution was varied. After 
photopolymerization, the cantilevers were allowed to swell in PBS on a shaker overnight at room 
temperature. An inverted fluorescent microscope (IX81, Olympus) with IPLab (Becton 
Dickenson) software was used to optically measure the vertical position of the microscope stage 
by manually adjusting the focus on the topmost layer of beads in the gel, z1. The vertical position 
was then readjusted to the bottommost layer of beads in the gel, z2. The cantilever thickness was 
then calculated using: d = z2 - z1. 
6.2.7 DETERMINATION OF THE RADII OF CURVATURE 
To minimize manual error in measuring the radius of curvature (ROC), we used the 
average of the three ROCs obtained by three independent methods. First, we used the 
ThreePointCircularROI plugin in ImageJ software (NIH), which automatically calculates the 
center of circle and the radius of curvature from the three manually-specified points on the 
cantilever image. Secondly, we used the arc angle of the bent cantilever, θ to calculate ROC. The 
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center of the circle calculated with previous method was used to measure the arc angle. Since the 
length of the cantilever, Lc is fixed to be 4 mm, the ROC can be readily obtained with a simple 
equation Lc = θ *ROC. Lastly, the fitting circle was manually superimposed on the cantilever 
images and the radius of the circle was used. 
6.2.8 FINITE ELEMENT SIMULATION OF CANTILEVER SURFACE STRESSES 
The residual and cell-induced surface stresses were extracted with finite element analysis 
software (ANSYS). The radius of curvature (ROC) of the cantilever with varying surface stress 
(0~0.5N/m) on its bottom side was simulated and the residual surface stress was interpolated 
from the simulation results with the measured ROC from the experimental images. The cell-
induced surface stress was obtained in similar manner. The ROC of the cantilever with the 
previously obtained residual surface stress on the bottom side and varying surface stress 
(0~0.5N/m) on the top side, as simulated and the cell-induced stress was interpolated with the 
experimentally measured ROC. 
6.3 RESULTS 
6.3.1 BIO-BOT FABRICATION 
A 3D stereo-lithographic printer was used to build an array of multi-material bio-bots 
(Fig. 6.1A). Each bio-bot consisted of 'biological bimorph' cantilever structures and a base 
structure as its main components. The cantilevers were fabricated first; a pattern of the 
cantilevers was traced onto the surface of a thin layer of PEGDA (Mw 3,400) hydrogel precursor 
solution with an ultraviolet (UV, 325 nm) laser beam. The part was then recoated with a thin 
layer of PEGDA (Mw 700) hydrogel precursor solution, and the laser traced a pattern of the 
bases. This layer-by-layer process was repeated until the base structures were complete (Fig. 
6.1B). The cantilever material was chosen to mimic the elasticity of the rat heart muscle (22-50 
kPa),24 while the base material was chosen to be rigid (~500 kPa) and to retain its shape.19 A top 
down image of an array of bio-bots with cantilevers (7 x 2 mm) attached to their corresponding 
bases (2 x 2 mm) is shown (Fig. 6.1C). Since PEG is relatively inert, it requires surface 
modification with extracellular matrix proteins to enable subsequent cell attachment. We coated 
type I collagen onto the surface of the cantilever through addition reactions of light-activated 
Sulfo-SANPAH. Cardiomyocytes derived from neonatal rat hearts were extracted and seeded 
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onto the cantilevers (Fig. 6.1D). The cardiomyocytes attached to the cantilevers, increased in 
size, and exhibited spontaneous contractile activity. Over several days, they produced a confluent 
culture and formed a cardiac cell sheet that contracted in synchrony.  
6.3.2 DESIGN CONSIDERATIONS FOR LOCOMOTION 
Our primary experimental approach was to use the 3D printer to generate precise and 
iterative designs of a bio-bot that would demonstrate and help understand the basic mechanical 
principles for simple locomotion. The first condition was to design a bio-bot that could produce 
asymmetric actuation. Actuation was a result of the contractile forces of a cardiac cell sheet to 
retract a cantilever structure (a power stroke). A bio-bot with appropriate asymmetry would 
maximize the use of a power stroke for net forward movement. To support this argument, we 
created a symmetric bio-bot in which the base was positioned at the center of the cantilever. 
While the bio-bot actuated with each power stroke, it did not generate any net forward 
movement. Consequently, we re-positioned the base away from the center of the cantilever to 
establish an asymmetric structure. To accomplish this, the length of the cantilever was shortened 
on one side of the base. Cross-sectional images showing several iterations of the bio-bot were 
taken after rotating it onto its base (Fig. 6.1E). The last iteration was used as the final bio-bot 
design, as illustrated by a schematic image with attached cardiac cell sheet (Fig. 6.1F). 
The second condition was to optimize the shape of the bio-bot, which was determined by 
the curvature of the cantilever, in order to regulate the friction between bio-bot “legs” and 
substrate. Friction is necessary to generate propulsive forces for locomotion. As it relates to the 
surface area of contact, friction can be optimized by using a cantilever with proper curvature. 
The residual surface stress generated during photopolymerization was employed to introduce a 
well-controlled curvature on the hydrogel cantilever following hydrogel swelling. The final 
curvature of the cantilever was a combined effect of the residual surface stress in the hydrogel 
fabrication process and a cell-induced surface stress originated from the cardiac cell sheet. By 
varying the thickness of the cantilever, we were able to control the initial and final curvature of 
the cantilever as well as the locomotive mechanism of the bio-bots. The thickness of the 
cantilever can be easily controlled by adjusting the volume of PEGDA (MW 3400) hydrogel 
precursor solution that was added during fabrication (Fig. 6.2).  
6.3.3 EXTRACTION OF RESIDUAL AND CELL-INDUCED SURFACE STRESSES 
116 
 
For quantitative analysis of the bending mechanism of the cantilever, bio-bots with five 
different cantilever thicknesses were fabricated and imaged before seeding the cardiomyocytes 
(Fig. 6.3A) and after formation of the cardiac cell sheet (Fig. 6.3B). The cantilevers before cell 
seeding were bent upward by the residual surface stress on the top side of the cantilever and the 
curvature of the cantilever increased with decreasing cantilever thickness. After the formation of 
the cardiac cell sheet, it was clearly shown that the cell-induced surface stress on the bottom side 
of the cantilever decreased the curvature of the cantilever or even bent the cantilever downward.  
The radii of curvature (ROC) of the cantilevers were measured from the cross-sectional 
images and presented as the inverse of the measured ROC (Fig. 6.3C). From the measured ROC 
of the cantilevers, the intrinsic residual surface stress and the cell-induced surface stress were 
extracted using finite element analysis (Fig. 6.3D and 6.4). The intrinsic residual surface stress 
was 200 ± 62 mN·m-1, and decreased with decreasing cantilever thickness. The origin of the 
residual surface stress can be attributed to the changes of laser intensity through the thickness of 
the cantilever during photopolymerization. As the laser penetrates the hydrogel precursor 
solution, its intensity decreases exponentially as described by the Beer-Lambert law. It is 
speculated that varying the intensity of the laser affected the mechanical properties of the 
hydrogel during photopolymerization, and that the variation in the swelling properties would 
lead to the generation of the surface stress.19 The dependence of the residual surface stress on the 
cantilever thickness can be explained in a similar manner. As the cantilever becomes thicker, the 
difference in laser intensity increases and the cantilever experiences a larger variation in 
hydrogel swelling, resulting in higher residual surface stress. The final curvature of the cantilever 
was also affected by the surface stress induced by cytoskeletal tension of the cardiac cell sheet on 
the bottom side of the cantilever. As the cardiac cells adhered to the cantilever surface and 
formed a sheet, cell traction forces25 from that sheet generated a compressive surface stress on 
the bottom side of cantilever surface and forced the cantilever to bend downward. This cell-
induced surface stress was found to be 155 ± 30 mN·m-1. 
6.3.4 DEMONSTRATION OF LOCOMOTION 
By varying the thickness and the curvature of the cantilever, three distinctive locomotive 
mechanisms were demonstrated (Fig. 6.5). Bio-bot 1 with 229~326 µm thick cantilever exhibited 
the first locomotive mechanism, in which the bio-bot was turned upside-down with an up-facing 
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base so that the actuating leg would be in contact with the substrate. The 182 µm thick cantilever 
would result in the bio-bot 2. When relaxed, the actuating leg of bio-bot 2 was not in contact 
with the substrate, but the leg retracted against the substrate during its power stroke. Bio-bot 3 
was implemented with the 155 µm thick cantilever. The locomotive mechanism of bio-bot 3 was 
similar to that of bio-bot 2, except that the actuating leg was always in contact with the substrate. 
The movements of the bio-bots with the following cantilever thicknesses, 326 ± 17 (bio-bot 1), 
182 ± 31 (bio-bot 2), and 155 ± 9 (bio-bot 3) µm, were further evaluated by quantitative 
characterization. 
Time course images show net displacement of the bio-bots (Fig. 6.5 A-C). The 
cumulative net displacement over 30 seconds was 0, 7.15, and 1.95 mm, with an average velocity 
of 0, 236, and 71 µm·s-1 for bio-bots 1, 2, and 3, respectively (Fig. 6.5D). We also measured the 
net displacement of the bio-bots over 10 power strokes. The cumulative net displacement over 10 
power strokes was 0, 3.37, and 1.82 mm, with an average displacement per power stroke of 0, 
337, and 182 µm for bio-bot 1, 2, and 3, respectively. High R-squared values (above 0.999) 
shows that the locomotive mechanism produces a stable and identical movement of the bio-bots 
for each power stroke. The average beating frequencies of the cardiac cell sheets were found to 
be 1.14, 1.50, and 0.39 Hz for bio-bots 1, 2, and 3, respectively, at the time of recording (Fig. 
6.6A). The beating frequencies showed fluctuations during different measurement periods (Fig. 
6.6B).  
6.3.5 EVALUATION OF THE LOCOMOTIVE MECHANISMS 
The driving force for locomotion of our bio-bot is the ‘biological bimorph’ cantilever 
consisting of a cardiac cell sheet and a variably-thick hydrogel layer. Spontaneous contraction of 
the cell sheet causes the cantilever to actuate and produce a power stroke. We will refer to the 
cantilever as the actuating leg. The power stroke of the actuating leg must exceed all opposing 
forces which are dominant at these length scales, including drag force and friction in an aqueous 
medium. Friction between the actuating leg and substrate must be present. If it is too low, the 
actuating leg will slide; if it is too high, it will prevent the bio-bot from moving forward. Friction 
between the supporting leg and substrate is also needed to balance the relaxation force of the 
actuating leg; otherwise, the bio-bot will slide back to its original position. Therefore, friction 
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between the legs and substrate need to be adjusted to maximize the power stroke for net forward 
movement. 
Friction (F) is proportional to the actual area of contact (A): ܨ ൌ ߤܰ ൌ ߤܰሺܣሻ, where µ 
is the coefficient of friction and N is the normal force.26 There are two forms of friction to 
consider here: kinetic and static. The applied force needed to overcome static friction of a 
stationary bio-bot is greater than that to keep it sliding, or kinetic friction. The angle of repose 
method was used to determine the coefficients of static (µs) and kinetic (µk) friction by raising 
and lowering the incline plane until the bio-bot started and stopped sliding, respectively. The 
measured angles, ߠ௦ = 39.7 º for static friction and ߠ௞ = 18.9 º for kinetic friction, were used to 
calculate their coefficients of friction: ߤ௫ ൌ tanߠ௫, which were µs = 0.83 and µk = 0.34. Relative 
friction forces were generated for each of the legs against the substrate by multiplying the area of 
contact by the normalized ratio of µx/µk depending on the motion state, as assessed through video 
capture (Fig. 6.7). 
By changing the ROC of the cantilevers, we were able to generate three different 
iterations of bio-bots with distinct locomotive mechanisms. To evaluate how these bio-bots 
moved, we analyzed their representative power strokes using a digital camcorder at 30 frames 
per second (fps). A single power stroke spanned a total of 39, 27, and 30 ms each for bio-bots 1, 
2, and 3, respectively. Bio-bot 2 produced power strokes with the shortest time and farthest 
distance of all three bio-bot designs. The sequence of a single power stroke for each bio-bot was 
revealed in several characteristic steps (Fig. 6.8). We examined each of these power strokes as it 
relates to the aforementioned principles to evaluate the efficiency of their locomotive 
mechanisms: 
Bio-bot 1 – Generally, there was no net forward movement from bio-bot 1. The actuating 
leg slid back and forth between power strokes and subsequent relaxation periods (Fig. 6.8 A and 
B). This would indicate that there was not enough friction between the actuating leg and 
substrate to generate enough propulsion force to overcome the friction between the supporting 
legs and substrate (Fig. 6.8C). Without displacement of the supporting leg, the actuating leg 
returned to its original position. As it relates to friction, similar surface areas of contact between 
both legs and the substrate seem to support this argument. Without a dominant power stroke, bio-
bot 1 would not able to overcome the opposing friction of the supporting leg to produce net 
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forward movement. However, there was the rare case that bio-bot 1 moved very slowly (27 
µm·s-1). 
Bio-bot 2 – The mechanism of locomotion for bio-bot 2 was the most efficient and 
produced the largest net displacement. During the power stroke, the actuating leg bent against the 
substrate, which caused a conformational change in its shape (Fig. 6.8 D and E). As a result, 
there was an increase in contact area of the actuating leg. The supporting leg tilted upward, 
causing a decrease in its area of contact. During relaxation, the bio-bot reverted back to its 
original conformation. Because the friction of the actuating leg was greater than the friction of 
the supporting leg, it resulted in net forward motion (Fig. 6.8F). After returning to its original 
conformation, the contact area (and thus, the friction) of the supporting leg increased, which 
prevented the bio-bot from moving backwards. 
Bio-bot 3 – The mechanism of movement for bio-bot 3 worked similarly, but less 
efficiently. The actuating leg was already in contact with the substrate. During the power stroke, 
it retracted, causing a similar forward tilt of the supporting leg (Fig. 6.8 G and H). However, the 
friction of the actuating leg was smaller and did not change much. The supporting leg friction 
decreased as a result of the tilt, causing net forward movement during relaxation. However, 
during relaxation, the friction of the supporting leg was not high enough to withstand the 
momentum from relaxation of the actuating leg, which caused the bio-bot to slide back slightly. 
Therefore, the net displacement of bio-bot 3 was smaller than that of bio-bot 2 (Fig. 6.8I). 
6.4 DISCUSSION 
While various non-biological mechanical devices have been reported for locomotion on 
surfaces27,28 and in aquatic environments29, locomotion using biological elements has remained a 
major challenge. Inspired from biological micromachines, we have developed precise and 
repeatable methodologies for realizing autonomous, walking biological machines using a 3D 
stereo-lithographic printer. This technology enables convenient design and fabrication of bio-
bots for actuation and locomotion. The 3D printer is particularly useful for testing numerous 
iterations of designs because of the reduction in cycle time for fabricating new constructs and the 
ease with which to do so by simply editing a CAD model. In contrast, micro-fabrication 
techniques require master molds patterned by photolithography. This conventional process 
requires clean room facilities and equipment, which limits the complexity of multi-layer 
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constructs and the ability to make changes rapidly. Furthermore, a multi-material component can 
be added to the 3D printer for changing the synthetic material composition or inserting cells or 
proteins at precise locations in the structure. Thus, material properties, such as substrate elasticity 
or cell adhesiveness, can be specified depending on the desired structure and function of the bio-
bot to maximize force output. Hydrogels also have the unique capability of being used 
simultaneously as sensors, actuators, and delivery systems for therapeutic agents. Kong and 
colleagues demonstrated that reservoirs of living ‘cell factories’ can be embedded in a 
numerically-designed, 3D-printed hydrogel to produce and deliver growth factors in a sustained 
and targeted manner. These cell factories were used to actively stimulate and pattern new blood 
vessels.30 Shinohara and colleagues demonstrated that glucose oxidase can be combined with 
pH-sensitive hydrogels to sense glucose and regulate insulin release. The presence of glucose 
and its subsequent conversion to gluconic acid by glucose oxidase enhanced insulin permeability 
through the hydrogel because of the lower pH.31 These and other intelligent hydrogels, which 
respond to stimuli such as pH, temperature, enzyme, antigen, glucose, and electrical stimulation, 
can eventually be integrated into the bio-bots to add new tasks and functionalities.32 
It will be necessary to further improve net displacement and longevity of the bio-bots, as 
well as to implement control mechanisms for developing more complex biological machines. 
Improved net displacement will be dependent on an optimized bio-bot design and proper 
formation of the cardiac cell sheet to include alignment and appropriate ratios of 
cardiomyocytes-to-fibroblasts. Increased longevity is important for long-term function of 
complex biological machines. The ‘biological bimorph’ cantilevers of our bio-bots perform 
optimally for 3-5 days before the contraction force of the power stroke decreases significantly. 
This is also seen in other cell-based biohybrid actuators.9,10 A decrease in performance can be 
attributed to enzymatically-isolated cardiac myocytes reverting to a less differentiated phenotype 
by losing many of their myofibrils and other ultrastructural properties when cultured in 
monolayers. Furthermore, while a heterogeneous cell composition is necessary for the alignment, 
elongation, and network formation of cardiac myocytes and the secretion and degradation of 
ECM components,34 high fractions of proliferative noncardiac cell populations can be 
detrimental to the performance by forming high resistance junctions with cardiac myocytes that 
act as passive current sinks.35 It has also been found that the ultrastructure closely resembles the 
adult ultrastructure if the culture cells are placed into media containing low serum concentrations 
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which inhibits cell division and favors differentiation. By optimizing factors such as plating 
density, embryonic/neonatal age of the hearts, composition of the culture medium, and period in 
culture while minimizing damage during cell isolation, we can improve its long-term 
performance. Cultivation of cardiac myocytes in 3D biomaterial scaffolds along with 
electrically-induced stimulation rather than relying on spontaneous contraction may also promote 
more differentiated cellular phenotype and function.36  
Future work to control when the bio-bot starts and stops or changes speed or direction 
can be implemented for more complex locomotion. For example, influence of various drug 
treatments and other control mechanisms are available.37 The addition of isoproterenol (β-
agonist) or carbamylcholine chloride (cholinergic agonist) will increase or decrease contraction 
frequency of the cardiac cell sheet, respectively. Heptanol is a gap junction blocker that will 
reversibly stop synchronous contraction. Pulsatile electrical stimulation can also be used to 
induce and pace the muscle cells.38 Recently, light-induced stimulation of genetically-engineered 
muscle cells that express the light-activated cation channels, halorhodopsin or channelrhodopsin-
2 was demonstrated.39-42 Integration of these engineered muscle cells to optically drive the bio-
bots offers another exciting future possibility. Furthermore, we envision that neural networks can 
be integrated into our bio-bots to regulate muscle contraction through neuromuscular 
junctions.43,44 Clusters of sensory neurons can be engineered to sense and monitor the 
concentration of a particular species, drive the synthesis of a neurotransmitter, and communicate 
it to the processing neurons. The processing neurons can then initiate locomotion by translating 
these sensory events into action potentials that activate muscle contraction. One particular task 
that the bio-bots could be instructed to perform is to sense and move toward a chemical toxin and 
subsequently release chemicals to neutralize the toxin. Many challenges would still need to be 
addressed, including the development of in vitro neuromuscular junctions, neuronal circuitry to 
control the actuation of the muscle strips, coordination of the biological actuators for net 
movement, sensing of the target neurotoxins, and release of the neutralization agents by cell 
factories embedded in the hydrogels. Overall, the potential applications for these bio-bots can be 
truly transformative in the areas of biosensing, drug delivery, energy production, environmental 
remediation, and the development of artificial immune systems. In summary, we believe that our 
work provides a path to design and produce intelligent multi-cellular bio-bots for applications in 
health, security, and the environment.  
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6.7 FIGURES AND CAPTIONS 
 
 
Fig. 6.1 | Fabrication and cell seeding methods. (A) Diagram of 3D stereo-lithographic printer 
consisting of a HeCd laser at 325 nm and galvanometer scanning mirrors. The mirrors are 
computer-controlled, and a stage lowers the part a specified distance after each layer. (B) Process 
flow diagram for high-throughput array of bio-bots. (C) Representative top-down images 
depicting an array of fabricated bio-bots with cantilever and base structures. (D) Process flow 
diagram for functionalization of the cantilevers with collagen and seeding of cardiac cells. (E) 
Representative cross-sectional images depicting iterative bio-bot designs from symmetry-to-
asymmetry. (F) Diagram of final bio-bot design consisting of biological bimorph cantilever with 
seeded cardiac cell sheet. All scale bars are 1 mm 
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Fig. 6.2 | Characterization of cantilever thickness. Plot of cantilever thickness vs. volume of 
pre-polymer solution in experimental set-up. Volumes below 550 µL did not cover build area for 
uniformly-thick polymerization. 
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Fig. 6.3 | Design of bio-bots through residual and cell-induced surface stresses. (A) 
Representative cross-sectional images of bio-bots with varying cantilever thicknesses. After 
overnight swelling, the residual stresses cause the cantilevers to curl upward, depending on the 
thickness of the cantilever. (B) Representative cross-sectional images of bio-bots three days after 
cardiac cell seeding on the cantilever side facing the base. Cytoskeletal tension from the cells 
causes the cantilever to curl downward to a final bio-bot shape. (C) Plot of inverse radius of 
curvature vs. cantilever thickness for residual (pre-seeded) and residual + cell-induced curvature 
(post-seeded). (D) Plot of surface stress vs. cantilever thickness for residual and residual + cell-
induced curvature. All scale bars are 1 mm. 
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Fig. 6.4 | Extraction of residual and cell-induced surface stresses. (A) Plot of inverse radius 
of curvature vs. surface stress for residual curvature (pre-seed). (B) Plot of inverse radius of 
curvature vs. surface stress for residual + cell-induced curvature (post-seed). The measured 
radius of curvature was used to interpolate residual and cell-induced surface stresses from these 
plots. 
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Fig. 6.5 | Demonstrations of bio-bot locomotion. (A-C) Time course of net forward motion for 
“bio-bot 1” (326 μm thick), “bio-bot 2” (182 μm thick), and “bio-bot 3” (155 μm thick) over 5 
second intervals for a period of 15 seconds. (D) Plot of net displacement vs. time for all three 
bio-bot designs. The inset is a plot of average velocity vs. bio-bot design, which is extracted 
from the plot of net displacement vs. time. All scale bars are 1 mm. 
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Fig. 6.6 | Measured frequency of contraction for bio-bots. (A) Plot of frequency of 
contraction vs. bio-bot. (B) Plot of frequency of contraction vs. number of measurement for bio-
bot 2. Each measurement took approximately 5 minutes each. 
  
132 
 
 
 
Fig. 6.7 | Derivation of relative friction force: F = µ·N(A), where µ is the coefficient of friction 
and N(A) is the normal force as a function of the surface area of contact. (A) Plot of displacement 
vs. time for the actuating and supporting legs during a single power stroke to determine their 
motion state. (B) Plot of the surface area of contact vs. time between the legs and substrate 
during a single power stroke. (C) Plot of relative friction force vs. time by multiplying the 
surface area of contact by the normalized ratio of static and kinetic friction depending on the 
motion state of each leg. 
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Fig. 6.8 | Mechanisms of bio-bot locomotion. (A) Representative cross-sectional images of a 
bio-bot 1 power stroke. (B) Step-by-step diagram of bio-bot 1 power stroke depicting no change 
between the friction forces of the actuating (Fa) and supporting legs (Fs), which results in no net 
forward motion. (C) Plot of friction force vs. time for a single power stroke of bio-bot 1 showing 
the change between the coefficients of static friction (µs, open fill) and kinetic friction (µk, solid 
fill). (D) Representative cross-sectional images of a bio-bot 2 power stroke. (E) Step-by-step 
diagram of bio-bot 2 power stroke depicting changes between Fa and Fs, which results in net 
forward motion. (F) Plot of friction force vs. time for a single power stroke of bio-bot 2 showing 
changes in µs (open fill) and µk (solid fill). (G) Representative cross-sectional images of a bio-bot 
3 power stroke. (H) Step-by-step diagram of bio-bot 3 power stroke depicting changes between 
Fa and Fs, which results in net forward motion. (I) Plot of friction force vs. time for a single 
power stroke of bio-bot 3 showing changes in µs (open fill) and µk (solid fill). All scale bars are 1 
mm. 
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CHAPTER 7: 3D MUSCLE STRIPS FOR BIO-BOTS 
7.1 INTRODUCTION 
The development of locomotive biological machines, or ‘bio-bots’, is beginning to make 
significant progress in the last few years. To date, locomotive bio-bots have been commonly (1) 
powered by cardiac myocytes, and (2) assembled on 2D substrates.1-5 Xi et al. (2005)1 cultured 
cardiac myocytes on a hard substrate (a thin film of chromium and gold on silicon) that would 
bend and stretch during contraction in a walking motion (38 µm·s-1). Kim et al. (2007)2 
fabricated grooved cantilever beams on PDMS in order to align cardiac myocytes for enhanced 
force (88%) and bending (40%) relative to flat beams during its walking motion (140 µm·s-1). 
Feinberg et al. (2007)3 cultured cardiac myocytes on geometrically-defined 2D thin films of 
PDMS, which curled or twisted into 3D conformations, and demonstrated gripping, pumping, 
walking (133 µm·s-1), and swimming (400 µm·s-1) motions. Nawroth et al. (2012)4 used this 
same technology to reverse engineer jellyfish-like constructs dubbed ‘medusoids’. Chan et al. 
(2012)5 cultured cardiac myocytes on 3D printed hydrogels with a long, thin leg supported by a 
stout supporting leg. When the cardiac myocytes contracted, the long leg pulsed, propelling the 
bio-bot forward. 
There is considerable interest now in using skeletal muscle as a cell source for the bio-
bots because of favorable attributes not available in cardiac muscle.6 In the body, skeletal muscle 
facilitates movement by applying forces against bones and joints. The organization of the muscle 
is modular, having many longitudinally-aligned, multinucleated muscle fibers assembled 
together by connective tissue to form a densely-packed structure.7 Recruitment of these fibers 
can be finely controlled by the nervous system, which innervates individual muscle fibers at 
localized regions.8 By adjusting the number of contractile muscle fibers and the tension 
developed collectively, the nervous system can regulate graded muscle response for controlled 
movement. Consequently, skeletal muscle can be used in bio-bot designs to switch locomotion 
on and off by neural signals, to regulate step stroke and pacing by altering the combined 
contractile force, and to generate a wide range of motion by localized innervation of muscle 
fibers. 
Recently, optical methods have been developed to depolarize or hyperpolarize neurons 
using specific wavelengths of light.9-11 This method, known as ‘optogenetics,’ combines the 
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temporal and spatial precision of light pulses with cellular specificity of genetic targeting. The 
general strategy of optogenetics involves introducing a light-sensitive protein, such as 
channelrhodopsin-2 (ChR2, discovered in green algae) to a specific cell type, illuminating the 
cells with defined spatiotemporal parameters, and obtaining reliable readout of the cellular 
behavior.12 This past year, the method was applied to cardiac13,14 and skeletal15,16 muscle cells to 
rhythmically control their contractions. It was also used to locally innervate specific regions of 
muscle tissue to generate movement in multiple degrees of freedom (multi-DOF). Overall, the 
advantage of optogenetics is its fast, precise, and local stimulation of cells and tissues, relative to 
electrical stimulation. Moreover, it does not require complex heterotypic cell-cell interactions 
that are needed for neuromuscular (neuron-to-muscle) junctions.17,18 
The other area of improvement in locomotive bio-bots is the culture of skeletal muscle 
cells in 3D, rather than 2D. 3D culture is more conducive to growth and differentiation because 
they support a high density and 3D spreading of muscle cells, unidirectional cell alignment 
through the application of geometric constraints, and macroscope tissue contractions.19 There are 
two current methods for engineering artificial skeletal muscle in 3D: (1) 2D-to-3D, and (2) 3D-
to-3D. The first method was developed by Dennis and Kosnik (2000).20,21 It consisted of 
myotubes, fibroblasts, cell-secreted ECM, and synthetic tendons. The beauty of this approach is 
that it does not require a pre-existing scaffold. Briefly, PDMS was set in a culture dish, and 
absorbed with a thin layer of laminin. Synthetic tendons were fixed at opposite ends and at a 
desired distance apart. Cells of myoblasts and fibroblasts were seeded, and upon reaching 
confluence, the medium was switched from growth to differentiation. After 2-3 weeks, the 
monolayer of myotubes would detach and self-organize to form a 3D muscle strip, dubbed 
‘myooids’. Huang et al. (2006) later modified the method to improve the speed of myooid 
formation.22 Lam et al. (2009) used wavy PDMS substrates to align the myotubes in the 
myooids.23 The second method was developed by Vandenburgh et al.,24 although many 
variations exist.25-27 It typically consisted of a pre-existing scaffold in 3D, either derived 
naturally (most common) or synthetically. Myoblasts with or without fibroblasts were embedded 
in the 3D scaffold and casted in molds. The molds were there for 3D scaffolds compacted by 
cells to retain certain shapes, such as strips and rings. 
Here, we built on our previous work by integrating our locomotive bio-bots with a cluster 
of light-activated skeletal muscle cells (C2C12-ChR2 myoblasts) in 3D-to-3D scaffolding. These 
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skeletal muscle cells were transfected with channelrhodpsin-2, a directly light-gated cation-
selective membrane channel. First, we fabricated two-legged hydrogel constructs in a pillar/beam 
configuration using a 3D stereo-lithographic apparatus (SLA). The SLA is a rapid prototyping 
tool that is used to produce 3D models, prototypes, and patterns by repetitive deposition and 
processing of individual layers.28,29 The C2C12-ChR2 myoblasts were embedded in type I 
collagen and Matrigel™ extracellular matrix (ECM) proteins and cast around the pillars of the 
hydrogel constructs to form the 3D muscle strips. A number of parameters, such as the cell 
concentration, ECM composition, and protease inhibitors were evaluated to determine their 
importance in muscle formation and contractile function. Beam stiffness was also adjusted 
through exposure energy during fabrication to accommodate for the passive tension of the 3D 
muscle strips. Finally, we qualitatively assessed the differentiation and contractility of myotubes 
in our 3D muscle strips by fluorescently staining and visualization. 
7.2 MATERIALS AND METHODS 
7.2.1 FABRICATION OF HYDROGEL CONSTRUCT 
The bio-bots were constructed with two capped posts as the ‘legs’ connected by a thin 
beam. A CAD model of these bio-bots was generated using AutoCAD 2012 (Autodesk) and 
exported to 3D Lightyear v1.4 (3D Systems) in .stl format. The models were sliced into thin 2D 
cross-sectional layers of specified thickness (100 µm). A pre-polymer solution of 20% (w/v) 
poly(ethylene glycol) diacrylate (PEGDA Mw 700) was prepared with 0.5% (w/v) Irgacure 2959 
photoinitiator in distilled water to form the pre-polymer solution. PEGDA MW 700 solution was 
pipetted into the culture dish at carefully characterized volumes. An ultraviolet laser beam was 
used to selectively crosslink the hydrogel structures. The energy dose of the laser was varied by 
controlling the scan speed. The elevator operated by the SLA 250/50 computer was lowered by a 
distance equal to the thickness of the layer. The process was then repeated until completion of 
the 3D part. Overnight, the bio-bots were sterilized in 100% ethanol and rinsed in PBS before 
interaction with cells and growth medium. 
7.2.2 CELL CULTURE 
C2C12-ChR2 cells were a gift from H. Harry Asada (MIT). Briefly, C2C12 myoblasts 
were purchased from American Type Culture Collection (ATCC). For the generation of the 
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transgenic cell line, C2C12-ChR2, the cells were transfected with pAAV-Cag-Chr2-GFP-2A-
Puro with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and were grown under puromycin (2.5 
µg ml-1) selection for 2 weeks. More than 98% of the population expressed ChR2 after selection. 
C2C12-ChR2 cells were cultured in growth medium containing Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals) and 
100 U ml-1 penicillin, and 100 µg ml-1 streptomycin (Gibco). C2C12-ChR2 cells were not grown 
over confluence of 70% and passaged over 10 times in culture.  
7.2.3 MECHANICAL PROPERTIES OF HYDROGEL BEAM 
Hydrogel constructs in the form of dumbbells were fabricated with stereolithography (3D 
Systems). A pair of 1.2 mm diameter bent stainless steel rods (McMaster Carr) was super-glued 
to the ends of the dumbbells. The rods were placed into a custom-made fixture fabricated from 
VeroWhite polymer with an Eden 350 3D printing system (Objet). The fixture was designed to 
fit within an Electroforce Biodynamic test frame (Bose). The Electroforce system was fitted with 
a 1000 g load cell and sealed sample chamber for submerged testing. Testing was conducted 
within a 37 oC incubator. Once the hydrogel construct was placed in the fixture, the distance 
between the rods was measured with calipers and the fluid chamber was filled with 37 oC 
phosphate buffered saline (Lonza). The test was conducted in displacement control using 
WinTest control software (Bose). The samples were stretched under uniaxial tension in a Bose 
Electroforce Biodynamic tester at 0.05 mm/s. A video extensometer was used to track the 
displacement of four dots placed on the sample with a permanent marker. Load, displacement, 
and strain data were collected at 10 Hz using the Wintest software. The cross-sectional area of 
each sample was measured with calipers following the test. 
7.2.4 FORMATION OF 3D MUSCLE STRIPS 
A cooled suspension of liquid type I collagen from rat tail (0.8, 1.4, or 2.0 mg ml-1, BD 
Biosciences) was mixed with equal parts ice-cold growth medium and neutralized with 0.01 N 
NaOH. Pelleted cells (1.0, 2.5, or 5.0 x 106 cells ml-1) were resuspended in ice-cold growth 
medium and mixed with Matrigel™ (30% v/v, BD Biosciences). Liquid neutralized type I 
collagen was combined and mixed thoroughly with cells and Matrigel™. The mixture was then 
added to the post/beam assembly and incubated at 37 oC to induce collagen polymerization. 
Growth medium was added to each assembly upon gelation. Time-lapsed compaction was 
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captured with a stereomicroscope (MZ FL III, Leica). Growth medium was changed every other 
day. After 7 days, the myoblasts were induced to differentiate by switching to high-glucose 
DMEM supplemented with 10% horse serum (Lonza) and 50 ng ml-1 insulin-like growth factor-1 
(IGF-1, Sigma). A protease inhibitor, -aminocaproic acid (EAC, 1 mg ml-1, Sigma) was added 
to the growth and differentiation medium to prevent degradation of the extracellular matrix 
(ECM) proteins by the cells. 
7.2.5 OPTICAL STIMULATION OF MYOTUBES 
Contractile myotubes in the muscle strips were stimulated with blue light using a 
fluorescent light (Xeon) that is passed through a FITC filter (460-490 nm) and focused through a 
20X objective lens. The light was switched on and off at 5 second intervals using this setup. For 
pulsed light, a blue LED light was connected to a waveform generator (Agilent) and pulsed at 
different periods (250, 500, and 1000 ms) with a pulse width of 100 ms. Actuation of the bio-bot 
legs were imaged with an inverted microscope (IX81, Olympus). 
7.2.6 CONFOCAL FLUORESCENCE IMAGING 
Muscle strips were washed with PBS containing calcium and magnesium and fixed in 4% 
(v/v) formaldehyde solution for 10 minutes at room temperature. The strips were permeabilized 
in 0.2% (v/v) Triton-X 100 in HBSS for 10 minutes at room temperature. The samples were 
washed twice with PBS before a blocking agent, Signal FX (Invitrogen), was added for 30 
minutes. After another wash step, the samples were incubated overnight at 4 °C with primary 
antibodies, rabbit anti-α-actinin (sarcomeric) and mouse MF-20. The tissues were washed twice 
before being incubated with Alexa Fluor 594 goat anti-rabbit and Alexa Fluor 488 goat anti-
mouse secondary antibodies for 2 hours at 37 °C. The stained samples were washed with PBS 
and subsequently stained with an antibody for DNA, 4′,6-diamindino-2-phenylindole (DAPI, 
Sigma Aldrich) for 5 minutes. After a final wash step, the cells on the cantilevers were imaged 
using an inverted fluorescent microscope (IX81, Olympus). The samples were also imaged with 
a multi-photon confocal microscope (710, Zeiss) and Mai Tai eHP Ti:sapphire laser. Images 
were tiled and stitched together to get a full view of the muscle strips. 
7.3 RESULTS AND DISCUSSION 
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7.3.1 FABRICATION OF HYDROGEL CONSTRUCTS 
 The cantilevers previously developed were modified with a design for two capped posts 
or ‘legs’ to accommodate for the cell-embedded 3D collagen gels (Fig. 7.1). Without this design, 
the cell-embedded 3D collagen gels detached from the beam and aggregated into the shape of a 
ball due to cell traction forces. The capped posts acted like synthetic tendons that kept the 
collagen gels from shrinking and provided uniaxial tension that aligned the cells. The stiffness of 
the beam that connected the two legs could be modulated by the laser exposure energy. The 
dimensions (length x width x thickness) of the beams were 4 x 2 x 0.5 mm. These posts can later 
be re-designed with asymmetry for net movement (locomotion). In addition, the PEGDA 
backbone was not chemically-linked with cell attachment proteins because it hindered 
compaction of the muscle strips. Four post/beam assemblies were built for every fabrication run, 
and PEGDA ‘holders’ were built separately to confine the hydrogel constructs for 3D muscle 
strip formation. 
7.3.2 CHARACTERIZATION OF HYDROGEL CONSTRUCTS 
While our previous cantilevers and actuators were constructed with two different Mw 
(700 and 3,400 g mol-1), the post/beam assembly was constructed with only one Mw (700 g mol-
1). Instead of tuning the elastic modulus of the beam by changing its Mw, we realized that this 
could be done simply by varying the laser exposure energy. To measure the bulk elastic modulus 
of the beams, we fabricated dumbbell-shaped hydrogels with four different laser exposure 
energies: 100, 150, 250, and 550 mJ cm-1. The dumbbells were fit to a tensile tester and stretched 
under uniaxial tension in liquid (Fig. 7.1A). The extracted elastic moduli were 155, 402, 551, and 
757 kPa, respectively (Fig. 7.2B). This wide range in values demonstrates the utility of laser 
exposure energy in tuning the elastic modulus of the beam without having to change materials. It 
is a unique advantage of the SLA that would otherwise be difficult to do with other UV light 
sources. 
Furthermore, we previously demonstrated that hydrogels with Mw 3,400 g mol-1 have an 
inherent residual surface stress that causes them to curl. The radius of curvature depended on the 
thickness of the cantilever. We have found this to be true of hydrogels with Mw 700 g mol-1 as 
well, despite their higher elastic modulus values. Additionally, the laser exposure energy was a 
contributing factor to the radius of curvature, independent of thickness. At low energy doses, the 
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cantilevers were straight, yet flexible; at higher energy doses, the cantilevers are rigid, yet 
curved. 
7.3.3 FORMATION OF 3D MUSCLE STRIPS 
3D muscle strips were formed by embedding cells in extracellular matrix (ECM) 
proteins. In this particular case, the ECM was a mixture of type I collagen and Matrigel™, a 
composition of laminin, entactin, and type IV collagen. We chose collagen because naturally-
derived hydrogels undergo macro-scale compaction when mixed with cells. This leads to a much 
higher cell density and unidirectional cell alignment between the posts. After pH neutralization, 
the ECM proteins gelled, and the cells were immobilized inside. The mixture was incubated in 
growth medium, allowing the cells to attach and generate traction forces on the fibers. 
Spontaneous compaction (or ‘shrinkage’) of the gels occurred as a result over time. 
After several days, the gels compacted around the two posts, which served to restrict 
compaction and act as synthetic tendons, to create passive, or static, tension on the muscle strips 
(Fig. 7.3A). Caps at the end of the posts prevented the muscle strips from sliding off and kept 
them anchored in one position. As a control, the muscle strips were treated with blebbistatin (50 
µg ml-1) to confirm that gel compaction was caused by traction forces from the cells (Fig. 7.3B). 
Blebbistatin blocks myosin II activity in the cells, which prevents inward translation of the 
traction forces. Dissipation of compressive strain and lack of compaction on the ECM proteins 
followed. Separately, we treated cells with insulin-like growth factor 1 (IGF-1, 50 ng ml-1), 
which is strongly mitogenic but also known to enhance differentiation in C2C12 cells. The 
muscle strips compacted rapidly but snapped near the posts within 24 hours (Fig. 7.3C). As a 
result, we showed that the formation of 3D muscle strips was cell-induced through passive 
tension around the two posts. However, it will be critical to adjust the passive tension 
accordingly on the muscle strips to prevent them from snapping. 
7.3.4 OPTIMIZATION OF PASSIVE TENSION 
 There are several methods that we can use to adjust or control the passive tension exerted 
by the cells on the muscle strips. In this study, we focused on the cell concentration, collagen 
concentration, protease inhibitors, and beam stiffness. As we saw with the IGF-1 results, a high 
cell concentration, either initially or through proliferation during culture, produced higher 
traction forces that ultimately led to snapping of the muscle strips (normally at its weakest point, 
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near the posts). We systematically varied cell concentration at 1.0 (Fig. 7.4A), 2.5 (Fig. 7.4B), 
and 5 x 106 (Fig. 7.4C) cells ml-1. All three conditions snapped before the 5th day (120 hours). 
We also varied the collagen concentration at 0.8 (Fig. 7.4A), 1.4 (Fig. 7.4D), and 2.0 (Fig. 7.4E) 
mg ml-1, which increased the stiffness of the muscle strip due to higher crosslinking densities. 
Again, all the conditions snapped before the 5th day. However, when we added a protease 
inhibitor known as ε-aminocaproic acid (1 mg ml-1) to the medium, the muscle strips remained 
intact (Fig. 7.4F). Proteases, which are either secreted by cells or presented in the serum of 
growth medium, break down the structural integrity of the muscle strip, leading to eventual 
rupture. Supplementing the medium with ε-aminocaproic acid inhibited the proteases and 
prevented the muscle strips from breaking down. Aprotinin is another known protease inhibitor.  
7.3.5 DIFFERENTIATION OF 3D MUSCLE STRIPS 
The C2C12-ChR2 muscle strips were incubated in growth medium for 7 days, followed by 
a switch to differentiation medium for an additional 7 days. After two weeks in culture, the 
muscle strips stained for heavy myosin chain and sarcomeric -actinin. Multiple myotubes were 
aligned within each muscle strip (Fig. 7.6A). Because of the size of the muscle strip, it was 
apparent that the majority of the myotubes had formed around the exterior. This may be a result 
of the lack of oxygen and nutrient transport to the core of the muscle strip. A closer look at the 
myotubes did not reveal the well-developed parallel cross-striations (Fig. 7.6B). Curiously, the 
muscle strip did start to twitch spontaneously. Each time the muscle strip twitched, the posts 
displaced inward and returned to their original position upon relaxation. When the muscle strips 
were exposed to blue light, either continuously or pulsed at 500 ms intervals, there were several 
cases that the frequency of the twitching had increased. However, there was no evidence that 
pulsed blue light was controlling the actuation of the muscle strips. 
7.4 CONCLUSION 
We have demonstrated that skeletal muscle can be integrated into our locomotive bio-bot 
designs. We have also demonstrated that formation of muscle strips in 3D-to-3D scaffolding on 
our locomotive bio-bot designs is possible simply by adding a second leg to anchor and retain the 
bundled shape of matrix. To produce muscle strips that twitch against the legs, the optimal 
conditions were (1) cell concentration: 2.5 – 5.0 x 106 cells ml-1; (2) matrix concentration: 1.4 
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mg ml-1 type 1 collagen and 30% v/v Matrigel™; (3) beam parameters: ~500 µm thick with an 
elastic modulus of ~400 kPa. 
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7.7 FIGURES AND CAPTIONS 
 
 
Fig. 7.1 | Fabrication of hydrogel constructs. (A) Fabrication process flow of hydrogel 
constructs and formation of 3D muscle strips: (1) Glass substrates were cleaned with oxygen-
plasma treatment, (2) Dilute 3-(trimethoxysilyl)propyl methacrylate (TPM, 2% v/v) in 100% 
ethanol was added to methacrylate the glass substrate, (3) Poly(ethylene glycol) diacrylate 
(PEGDA, 20% v/v Mw 700) was layered and photopolymerized with the SLA to fabricate 
pillar/beam hydrogel constructs, (4) Mixtures of cell-embedded type I collagen and Matrigel™ 
were casted around the pillars and set in the incubator, (5) Cell attachment and traction forces 
pulled on and compacted the gels to form 3D muscle strip. (B) AutoCAD drawing (3D views) of 
PEG pillar/beam. Fabrication can be scaled-up to generate high-throughput, multiple arrays. (C) 
Actual image (side view) of PEG pillar/beam positioned in a PEG ‘holder’ for casting of a 
cell/gel mixture.  
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Fig. 7.2 | Mechanical testing of hydrogel beam properties. (A) ElectroForce (Bose) tensile 
tests were performed on dumbbell-shaped hydrogel samples fabricated in the SLA at various 
exposure energies (100, 150, 250, and 500 mJ cm-2) to extract elastic modulus values. The 
shoulder region of the samples were glued to steel rods and inserted on clamps connected to the 
load frame systems. Four glued dots were added to the gauge region of the samples to track the 
load displacements (Inset). (B) Boxplot of the calculated elastic modulus values.  
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Fig. 7.3 | Formation of 3D skeletal muscle strips. (A) The traction forces of skeletal myoblasts 
(C2C12) embedded in and attached to type I collagen and Matrigel™ caused compaction of the 
solidified gels around pillar/beam hydrogel constructs. This was verified by independently 
adding (B) insulin-like growth factor 1 (IGF-1, 50 ng ml-1) and (C) blebbistatin (50 µM) to the 
medium. Since IGF-1 is a potent mitogen, there were increased traction forces on the muscle 
strip, which caused it to break within 48 hours of culture. In contrast, blebbistatin is a myosin 
ATPase inhibitor that reduced cell contraction on the muscle strip and prevented its compaction 
after 48 hours of culture. 
  
148 
 
 
 
Fig. 7.4 | Optimization of passive tension parameters. 3D skeletal muscle strips consistently 
snapped after 5 days in culture, which led us to vary a number of parameters, such as cell (C2C12 
myoblast) concentration, matrix (type I collagen) concentration, and the presence of protease 
inhibitors (-aminocaproic acid). Despite variation of cell concentrations at (A) 1.0, (B) 2.5, and 
(C) 5.0 cells ml-1 in 0.8 mg ml-1 type I collagen, all the muscle strips continued to snap within 5 
days. This was the also the case with increasing the matrix concentration at 0.8, (D) 1.4, and (E) 
2.0 mg ml-1. It is noteworthy to mention that the area of the muscle strips decreases with cell 
concentration, but increases with matrix concentration. (F) Finally, -aminocaproic acid (EAC) 
inhibits protease activity that degrades proteins, such as collagen. Addition of EAC (1 mg ml-1) 
prevented the muscle strip from snapping (stable even after 14 days). 
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Fig. 7.5 | Optimization of beam stiffness with passive tension parameters. The beam stiffness 
between the pillars was varied as a function of exposure energy for (A) 500, (B) 150, (C) 125, 
and (D) 100 mJ cm-1. The passive tensions generated by the muscle strips were applied to the 
beam, causing it to flex. The degree of flexure was dependent on the stiffness of the beam. 
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Fig. 7.6 | Differentiation of myotubes in 3D muscle strips. After 7 days in growth medium 
(10% fetal bovine serum) and another 7 days in differentiation medium (10% horse serum), the 
3D muscle strips were stained and visualized with epifluorescence. (A) A view of the entire 
muscle strip shows dense clusters of differentiated myotubes (green). (B) However, a closer look 
at the organization of sarcomeres in individual myotubes did not display the characteristic 
striations found in contractile muscle fibers (red). 
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CHAPTER 8: BLOOD VESSEL PATTERNING 
8.1 INTRODUCTION 
Neovessels play a critical role in homeostasis, regeneration, and pathogenesis of tissues 
and organs, and their spatial organization is a major factor in influencing vascular function.1,2 
Therefore, successful treatments of wounds, ischemic tissue, and tissue defects greatly rely on 
the ability to control the number, size, spacing, and maturity of blood vessels regenerated within 
a target tissue.3,4 However, technologies to control the spatial organization of mature neovessels 
in vivo over physiologically relevant length scales are still lacking. Here, we present a study of a 
“living” microvascular stamp that releases multiple angiogenic factors and subsequently creates 
neovessels with the same pattern as that engraved in the stamp. The stamp consists of live cells 
that secrete angiogenic factors, an engineered hydrogel matrix that promotes cellular expression 
of angiogenic factors, and a three-dimensional (3D) geometry that localizes the angiogenic 
factors within the pattern. When the stamp was implanted on a target tissue, it created the desired 
pattern of neovessels based on 3D geometry of the stamp, allowing the control of the density and 
spacing of blood vessels (Fig. 8.1). Analytical modeling and numerical simulations validated the 
experimental observations that the desired blood vessel patterns were formed under specific 
physical 3D designs of the stamp. The microvascular stamp developed in this study would serve 
to direct the emergent cellular behavior towards vascularization, improve the quality of 
revascularization therapies, and allow the vascularization of biological machines in vitro. 
Prior studies have demonstrated that spatiotemporal distributions of multiple angiogenic 
growth factors can control growth direction and macro-scale spacing of neovessels. For example, 
polymeric scaffolds were developed by chemically attaching a growth factor-releasing layer with 
a growth factor-free layer, while varying layer thickness at millimeter scales.4,5 In addition, 
certain membranes prepared with polytetrafluoroethylene have been clinically used to guide the 
growth of capillaries into tissue defects.6 These results have advanced the state of the art, but 
many challenges remain unaddressed for precise patterning of functional blood vessels at the 
physiologically relevant sub-micrometer scale. Recently, various micropatterning, ink-jet 
printing, and microfluidic techniques have been reported to pattern molecules or cells on surfaces 
and in microfluidic environments.7–9 These techniques have created patterned cell adhesion 
substrates, microfluidic devices or microfiber patches with chemotactic protein concentration 
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gradients,10 and cell-laden microporous tissue engineering scaffolds. However, these 
microfabricated devices still have to advance to regulate the desired spatial organization of 
mature and functional neovessels. 
In response to the above challenges, we hypothesized that a construct assembled to 
sustainably release multiple angiogenic factors along a pre-defined micrometer-sized pattern 
would generate mature and functional neovessels with a desired pattern at an implant site. 
Therefore, the construct would allow us to control the area density and spacing of neovessels 
generated at the implant site. We examined this hypothesis by encapsulating cells that 
endogenously express multiple angiogenic growth factors into a rigid but permeable hydrogel of 
poly(ethylene glycol) (PEGDA) and methacrylic alginate (MA). Vertical microchannels with 
tuned diameter and spacing were incorporated into the cell-encapsulating hydrogel using a 
stereolithographic assembly (SLA) unit, in order to attain the local increase of angiogenic factors 
within the circularly patterned areas. The resulting living microvascular stamp was implanted 
onto a chick embryo chorioallantoic membrane (CAM) to confirm its ability to create the 
patterned neovessels within tissue covered by the stamp. 
8.2 MATERIALS AND METHODS 
8.2.1 SYNTHESIS OF MA AND PEGDA 
Gel-forming polymers, poly(ethylene glycol) diacrylate (PEGDA) and methacrylic 
alginate (MA), were synthesized in our previous work.11 For the synthesis of MA, 2-aminoethyl 
methacrylate was conjugated to the carboxylate group of alginate via EDC chemistry. The 
alginate used in this experiment (molecular weight (Mw) ~ 50,000 g/mol) was obtained by 
irradiating alginate rich in gluronic acid residues, (LF20/40, FMC Technologies, Mw ~ 250,000 
g/mol) with a dose of 2 Mrad for 4 hours from a 60Co source. The irradiated alginate was 
dissolved in the 0.1 M MES ((2-(N-morpholino) ethanesulfonic acid) buffer (pH 6.4, Sigma-
Aldrich) at the concentration of 1.0 % (w/v). Then, 1-hydroxybenzotriazole (HOBt, Fluka), 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Thermo Scientific) and 2-aminoethyl 
methacrylate (AEMA, Sigma Aldrich) were dissolved in the alginate solution and stirred for 18 
hours. Both the molar ratio of HOBt to AEMA and the molar ratio of EDC to AEMA were kept 
constant at 2:1. The mixture was dialyzed extensively against deionized (DI) water for three days, 
while exchanging the DI water every 12 hours. The dialyzed alginate solution was lyophilized, 
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and reconstituted to a 3 wt % stock solution. The conjugation of methacrylate groups onto the 
alginate was confirmed by 1H-NMR (300MHz, QE300, General Electric), as previously reported. 
In this study, the number of methacrylates linked to a single alginate with molecular weight (Mw) 
of 50,000 g/mol was kept constant at 60.  
In parallel, PEGDA was synthesized via chemical reaction between poly(ethylene glycol) 
(PEG, Sigma Aldrich) and acryloyl chloride (Sigma Aldrich). First, PEG was dissolved in 
dichloromethane at the concentration of 10 wt %. Next, acryloyl chloride and triethylamine 
(Fisher Chemical) were dissolved in the PEG solution and stirred overnight under dry N2 gas. 
The molar ratio of PEG, acryloyl chloride and triethylamine was 1:4:4. Finally, the insoluble salt 
(triethylamine-HCl) was filtered, and the product was precipitated by adding ice-cold ether. The 
crude product was dissolved into DI water and dialyzed for one day to remove unreacted starting 
materials and the salt, a byproduct. Then, the product was frozen at -20 ºC and lyophilized. The 
conjugation of acrylate groups onto PEG was confirmed by 1H-NMR (300 MHz, QE300, 
General Electric). 
8.2.2 HYDROGEL PREPARATION 
The PEGDA and MA dissolved in Dulbecco’s modified Eagle’s medium (DMEM, Sigma 
Aldrich) were mixed at varied mass ratios, while keeping the total polymer concentrations 
constant. The pre-gel solution was subsequently placed into the dish at the center of the platform 
in SLA.12 The SLA process was repeated until completion of the 3D assembly of the hydrogel. 
For cell encapsulation, the mixture of NIH/3T3 cells (ATCC) (5.0 × 106 cells/mL) and pre-gel 
solution was exposed to the laser of SLA to activate hydrogel formation. 
8.2.3 HYDROGEL CHARACTERIZATION 
The hydrogel stiffness was evaluated with measurement of the elastic modulus of a 
hydrogel using a mechanical testing system (MTS Insight). The hydrogel swelling ratio at 
equilibrium was determined by measuring the weight of the hydrated gel after 24 hours in neutral 
buffered solution at 37 °C and that of the dried gel. The hydrogel permeability was also 
evaluated by monitoring water uptake into a hydrogel at non-equilibrium state with the magnetic 
resonance imaging (600 MHz Varian Unity/Inova nuclear magnetic resonance (NMR) 
spectrometer (14.1 T Magnet). 
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8.2.4 MAGNETIC RESONANCE IMAGING (MRI) 
Spin echo multi-slice (SEMS) pulse sequence for MR imaging of the hydrogel was used 
to acquire resonance data, which were then converted into water density map using VNMR 6.1C 
software. For SEMS pulse sequence, the repetition time (TR) of 2.5 s and the echo time (TE) of 
5 ms were used. The field of view (FOV) was 1.6 x 1.6 cm, and the image matrix was 128 x 64 
pixels. The resulting water density images were processed to present the density spectrum for 
comparison using MATLAB (Mathworks). For visualization, pseudo-color was added to the 
images using the ImageJ software (free image analysis software from National Institutes of 
Health). For counting water intensity peaks, the rectangular gel picture from the image was 
selected, and the histogram of the image (count vs. color intensity) was taken using the ImageJ 
software. 
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8.2.5 NUMERICAL ANALYSIS 
An axisymmetric finite element model was created using Abaqus/CAE version 6.8 - 4. It 
was assumed that the diffusional flow effects of each microchannel had a negligible impact on 
the neighboring microchannels and therefore the modeling focused on an individual 
microchannel of varying diameter. Only the radius of the hole and the corresponding area of the 
tissue would be changed from one model to the next. The size of hydrogel stamp used in the 
model was held constant at 250 μm in width and 200 μm in height to correspond with the 
experimental stamp height and spacing between channels. A mesh was created with 
microchannel with diameters of 300, 500, 750, and 1,000 μm using 3 node axisymmetric 
triangles. The top surface of the model was assumed to have no diffusional flow or loss through 
the top of the gel and microchannel as was dictated by the experimental setup. The outer vertical 
surface was also assumed to have no diffusional flow in the horizontal direction outside of the 
control volume. The CAM membrane was modeled as being 400 μm thick with a constant 
concentration of zero at the lower boundary of the model. This constant concentration acted as a 
sink, thereby consuming the VEGF once it reached the bottom surface of the model. The 
diffusion calculations were governed by Fick’s law of diffusion with diffusion coefficients of 
200 μm2/s, 1.0 μm2/s, and 0.1 μm2/s for the media, CAM, and hydrogel stamp, respectively 
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(Equation 8.1). The diffusion across the boundaries between different materials was assumed to 
be unobstructed. The diffusion coefficient for each of the boundaries was subsequently set as the 
average of the two materials involved. The stamp had a constant body flux of 3.1×10-14 pg/μm3·s 
which represented the constant production of VEGF by the fibroblasts. All simulations were in 
micrometers, seconds, and picograms. Each of the diameters was modeled to simulate a period of 
7 days. 
8.2.6 CELL ENCAPSULATION 
NIH/3T3 cells (ATCC) were expanded and passaged at 37 °C with 5 % CO2 in 
Dulbecco’s modified Eagle’s medium (DMEM, ATCC) supplemented by 10 % fetal bovine 
serum (FBS, ATCC), and 1 % penicillin/streptomycin (ATCC). All the cells before the passage 
number of 10 were used in this study. Prior to encapsulation in hydrogels, cells were mixed with 
the pre-gel polymer solution. The cell density was kept constant at 2.0×106 cells/ml. The mixture 
of cell and pre-gel solution was exposed to the laser of SLA to activate hydrogel formation. The 
cell-hydrogels were incubated in DMEM supplemented by 10 % fetal bovine serum (FBS), while 
changing the media every two days. On days 0, 1, 3, 5, and 7, viability of cells encapsulated into 
the hydrogel was quantitatively evaluated using a MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) reagent (ATCC)) assay kit. The encapsulated cells were stimulated 
to secrete growth factors by adding 0.2 mL of DMEM and 100 ng/ml of 12-O-
tetradecanoylphorbol-13-acetate (TPA, ATCC) reagent into a well of a 96-well plate which 
contains each cell-encapsulating gel. After incubating the cell-hydrogel construct for 24 hours, 
100 μl of cell culture media was mixed with a cocktail of biotinylated detection antibodies, and 
incubated overnight with the proteome profiler mouse angiogenesis array (R&D Systems). The 
array membrane was washed to remove unbound material and streptavidin-Fluor® (430) 
conjugates (Invitrogen) and positively stained spots were imaged using a Phosphor Imager (Bio-
Rad). In addition, on days 1, 3, and 5, the amount of VEGF secreted by cells was quantitatively 
evaluated by the sandwich enzyme immunoassay technique using the mouse VEGF 
Immunoassay kit (R&D Systems). The sample containing VEGF was pipetted into a well where 
a polyclonal antibody specific for mouse VEGF has been pre-coated and incubated for 2 hours. 
After washing away any unbound substances, an enzyme-linked polyclonal antibody specific for 
mouse VEGF was added to the well. The enzyme reaction yielded a blue-colored product, and 
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the color intensity was measured using a microplate absorbance reader (Synergy HT, Biotek). 
The measured value was converted to the amount of VEGF using a calibration curve. The 
amount of VEGF was further normalized by the number density of cells initially encapsulated 
into each hydrogel. 
8.2.7 CHORIOALLONTOIC MEMBRANE (CAM)-BASED ANGIOGENESIS ASSAY 
The function of microvascular stamp to engineering neovessels pattern was examined by 
implanting the cell-hydrogel construct onto chicken chorioallontoic membrane (CAM) according 
to a previously developed method.13 Fertilized chicken eggs (Hy-Line W-36) were obtained from 
the University of Illinois Poultry Farm (Urbana, IL). Following the initial incubation, a small 
window (1.0 × 1.0 cm) was created on top of each egg shell. Then, a freshly fabricated 
fibroblasts-encapsulating hydrogel disk (5×106 cells/ml) was implanted on top of the CAM of 
individual embryos. At days 0, 2, 4 and 7 after implantation, CAM images were captured using a 
S6E stereomicroscope (Leica) linked with D-Lux E Camera (Leica). In parallel, the fixed 
membrane was also embedded in paraffin and the cross-section was stained for α-smooth muscle 
actin (α-SMA Immunohistology Kit, Sigma-Aldrich) to count the number of mature blood 
vessels. 
8.2.8 STATISTICAL ANALYSIS 
Error bars represent standard deviation, with n = 4 for all experiments. Statistical 
significance was determined using one-way ANOVA followed by Tukey’s Multiple Comparison 
Test (p < 0.05). 
8.3 RESULTS 
8.3.1 TUNING CELLULAR VIABILITY AND ANGIOGENIC FACTOR EXPRESSION 
First, the elastic modulus and swelling ratio of the PEGDA hydrogel were tuned to 
prepare a rigid and permeable hydrogel, so that the cell-encapsulated hydrogel would not only 
remain structurally stable at the implanted site but also support cellular activities. Increasing the 
total polymer concentration of the PEGDA hydrogel showed an increase in elastic modulus and a 
decrease in swelling ratio, which is the typical inverse relationship between stiffness and bulk 
permeability of conventional hydrogel systems. In contrast, the hydrogel consisting of PEGDA 
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and MA, which has multivalent methacrylic groups and hydrophilic hydroxyl groups,11 showed 
an increase in both elastic modulus and swelling ratio with increasing mass fraction of MA (Fig. 
8.2A). The role of MA in increasing the swelling ratio of the hydrogel was further examined by 
monitoring water uptake into a hydrogel at non-equilibrium state using magnetic resonance 
imaging (MRI). Despite the higher stiffness of the PEGDA-MA hydrogel compared to the 
PEGDA hydrogel, water diffused into the PEGDA-MA hydrogel more rapidly (Fig. 8.2B). 
Subsequently, cells were encapsulated into the PEGDA and PEGDA-MA hydrogels via 
in situ photo cross-linking reaction with SLA unit.12 Fibroblasts encapsulated into the PEGDA-
MA hydrogel exhibited higher viability than those encapsulated into the PEGDA hydrogel, as 
confirmed with the larger intracellular cleavage of yellow tetrazolium salt (MTT) into a purple 
formazan product (Fig. 8.3A). Human mesenchymal stem cells (hMSCs) also exhibited similar 
viability in PEGDA-MA to those of the fibroblasts (Fig. 8.3B). While hMSCs naturally secrete 
angiogenic growth factors, fibroblasts were stimulated to express multiple angiogenic factors by 
exposing them to a 12-O-tetradecanoylphorbol-13-acetate, protein kinase C (PKC) activator.14 
Nevertheless, hMSCs naturally secreted higher amounts of VEGF per day than the fibroblasts 
(Fig. 8.4A). The cellular expression levels of VEGF for both cell types in the PEGDA-MA 
hydrogel were higher and more sustained than those encapsulated in the pure PEGDA hydrogel. 
The multitude of angiogenic growth factors expressed by these cells was demonstrated by 
performing an angiogenesis assay of over 55 known growth factors (Fig. 8.4B). 
8.3.2 STEREOLITHOGRAPHIC ASSEMBLY OF ‘LIVING’ MICROVASCULAR STAMP  
Next, we introduced cylindrical microchannels (pores) into the PEGDA-MA hydrogels to 
localize cell-secreted angiogenic factors within the circular patterns (Fig. 8.5A and 8.5B). To 
determine the appropriate microchannel geometry, we estimated the dependency of the amount 
of angiogenic factors released through the channels on the microchannel diameter as follows. 
Assuming that the molar flux of angiogenic factors into the microchannel is J (depicted by the 
horizontal arrows in the side view of Fig. 8.5C), and that there is no consumption of angiogenic 
factors in the channel, the average molar flux to be delivered to the tissue through the bottom of 
the channel, Jchannel, would be: 
 J
d
dHJchannel  4/2
  (8.2) 
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where d is the diameter of the channel, and H is the height of the stamp. Therefore, the flux of 
angiogenic factors enhanced with the microchannels is: 
 
d
H
J
Jchannel 4  (8.3) 
Hence, for a stamp with a thickness of 200 μm, this simple scaling law predicts that the 
enhancement of flux increases as the diameter of the microchannels decreases. A microchannel 
of 800 μm diameter would be enhancement-neutral, i.e., would neither increase nor decrease the 
average amount of angiogenic factors delivered to the tissue through the channels. This critical 
microchannel diameter increases with thickness of the stamp (Fig. 8.5D). 
8.3.3 NUMERICAL ANALYSIS  
To validate the scaling law, a finite element model was created to simulate the molar flux 
of cell-secreted growth factors from the hydrogel with microchannels. The boundary conditions 
of the model are the constant production of VEGF molecules per unit volume in the hydrogel, 
with no diffusional flow or loss through the top of the gel. The diffusional flows in the hydrogel, 
microchannels, and within the tissue were presumed to be governed by the diffusion coefficients 
following Fick’s law of diffusion. The diffusion across the hydrogel-channel, channel-tissue, and 
hydrogel-tissue interfaces were estimated by taking the average values of the diffusion 
coefficients of the two neighboring materials. 
AutoCAD blueprints were shown for three different microchannel diameters (Fig. 8.6A). 
The simulation results clearly show that the concentration of VEGF below the smaller-diameter 
microchannel is much greater than that below the larger-diameter microchannel (Fig. 8.6B and 
8.6C). The concentration of VEGF directly below the stamp is lower than that below the channel, 
regardless of the difference of the microchannel diameter. This is due to the very slow 
diffusional rate in the hydrogel stamp compared to that in the media inside the microchannels. 
The media acts as a route for the VEGF to move along the entire inner surface of the channel, 
with a much higher diffusion rate at the surface of the tissue. In addition, there is an increased 
mass flow rate at the circumference of the microchannels (Fig. 8.6D). 
8.3.4 PATTERNING OF FUNCTIONAL NEOVESSELS USING THE ‘LIVING’ MICROVASCULAR STAMP 
Finally, the hydrogel-based vascular stamps with controlled microchannels were 
implanted onto chick chorioallantoic membrane (CAM) (Fig. 8.7A). Prior to their implantation, 
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all hydrogels with fibroblasts were incubated in media supplemented with the PKC activator for 
24 hours, in order to stimulate cellular expression of angiogenic factors. Implantation of the 
PEGDA hydrogel with cells onto the CAM stimulated inflammation within two days, most likely 
because of the low cell viability and extravasation of the debris from the dead cells. In contrast, 
the PEGDA-MA hydrogel minimally stimulated host inflammation, most likely because of its 
ability to increase the viability of encapsulated cells. Implantation of the PEGDA-MA hydrogel 
containing microchannels of diameter smaller than 800 μm stimulated the growth of neovessels 
with blood flow along its circular pattern (Fig. 8.7B). The spacing between the circular 
neovessels was 500 or 1000 μm which was the same as the spacing of the microchannels 
introduced into the hydrogel. The cells encapsulated in the stamps remained viable at the implant 
sites. In addition, the circularly patterned neovessels were interconnected to each other, which 
suggested that sprouting of new capillaries from the neovessels stimulated formation of 
neighboring patterned neovessels. The reproducibility of patterning neovessels was maintained 
with all of the samples (100%). None of the neovessels replicated the circular pattern of 
microchannels when the diameter of the microchannels was increased to 1,000 μm. Furthermore, 
other blood vessel patterning geometries, such as circles, lines, and text (‘uiuc’), were 
demonstrated using the microvascular stamp (Fig. 8.7C). Compared to the microchannel-free 
control conditions and the hydrogel containing microchannels with diameter of 1000 μm, the 
vascular stamp containing microchannels with diameter of 500 μm resulted in a significant 
increase in the number and size of mature neovessels at the implantation site. Furthermore, 
images of neovessels formed near 300 μm microchannels were straight and directed (Fig. 8.8A), 
while those formed near 1000 μm microchannels were winding and tortuous (Fig. 8.8B). The 
vascular stamp resulted in the 2.5-fold increase of the thickness of CAM, as compared with 
CAM implanted with other controls. The size analysis of the blood vessels exhibited that the 
microchannels with diameter of 500 μm significantly stimulated formation of arterioles with 
vessel area of over 1000 μm2 (i.e., 40% of total blood vessels in CAM). 
8.4 DISCUSSION 
Overall, our results demonstrate that the microvascular stamp created mature and 
functional neovessels with desired patterns in live tissue. Ultimately, the microvascular stamp 
could increase the vascular size and density at an implant site. To our knowledge, such refined 
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patterning of blood vessels through which blood flows has not been reported to date. One 
interesting feature of the vascular stamp is the capability to enable cells to retain their viability 
and growth factor production in a PEGDA-MA hydrogel system. We propose that MA in the 
PEGDA-MA hydrogel is a key factor because hydrophilic MA enhances the transport of oxygen 
and nutrients into the hydrogel.15,16 Therefore, the resulting PEGDA-MA hydrogel would greatly 
overcome the challenges encountered with current hydrogel design, which is often plagued by 
the inverse dependency between stiffness and permeability. This enhanced transport property can 
be further modulated by controlling size distribution of nanometer-sized pores in hydrogels with 
the molecular weights of PEGDA or MA.17 
Another highlight of the vascular stamp was its ability to localize angiogenic factors in a 
pre-defined pattern using microchannels incorporated into the gel. According to the diffusion-
based scaling law and the numerical analysis, the molar flow rate of angiogenic factors into the 
tissue beneath the circumference of the microchannel wall was increased with the use of the 
appropriate microchannel dimension. We propose that the local increase of the mass flow rate of 
angiogenic factors at the edge of the microchannel wall may be a key factor to determine 
whether blood vessels are able to grow in the circular pattern. As a newly formed blood vessel 
actively consumes angiogenic factors, regions that have a high mass flow rate and faster 
replenishment of angiogenic factors would stimulate the continued growth of a mature blood 
vessel.18,19 
In addition, when only VEGF was incorporated in the hydrogel, no patterning of the 
neovessels occurred, which suggests the importance of the constant production of multiple 
growth factors in generating mature and functional blood vessels in the desired patterns. It is also 
possible that VEGF may be denatured during the in situ cross-linking reaction activated by the 
high intensity laser. Therefore, live cells may provide an improved method for patterning the 
neovessels, because of their intrinsic properties of synthesizing and secreting multiple angiogenic 
factors in a sustained manner. We also hypothesize that the sustained delivery of angiogenic 
factors increases the vascular size as well as vascular density, although this aspect needs to be 
confirmed in future studies.20,21 
8.5 CONCLUSION 
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In the end, controlling the “bottom-up” emerging behavior of the neovessel formation via 
“directed top-down” cues using the “living” microvascular stamp can be a major step forward to 
better understanding and engineering the development of neovessels and further improving 
treatment of various injuries, traumas, and diseases. For example, neovessels patterned by a 
microvascular stamp will be discernible from other pre-existing neovessels, so the roles of 
normal or pathologic extracellular microenvironment in development, homeostasis, and 
remodeling of neovessels can be better understood. The microvascular stamp can also be 
implanted in ischemic tissues to engineer mature neovessels with regular spacing and 
subsequently improve recovery of tissue and organ functions. Finally, the design principles 
established to assemble the microvascular stamp will be useful in designing a broad array of 
bioimplants and tissue engineering scaffolds to create “on demand” microvascular networks in 
an organized fashion. 
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8.8 FIGURES AND CAPTIONS 
 
 
Fig. 8.1 | Schematic of the microvascular stamp. The overall concept of the microvascular 
stamp is that it releases multiple angiogenic growth factors that are geometrically localized to 
grow and guide new blood vessels within the same pattern as the stamp. The stamp consists of 
live cells that secrete angiogenic factors, an engineered hydrogel matrix that promotes cellular 
expression of angiogenic factors, and a three-dimensional (3D) geometry that localizes the 
angiogenic factors within the pattern. The stamp is then implanted on a target tissue to create the 
desired blood vessel pattern, allowing precise control over the density and spacing of the blood 
vessels. 
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Fig. 8.2 | Characterization of PEGDA and PEGDA-MA hydrogels. The addition of 
methacrylic alginate (MA) to the PEG-based backbone decoupled elastic modulus from swelling 
ratio. (A) PEGDA hydrogels had a hallmark inverse dependency: as the elastic modulus 
increased with PEG composition, the swelling ratio decreased. PEGDA-MA hydrogels, however, 
had a direct dependency: as the elastic modulus increased with MA composition, the swelling 
ratio also increased. (B) Diffusion of water protons into PEGDA and PEGDA-MA hydrogels 
were visualized with MRI. The pseudo-color represents relative peak intensity of the water 
protons. The incorporation of both MA and microchannels resulted in higher oxygen diffusion, 
while maintaining rigidity. 
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Fig. 8.3 | Viability of cells in PEGDA and PEGDA-MA hydrogels. The relative cell viability 
was quantified by normalizing the absorbance values of samples treated with MTT reagent to 
that measured on day 0. (A) Viability was evaluated with NIH/3T3 fibroblasts encapsulated in 
PEGDA (black), PEGDA-MA (green), and PEGDA-MA + microchannels (blue) hydrogels. (B) 
Viability was evaluated with human mesenchymal stem cells (hMSCs) encapsulated in PEGDA-
MA + microchannels hydrogels and compared to the results with NIH/3T3 fibroblasts. For both 
cell types, the addition of MA and microchannels significantly increases the viability over 7 days 
(*p<0.05). 
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Fig. 8.4 | Secretion of angiogenic growth factors by encapsulated cells. (A) The amount of 
VEGF secreted by hMSCs and NIH/3T3 fibroblasts encapsulated in PEGDA-MA hydrogels 
were evaluated using a VEGF ELISA kit over 5 days (*p<0.05). Fibroblasts were stimulated 
with 12-O-tetradecanoylphorbol-13-acetate (TPA), a protein kinase C activator, to secrete 
growth factors. Despite chemical stimulation of fibroblasts, hMSCs naturally secreted higher 
amounts of VEGF per day. (B) An angiogenesis assay kit was used to evaluate the presence of 
over 55 different angiogenic growth factors to demonstrate the multitude of angiogenic growth 
factors secreted by the cell-based microvascular stamp. 
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Fig. 8.5 | Fabrication of microvascular stamp with stereolithography. (A) Schematic of the 
stereolithography set up for fabrication of the microvascular stamp. (B) Schematic top-view of 
microvascular stamp assembled with various diameters of microchannels. (C and D) The scaling 
law suggests that the average molar flux (J) delivered to the tissue through the bottom of the 
channel, Jchannel, is enhanced, as the microchannel diameter becomes smaller than 800 μm for a 
hydrogel with thickness of 200 μm. 
   
169 
 
 
 
Fig. 8.6 | Numerical analysis of angiogenic growth factor diffusion. (A) AutoCAD blueprints 
for three different microchannel diameters (300 μm, 500 μm, and 1000 μm). (B) Numerical 
analysis of the top view of the mass flow rate of VEGF on a plane 20 μm below the hydrogel 
stamp-CAM interface. Scale bars represent 300 μm. Plots show the numerical values of VEGF 
concentration distributions (C) Numerical analysis of the cross-sectional contours of VEGF 
concentration distributions at Day 7. (D) VEGF concentration distributions and mass flow rates 
across the diameter of the channel at 20 μm below the stamp-tissue interface. e) Pictures of the 
hydrogel stamp with the three different microchannels diameters. 
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Fig. 8.7 | Formation of patterned blood vessels on chick chorioallantoic membranes. (A) 
Schematic illustrating the blood vessel patterning process: (1) egg shell windowing, (2) 
microvascular stamp implantation on CAMs, (3) and fixed membrane imaging. (B) Bright-field 
images of new blood vessels formed under PEGDA-MA hydrogels containing microchannels of 
diameters at 0, 300, 500, and 1,000 μm. (C) Bright-field images of new blood vessels formed 
under PEGDA-MA hydrogels containing circles, lines, and text (‘uiuc’). 
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Fig. 8.8 | Images of new blood vessels formed near microchannels. (A) SEM image of new 
blood vessels formed near 300 μm microchannels are straight and directed. (B) SEM image of 
new blood vessels formed near 1000 μm microchannels are winding and tortuous. 
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CHAPTER 9: CONCLUSION AND FUTURE DIRECTIONS 
9.1 CONCLUSION 
We demonstrated millimeter-scale "bio-bots" that could walk across surfaces in fluid. 
The bio-bots were fabricated using a 3D printer and seeded with a sheet of cardiac cells. The 
contraction (power stroke) and subsequent relaxation of the cell sheet powered the constructs. 
The bio-bots moved as a result of their simple asymmetric shape, with one long, thin leg resting 
on a shorter, wider support leg. The bio-bots walked at an average velocity of ~236 µm·s-1, an 
average displacement per power stroke of ~354 µm, and an average beating frequency of ~1.5 
Hz. 
9.2 FUTURE DIRECTIONS 
This was an important achievement in our quest to ‘forward-engineer’ biological 
machines. We envision that these bio-bots could be integrated with other cell types and clusters 
that have different functionalities. One compartment in the bio-bot could accommodate for a 
‘toggle switch’ made of neural networks that sense a signal, process that signal, and instruct the 
sheet of cardiac cells to contract (Fig. 9.1). Another compartment in the bio-bot could 
accommodate for a cell-based ‘factory’ with specialized cell clusters that release chemicals into 
the environment (Fig. 9.2). Below is a short list of targeted goals in our bio-bot roadmap: 
 
 External control of the bio-bots by integrating them with light-driven ‘optogenetic’ C2C12 
skeletal muscle to move/stop, pace, and steer. 
 External control of the bio-bots by integrating them with C2C12 skeletal muscle and motor 
neurons through neuromuscular junctions by innervation. 
 Autonomous control of the bio-bots by constructing synthetic gene networks in the 
neurons to enable a wide range of new programmed cell applications. 
 
The long term goal is to develop millimeter-scale biological machines constructed with 
intelligent polymers (i.e. hydrogels) and living cells that can achieve net motion towards a 
chemical toxin and subsequently release chemicals to neutralize the toxins. 
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9.3 FIGURES AND CAPTIONS 
 
 
Fig. 9.1 | Schematic of a neural ‘toggle switch’. Example of one compartment in the bio-bot 
that could be used for a ‘toggle switch’ made of neural networks to sense a signal, process that 
signal, and instruct the sheet of cardiac cells to contract. 
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Fig. 9.2 | Schematic of a cell-based ‘factory’. Example of another compartment in the bio-bot 
that could be used for a ‘cell-based factory’ with specialized cell clusters to release chemicals 
into the environment. 
